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Summary 
To map and understand changes in production pattern of a pharmaceutical protein in 
Saccharomyces cerevisiae during prolonged growth at limited and unlimited conditions 
was the main focus of my Ph.D. project. The protein under investigation was aprotinin. 
S. cerevisiae is a well-known microorganism, which has been used for baking and 
brewing for centuries. Thus many aspects of the metabolism of S. cerevisiae are well 
characterised, but production of a heterologous protein during prolonged cultivation, 
i.e. during chemostats up to 150 generations, which was the topic of my investigations, 
has not earlier been studied in detail. 
A decrease of heterologous protein production has been observed during prolonged 
glucose limited cultivations, and my study was focused on a characterisation of 
changes causing this decline in productivity as well as the general changes in 
metabolism. A decline in productivity has earlier been observed with an industrial 
strain, so a laboratory strain was included in my study to determine if the changes 
were strain specific or more global. The productivity and metabolism of S. cerevisiae 
was studied using different cultivation methods, both batch and chemostat cultivations 
were applied. Generally batch cultivations are characterised by variations in the 
composition of the medium whereas chemostat cultivations are characterised by a 
constant environment. Sequential shake flasks (batch cultivations) made it possible to 
grow the microorganism for a large number of generations at the maximal specific 
growth rate, as the strains were transferred to fresh medium before any limitation 
occurred. The heterologous protein production decreased over time in both strains in 
both batch and chemostat cultivations. 
Adaptations, which are the process of becoming better suited to the environment and 
thus gain an advantage, are believed to be caused by random events. It was therefore 
surprising to discover that the time profile of the aprotinin concentration in the 
cultivation broth in cultivations with the industrial strain were identical in all 
cultivations with this strain, in all the cultivations the concentration of aprotinin in the 
cultivation broth increased during the first 20 generations after connection of the feed. 
After 20 generations the concentration started to decline in all the cultivations with the 
industrial strain. At approximately 100 generations the concentration stabilized at 45% 
of the maximal value. Constant selection pressure under glucose limited conditions 
also led to a decline in protein production in cultivations with the laboratory strain, but 
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the time profile was dissimilar in the different cultivations. A general picture of an 
initial increase could also be seen in the cultivations with the laboratory strain, but the 
number of generations at which the maximal aprotinin concentration was reached 
varied between the different cultivations. 
The DNA encoding the heterologous protein was introduced into the strains on a 
plasmid; and I investigated if loss of the plasmid caused the decline in heterologous 
protein production. My investigations showed that loss of plasmid was not the cause 
of decreasing protein production. Measurements of the plasmid copy number, level of 
mRNA corresponding to aprotinin and aprotinin in the cultivation broth after 0, 250 
and 500 generations at unlimited conditions (batch cultivations) revealed that the ratios 
between these variables changed. It was found that changes in protein production were 
not related to the level of mRNA, and fluctuations in the level of mRNA were not 
related to the copy number, which point towards complex regulation on several levels. 
The measurement of protein concentration was combined with transcriptome analysis 
to investigate changes in the gene expression during prolonged chemostat cultivations 
at glucose limited conditions; these findings were used to propose some hypotheses on 
the metabolic consequences, primarily in relation to heterologous protein production. 
The analyses were data-driven and resulted in the hypotheses stated below to explain 
the decline in protein production during prolonged chemostat cultivations: 
− A general decrease of transcription of genes under glycolytic promoters. This 
has been reported by others and as aprotinin was expressed from a glycolytic 
promoter this could be part of the cause of declining protein production. 
− Aprotinin has an inhibitory effect on serine proteases which affect metabolism. 
The cell can restore normal activity of serine proteases by reducing the amount 
of aprotinin produced. 
− The transcriptome analysis highlighted up-regulation of amino acid 
metabolism, which suggested recirculation of amino acids to occur. This can be 
due to insufficient folding of the heterologous protein. 
In conclusion, a large number of different metabolic responses were observed during 
prolonged chemostat cultivations, some changes were related to the growth conditions 
whereas others were related to the production of a heterologous protein. A 
combination of the above mentioned hypotheses are believed to be the cause of the 
observed decline in protein production. 
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Resumé 
Heterolog proteinproduktion har været fokusområdet for mit ph.d. projekt, en særlig 
slags heterolog proteinproduktion, nemlig produktion af et farmaceutisk protein i 
Saccharomyces cerevisiae er blevet undersøgt. S. cerevisiae er en velkarakteriseret 
mikroorganisme, som ud over anvendelse indenfor heterolog proteinproduktion har 
en lang historie indenfor brygning og bagning. Der er derfor megen information 
tilgængelig omkring S. cerevisiae, alligevel er der flere emner omkring heterolog 
proteinproduktion som ikke er fuldt belyst. Heriblandt heterolog proteinproduktion i 
lange kontinuerte kultiveringer (op til 150 generationer), hvilket jeg har studeret. I mit 
projekt er aprotinin blevet anvendt som modelprotein, dette er et protein, som er svært 
at producere for S. cerevisiae pga. et højt isoelektrisk punkt (10,5) og aprotinins funktion 
som en proteaseinhibitor. 
Det er tidligere blevet vist, at produktiviteten af det heterologe protein falder under en 
lang kontinuert glukosebegrænset kemostat. Hvorfor hovedtemaerne for mit projekt 
har været, at undersøge dette fald i produktiviteten samt en generel karakterisering af 
de ændringer der sker som følge af lang tids kultivering under konstante forhold. 
Batch og kontinuerte kultiveringer har jeg benyttet til at belyse disse problemstillinger. 
I mit projekt observeredes et fald i produktiviteten af aprotinin som funktion af tid ved 
begge kultiveringsmetoder. For mit projekt er de væsentligste forskelle på de to 
kultiveringsmetoder, at batchkultiveringer i begyndelsen er ubegrænsede og gæren 
derfor vokser ved den maksimale specifikke væksthastighed. I modsætning hertil er 
kontinuerte kultiveringer begrænsede, og væksthastigheden bestemmes ud fra den 
hastighed, hvormed det begrænsende substrat tilføres. To forskellige 
stammebaggrunde (en industriel- og laboratorie-stamme) er blevet undersøgt for at 
bestemme, om de fundne ændringer var stamme specifikke eller af en mere general 
karakter.  
Forløbet af lange kontinuerte kultiveringer adskilte sig mellem de to stammer, for den 
industrielle stamme observeredes identiske tidsforløb af aprotinin koncentrationen, 
hvorimod der var forskelle i tidsforløbet for laboratorie stammen. I begge stammer 
blev der observeret en initial forøgelse af proteinproduktionen. I kultiveringer med 
den industrielle stamme blev en maksimal proteinkoncentration i kultiveringsvæsken 
bestemt ved 20 generationer efter tilslutningen af føden. Ved omkring 100 generationer 
var proteinkoncentrationen faldet til 45% af den maksimale værdi i kultiveringerne 
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med den industrielle stamme. I kultiveringerne med laboratorie stammen var det 
forskelligt hvornår den maksimale aprotinin koncentration blev nået. 
Det heterologe gen er indsat i gæren på et plasmid, og det var derfor nærliggende at 
undersøge kopitallet af dette plasmid for at vurdere om plasmidtab kunne være 
årsagen til faldet i produktivitet. På baggrund af undersøgelserne kan det sluttes, at et 
fald i kopitallet ikke er årsag til faldet i produktivitet. Sammenligning af kopitallet, 
niveauet af mRNA og proteinkoncentration viste, at forholdet mellem de forskellige 
komponenter til proteinproduktionen ændredes under kultiveringsforlöber. 
Ændringer i proteinproduktion kan således ikke relateres til ændringer i mRNA 
niveau og ændringer i mRNA niveau kan ikke relateres til kopitalsændringer, hvilket 
tyder på en kompleks regulering af de forskellige delprocesser, som ændres som 
funktion af tiden. 
Transkriptomanalyse blev anvendt til at belyse ændringer i genudtykkelsen som følge 
af lang tids vækst under glukosebergænsende betingelser, der blev specielt fokuseret 
på ændringer, som kunne relateres til produktionen af det heterologe protein. 
Kombinationen af resultaterne fra transkriptomanalysen med aprotininbestemmelser 
medførte opstillingen af følgende hypoteser for de metabolske årsager til faldet i 
proteinproduktionen: 
− En general nedjustering af transkriptionen fra glykolytiske promotorer. Aprotinin er 
indsat under triose phosphat isomerase promoteren og en general nedjustering af 
glykolytiske promotorer er blevet rapporteret tidligere. 
− Inhibitorhaktivitet af aprotinin. Aprotinin er en kendt serinproteaseinhibitor og 
denne aktivitet vil have indflydelse på cellens metabolisme. For at genoprette 
normal aktivitet af serinproteaser kan cellen forsøge at nedjustere mængden af 
aprotinin som produceres. 
− Recirkulering af aminosyrer. Analysen af transkriptomdata påpegede, at der i løbet 
af de lange kemostatkultiveringer skete en opregulering af metabolismen af 
aminosyrer. Dette kan skyldes utilstrækkelige mængder af proteiner, som 
assisterer i foldning og processering af proteiner, hvilket kan medføre 
akkumulering af ufoldede proteiner. 
Konklusionen på projektet er, at der sker utrolig mange ændringer af metabolismen i 
løbet af lange kultiveringer, nogle af disse ændringer er knyttet til produktionen af det 
heterologe protein mens andre skyldes en tilpasning af metabolismen til de betingelser 
hvorunder cellerne blev dyrket. Projektet har desuden identificeret mulige årsager til 
ændringerne i produktiviteten af det heterologe protein.  
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Chapter 1 
Introduction 
The production of heterologous proteins in microorganisms using recombinant DNA 
technology has opened the door to a new world of biotechnological products. Proteins 
are complex molecules and therefore synthesis by cell free systems is difficult. 
Heterologous proteins cover both pharmaceutical products and industrial enzymes. 
The two classes of proteins differ in the amount needed, the value of the final product, 
the regulatory restrictions applied and the quality control needed during the 
production process. These differences have an effect on the requirements on the 
production process and its development. Today, recombinant DNA technology has in 
many cases made it possible to produce large quantities of the product at a relatively 
low price and perhaps most importantly at a constant high quality. 
The first product of recombinant DNA technology to gain regulatory approval was 
insulin in 1982, the product was humulin a recombinant insulin produced by Eli Lilly 
(Walsh, 2005) and since then several proteins have been approved. Earlier some of the 
proteins currently produced in microorganisms were extracted from tissue, e.g. since 
the 1920’s insulin was extracted from slaughterhouse animals. This production method 
has some drawbacks: it will be impossible to extract enough insulin to meet the 
demands for insulin today (Kjeldsen, 2000) and most importantly the sequence of both 
bovine and porcine insulin is different from the human sequence and thus potentially 
immunogenic. Currently 160 biopharmaceutical products (recombinant therapeutic 
proteins, monoclonal antibodies and nucleic acid-based drugs) have been approved 
(Walsh, 2005). Some proteins produced by recombinant technology can also be 
produced in other ways e.g. insulin, as mentioned above, whereas others are not 
naturally occurring. Recently the type of products being approved has shifted towards 
protein engineered products and thus away from the naturally occurring proteins. An 
example of protein engineering is the work done on insulin to obtain short- and long-
acting insulin, respectively; the protein engineering is driven by a wish to mimic the 
natural regulation of the blood sugar by insulin. Long-acting insulin is achieved by 
changing the isoelectric point of the insulin molecule, thereby delaying solubilization 
and release into the blood stream (Walsh, 2003b). 
Protein production in industry is generally based on fedbatch cultivations due to the 
risk of genetic instability and contamination of continuous cultures. However, insulin 
is produced by Novo Nordisk in continuous cultivation (Diers et al., 1991). Continuous 
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cultivation is less labor intensive than batch and fedbatch cultivations as the labor 
intensive parts are upstart and cleaning of the equipment. 
In my Ph.D. study, I have focused on Saccharomyces cerevisiae as production host for a 
pharmaceutical protein by the use of a model protein (Chapter 2 contains a comparison 
of different hosts available for heterologous protein production). Hence, in the 
following text focus will be on pharma product related issues (In Chapter 3, the main 
focus is heterologous protein production in S. cerevisiae). My Ph.D. study has several 
goals, but the overall theme of the project was heterologous protein production in 
Saccharomyces cerevisiae, a model protein, aprotinin, was used during the investigations. 
The goals were i) to investigate the causes of an earlier observed decline in the 
production of the heterologous protein during prolonged chemostat cultivation at 
glucose limited conditions and ii) to describe changes in cells during prolonged 
cultivations. To achieve these goals, strains developed during prolonged growth were 
evaluated with respect to heterologous protein production. Two different routes were 
pursued to find the possible causes of the observed decline in protein production: 
− A comparison of aprotinin producing strains evolved during prolonged growth 
at un-limited conditions and heterologous protein production after prolonged 
cultivation (Paper A & Paper B).  
− A comprehensive investigation of the underlying genetic changes in a 
population of S. cerevisiae producing aprotinin continuously cultivated under 
glucose-limited aerobic conditions (Paper C). 
The two different ways of reaching a high number of generations put different 
selection pressure on the cells: In the continuous cultivations a selection of cells with 
higher affinity for glucose occur (Adams et al., 1985) while a selection of cells with 
higher maximal specific growth rate occurs in the un-limited conditions (Different 
cultivation methods will be discussed in section 4.1). Independent of the cultivation 
method applied, the production of the heterologous protein will be a burden to the 
yeast cell and a decrease in the burden will be beneficial to the cell. The nature of the 
burden will be discussed in detail in section 5.1, but presently the burden is defined as 
all negative influence on the host metabolism by the heterologous protein, this includes 
presence of heterologous DNA, protein production and toxicity of the heterologous 
protein. Different ways for the cell to decrease the burden can be envisaged: loss of 
expression cassette, decreased transcription, translation or secretion and degradation 
of the final product or intermediates in the production of a secreted protein.  
In my Ph.D. study, changes caused by repeated cell cycles were evaluated and 
evolutionary engineering was used as a tool with understanding of the changes in the 
strains as a goal (Adaptation to chemostat cultivations is the topic of section 5.3). 
During my investigations, two different genetic backgrounds were used: one diploid 
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industrial and one haploid laboratory. The decrease in protein concentration has earlier 
been observed in cultivations with the industrial strain. The laboratory strain was 
included to investigate whether or not the changes during prolonged continuous 
cultivations were strain specific. 
The main scientific results of the study are an increased understanding of the 
underlying mechanisms controlling the stability of heterologous protein production by 
S. cerevisiae during prolonged glucose-limited continuous cultivation under respiratory 
metabolism. 
1.1 References 
Adams, J., Paquin, C., Oeller, P.W., and Lee, L.W. (1985) Physiological characterization 
of adaptive clones in evolving populations of the yeast Saccharomyces cerevisiae. Genetics 
110, 173-185. 
Diers, I.V., Rasmussen, E., Larsen, P.H., and Kjaersig, I.L. (1991) Yeast fermentation 
processes for insulin production. Bioprocess. Technol. 13, 166-176. 
Kjeldsen, T. (2000) Yeast secretory expression of insulin precoursors. Appl. Microbiol. 
Biotechnol. 54, 277-286. 
Walsh, G. (2003) Pharmaceutical biotechnology products approved within the 
European Union. Eur. J. Pharm. Biopharm. 55, 3-10. 
Walsh, G. (2005) Biopharmaceuticals: recent approvals and likely directions. Trends 
Biotechnol. 23, 553-558. 
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Chapter 2 
Production hosts  
Choosing the optimal microorganism for production is seldom straight forward, as 
many factors influence the fitness of the different microorganisms. Generally will the 
microorganism with the simplest growth requirements, which is capable of fast growth 
and which can produce the desired product, always be chosen. However, other issues 
such as patenting of the application of different hosts and in house experience with 
hosts can have a large influence on the choice. In the following paragraphs a short 
introduction to the different microorganisms applied for heterologous protein 
production is mentioned, including advantages and disadvantages for the application 
of the hosts (Table 2.1). Today both prokaryotic and eukaryotic microorganisms are 
used in the production of recombinant pharmaceutical proteins. When recombinant 
production started 25 years ago Escherichia coli and Saccharomyces cerevisiae were (and 
probably still are) the most studied strains at a genetical and physiological level. 
Therefore, these organisms have for a prolonged period of time been the preferred 
organisms an the knowledge has increased further. Currently, other microorganisms 
are applied as limitations in the metabolism of E. coli and S. cerevisiae have been 
discovered and the exploitation of other microorganisms has made it possible to 
genetically modify these organisms as well. At the moment, the workhorses of 
biopharmaceutical production are E. coli and mammalian cell lines. In the period from 
2003 to mid 2006, 9 of 31 approved products were produced in E. coli and 17 of 31 
approved products were produced in mammalian cell lines (Walsh, 2006). 
Production hosts 
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2.1 Bacterial  
The most applied prokaryotic host is E. coli. It is well characterized on both a genetic 
and physiological level. It has a high specific growth rate and is easy to handle. E. coli 
is not able to secrete large amounts of proteins due to limited chaperone and foldase 
levels, leading to intracellular accumulation of the protein either as soluble proteins or 
in inclusion bodies. Therefore the cells need to be erupted and the protein must in 
some cases also be refolded as a part of the downstream processing. Eruption of the 
cells leads to release of endotoxins which can limit the biological applications as they 
Table 2.1 Advantages and disadvantages of different hosts for production of heterologous 
proteins 
Host Advantages Disadvantages 
Cell growtha 
(doubling 
time) 
Bacteria  Wide choice of cloning vectors 
Gene expression easy to control 
High yields possible  
Inexpensive production 
Large scale production 
established 
Post-translational 
modifications lacking 
High endotoxin content 
Protein aggregation 
(inclusion bodies) 
Rapid 
(30 min) 
Yeast  
 
Generally regarded as safe 
(GRAS) 
No pathogens for humans 
Large scale production 
established 
Some post-translational 
modifications possible 
Secretion possible  
Glycosylation not identical 
to mammalian glycosylation  
Low production levels 
Rapid 
(90 min) 
Filamentous 
fungi 
Experience with large scale 
production 
Source of many industrial 
enzymes, but not therapeutic 
proteins 
Excellent protein secretion 
Glycosylation not identical 
to mammalian glycosylation  
Genetics not well 
characterized 
Medium 
(120 min) 
Mammalian cells  Extensively used for proteins 
which require correct 
mammalian glycosylation or 
posttranslational modifications 
Expensive production 
Low productivity 
Slow 
(24 h) 
Insect cells Post-translational modifications 
possible 
Not always 100% active 
proteins 
Mechanisms largely 
unknown 
Slow 
(18-24 h) 
a Yin et al., 2007 
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have a strong biological effect, even when low concentrations enter the human blood 
stream. Endotoxins are very stable molecules and thus additional downstream 
processing steps are required for their removal (Petsch and Anspach, 2000). The 
heterologous protein can also be directed to the periplasmic space, which removes the 
eruption step in the downstream processing. In order to direct a protein to the 
periplasmic space fusion of a leader peptide to the N-terminus is necessary. However, 
problems associated with incomplete translocation across the inner membrane, 
proteolytic degradation and insufficient capacity of the export machinery have also 
been reported (Terpe, 2006). Problems related to differences in codon usage in E. coli 
and the heterologous protein has been reported (Terpe, 2006). The pool of tRNA 
reflects the codon bias in the homologous mRNA, and expression of a heterologous 
protein with different codon bias could thus lead to limitations in one or more tRNA’s. 
However, E. coli strains have been engineered to supply additional tRNA’s to 
circumvent this limitation (Terpe, 2006). However, normally the gene encoding the 
heterologous protein is codon optimized to avoid problems with the availability of 
tRNA’s. Another shortage of E. coli is that it is not able to modify the protein 
posttranslational. Posttranslational modifications are highly important for the 
biological activity of some proteins and this is consequently a severe limitation in the 
application of E. coli in the production of various pharmaceutical proteins. 
A prokaryotic alternative to E. coli is Bacillus subtilis, B. subtilis is capable to secrete 
proteins into the medium, thus simplifying down stream processing. Another 
advantage of the application of B. subtilis in heterologous protein production lie in the 
fact that B. subtilis, in contrast to E. coli, has GRAS status. However, problems with 
degradation of the produced protein by proteases and instability of plasmids has been 
reported during heterologous protein production in B. subtilis (Yin et al., 2007). 
2.2 Yeast  
Many different eukaryotic strains are used in the production of proteins, earlier 
primarily S. cerevisiae was applied, but now other organisms are also used in industrial 
production. However, due to the long application of S. cerevisiae there are some 
advantages associated with the use of this microorganism in a new process: much 
knowledge of the organism has accumulated, and the approval process is considered 
to be easier/cheaper than when applying a new unknown organism. S. cerevisiae has 
been used in baking and alcoholic brewing for centuries, and has obtained GRAS 
(Generally Regarded As Safe) status by the FDA. The first genetically engineered 
vaccine licensed by the FDA for administration to humans was hepatitis B surface 
antigen produced in S. cerevisiae (Valenzuela et al., 1982). 
Production hosts 
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Furthermore, S. cerevisiae is capable of growth in a cheap medium and it can perform 
some posttranslational modifications. For instance, yeast is capable of disulfide bond 
formation and glycosylation of proteins; the oligosaccharides can be either N-linked to 
asparagine or O-linked to serine or threonine residues. Unfortunately, the 
glycosylation pattern in S. cerevisiae is different from the glycosylation found in 
humans. Especially, the O-linked oligosaccharides produced by S. cerevisiae are 
different from the human whereas the N-linked type of glycosylation is more equal 
(Romanos et al., 1992). The yeast glycosylation is characterized by a high number of 
mannan-residues, up to 100. This hyperglycosylation can change the biological activity 
of the proteins and in worst case result in immunological responses. To maintain some 
of the advantages of yeast as a production host, it has been investigated if it is possible 
to alter the glycosylation pattern. This humanizing has been performed in several 
ways, in vitro processing by mammalian glycosyltransferases and genetically 
engineering of the glycosylation pathway in yeast, the later method with the highest 
success (Gerngross, 2004). Posttranslational modifications in S. cerevisiae will be 
discussed in more detail in section 3.3. 
Since the mid 1980s there has been a search for alternatives to S. cerevisiae to avoid 
some of the disadvantages observed in heterologous protein production, e.g. lack of 
strong promoters and hyperglycosylation (Romanos et al., 1992). An advantage by 
applying methylotropic (can utilize reduced one carbon compounds as carbon source) 
or lactose utilizing yeasts is the presence of strong and tightly regulated promoters. 
The potential of other yeast species for recombinant protein production is currently 
being investigated; the yeast species are listed in Table 2.2. Kluyveromyces lactis and 
Yarrowia lipolytica are fully sequenced. K lactis has GRAS status due to its long time use 
in the food industry, where it has been used for production of β-galactosidase 
(Romanos et al., 1992). Pichia pastoris was first employed by Phillips Petroleum for 
single-cell protein (feed protein) production. P. pastoris is now considered superior to 
any other known yeast species in terms of secretion efficiency (Schmidt, 2004). 
 
Table 2.2 Yeast speices investigated for recombinant protein production (Porro et al., 2005)  
Nonmethylotrophic Methylotrophic 
Saccharomyces  cerevisiae Hansenula polymorpha 
Kluyveromyces lactis Pichia pastoris 
Yarrowia lipolytica Pichia methanolica 
Zygosaccharomyces rouxii Candida boidinii 
Zygosaccharomyces bailii Schwanniomyces (Debaryomyces) occidantalis 
Pichia stipitis  
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2.3 Filamentous fungi  
Filamentous fungi have shown some interesting high levels of secreted proteins and 
also more complex posttranslational modifications than S. cerevisiae. Aspergillus niger, 
Aspergillus oryzae and Trichoderma reesei are used as production hosts for industrial 
enzymes and are along with Aspergillus nidulans the most well-characterized with 
regard to heterologous protein production (Nevalainen et al., 2005). Aspergillus oryzae 
and Aspergillus niger have been used in food production for a long time, and the safety 
of these strains are generally acknowledged (Yin et al., 2007). Even though fungi are 
applied in heterologous protein production only a narrow selection of promoters are 
available. The use of one strong promoter in heterologous protein production can lead 
to saturation e.g. due to insufficient supply of factors required for promoter regulation. 
The number of copies of a promoter resulting in saturation is strain dependent 
(Nevalainen et al., 2005). High levels of secretion have been possible when producing 
proteins of fungal origin, but only low levels have been reported for protein of other 
origins. The low yields are probably caused by restrictions in posttranslational steps 
e.g. intracellular trafficking, folding and processing (Schmidt, 2004). 
2.4 Mammalian  
In order to obtain glycosylation patterns more similar to the pattern found in human 
cells, insect or mammalian cell cultures can be applied. Foreign genes are most often 
incorporated into the insect’s genome by infection with a baculovirus. However, the 
system has several disadvantages, one of them is that the infection eventually results in 
death of the host cell and the process can thus not be run continuously. Another is 
differences in glycosylation patterns between insect and mammalian cells (Yin et al., 
2007). Glycosylation of proteins in mammalian hosts have been shown to be 
heterogenous, and as the activity varies in the different glycoforms the relative 
distribution has to be kept constant and this can be a challenge (Gerngross, 2004). The 
mammalian cells are, complicated to grow; they require costly medium and the yields 
obtained are low and in addition they grow with specific growth rates that are a 
magnitude lower than in bacteria, yeast and filamentous fungi. Mammalian systems 
used in the pharmaceutical production are primarily Chinese Hamster Ovary (CHO) 
and Baby Hamster Kidney (BHK) cells.  
The primary factor determining which expression system to use for the production of a 
given product is the nature of the product itself. Roughly the proteins can be divided 
into proteins which require post-translational modification and proteins which do not 
require modification to be biological active. Non-glycosylated proteins are produced in 
either E. coli or S. cerevisiae, whereas glycosylated proteins need to be produced in 
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mammalian hosts. A list of pharmaceutical products approved in the period 2003 to 
2006 is shown in Table 2.3, which also gives information on the production host.  
 
Table 2.3 Pharmaceutical products approved 2003 to 2006a (Walsh, 2006) 
Product Company Therapeutic indication 
E. coli   
Exubera (rh insulin) Pfizer / Aventis Diabetes mellitus 
Apidra (insulin glulisine, rapid-
acting insulin analog) 
Aventis  Diabetes mellitus 
Omnitrop (somatropin, rh GH) Sandoz  Certain forms of growth 
disturbance in children and adults 
Fortical (r salmon calcitonin) Upsher-Smith 
Laboratories/ 
Unigene  
Postmenopausal osteoporosis 
Increlex (mecasermin, rh IGF-1) Tercica / Baxter Growth failure in children with 
severe primary IGF-1 deficiency 
or GH gene deletion (prolonged 
treatment) 
IPlex (mecasermin rinfabate, a 
complex of rh IGF-1 and rh IGFBP-3 
produced separately) 
Insmed  Growth failure in children with 
severe primary IGF-1 deficiency 
or GH gene deletion (prolonged 
treatment) 
Kepivance (palifermin, a 
recombinant keratinocyte growth 
factor) 
Amgen Severe oral mucositis in selected 
patients with hematologic 
malignancies 
S. cerevisiae   
Levemir (insulin detemir, long-acting 
rh insulin analog) 
Novo Nordisk Diabetes mellitus  
Valtropin (somatropin, rh GH) Biopartners Certain forms of growth 
disturbance in children and adults 
Gardasil (quadrivalent human 
papillomavirus (HPV) recombinant 
vaccine; contains major caspid 
proteins from four HPV types) 
Merck Therapeutic indication: 
Vaccination against diseases 
caused by HPV 
The table continues on the next page 
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Currently non-glycosylated proteins constitute 40% of the therapeutic protein market, 
the remaining 60% is glycosylated proteins (Gerngross, 2004). Generally the “simplest” 
production host, which is capable of producing the desired product, is the preferred 
production system. However, other factors such as downstream processing, patenting 
and the existing knowledge level of a host can also have a large impact on the choice of 
host organism. In house experience with an organism has significant influence on the 
choice of organism for a new process. In some instances production is possible in 
several hosts, e.g. production of insulin is currently performed in S. cerevisiae (Novo 
Nordisk) and E. coli (Eli Lilly, Aventis and Hoechst AG). In the rest of this thesis special 
focus is put on heterologous protein production in yeast and in particular S. cerevisiae. 
Table 2.3 continued from the previous page 
CHO   
Advate (octocog-α rh Factor VIII 
produced in CHO cell line grown in 
serum-free medium free from animal 
products) 
Baxter  Hemophilia A 
Luveris (lutropin α; rh luteinizing 
hormone) 
Ares-Serono  Some forms of infertility 
Zevalin (ibritumomab tiuxetan; 
murine mAb targeted against the 
CD20 antigen) 
Biogen/IDEC , 
Schering AG  
Non-Hodgkins lymphoma 
Raptiva (efalizumab; humanized mAb 
that binds to LFA-1, which is 
expressed on all leukocytes) 
Genentech Serono  Chronic moderate to severe plaque 
psoriasis in adults 
Avastin (bevacizumab; humanized 
mAb raised against vascular 
endothelial growth factor) 
Genentech Roche  Carcinoma of the colon or rectum 
Infuse bone graft (contains dibotermin 
α, a rh BMP-2) 
Wyeth Treatment of acute open tibial 
shaft fracture 
Myozyme (algulcosidase α, rh acid 
glucosidase) 
Genzyme Pompe disease 
Aldurazyme (laronidase; rh α-L-
iduronidase) 
Genzyme, BioMarin 
Pharmacuetials  
Prolonged enzyme replacement 
therapy in patients with 
mucopolysaccharidosis I 
Naglazyme (galsulfase, rh N-
acetylgalactosamine 4 sulfatase) 
BioMarin 
Pharmaceuticals 
Prolonged enzyme replacement 
therapy in patients with 
mucopolysaccharidosis VI 
Hylenex (rh hyaluronidase) Baxter/Halozyme 
Therapeutics 
Adjuvant to increase absorption 
and dispersion of other drugs 
a 20 products of 28 approved products are listed in the table, the approval of 2 of the 28 
products were suspended and for the remaining 6, it has not been possible to determine 
the production host. 
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Chapter 3 
Protein production in S. cerevisiae 
Protein production is a complex process, which is regulated at many different levels 
(Figure 3.1). DNA serves as the template for the production of protein. The method 
used to introduce DNA into the host influences the copy number which is of large 
importance to the protein production process. The rate of transcription is determined 
by several factors, including the promoter strength and a choice of constitutive or 
regulated promoter has to be made. The mRNA is translated into an amino acid 
sequence. Folding and perhaps post-translational modifications are performed before 
the protein can be secreted. The yeast cell also contains mechanisms to deal with 
incorrectly folded proteins, these proteins are degraded and the building blocks are 
recycled in the cell. Considerations of the influence of the different parts of 
heterologous protein production on the efficiency of the production are the topic of this 
chapter. Figure 3.1 gives an overview of the different steps in protein production and 
shows that the different parts are connected. This means that choices made in one part 
of heterologous protein production will have an effect on the whole process. Some 
choices may actually also have influences on the subsequent downstream processing. 
 
DNA mRNA protein
Extracellular
protein
Protein 
degradation
Transcription Translation Secretion of correctly folded protein
Incorrectly
folded
proteinCopy number
Promoter
Stability
Codon usage Posttranscriptional
modifications
 
Figure 3.1 Schematic drawing of the most important steps from DNA to secreted protein in S. 
cerevisiae. 
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3.1 Gene to protein 
Generally the stability of the production strain and the relation between gene dosage 
and product formation are major concerns determining the method for introduction of 
foreign DNA. The introduction can be obtained in several ways: e.g. chromosomal 
integration or on a plasmid. Chromosomal integration is generally more stable than 
introduction of the foreign gene on a plasmid, but in some instances a much lower 
copy number and thus gene dosage is achieved (Romanos et al., 1992). By the use of a 
YIp the integration can be directed to a specific chromosomal locus by including 
homology regions, even though this method generates duplications, which in theory 
could result in pop out, the integration has been shown to be very stable. If the cloned 
gene is targeted to the ribosomal DNA cluster multiple integrations can be obtained 
(Porro et al., 2005) and copy numbers between 100 and 200 have been reported (Lopes 
et al., 1989).  
Plasmids include ARS vectors (autonomous replication sequence) and 2µ plasmids 
(Table 3.1). The former is rarely used, unless in combination with a centromeric 
sequence (CEN), which increases stability, but lowers the copy number to 1 or 2 copies 
per cell. The ARS/CEN setup is thus only used when low-level expression is wanted. 
Native 2µ plasmids are present in S. cerevisiae at about 100 copies per haploid genome. 
No known phenotype is associated with the plasmid, but it is highly stable as only 1 
plasmid free cell is generated in 104 cells per generation (Futcher and Cox, 1983). 
Vectors based on the 2µ plasmid are less stable than the native plasmid, but still more 
stable than the ARS based vectors. The stability of the vector depends on how large a 
portion of the native 2µ plasmid is maintained in the vector and on the selection 
system applied to maintain the plasmid in the cell (different selection systems are 
discussed below). 
 
Table 3.1 Yeast plasmids (Romanos et al., 1992) 
Type Copy number Description 
ARSa  1-20 Highly unstable, in each generation 20% 
plasmid free cells are generated 
ARS/CENb  1-2 More stable than ARS-plasmids 
2µ  Most commonly used. Stability depend on 
how large a part of the native 2µ plasmid is 
included 
Regulated copy number ARS-type 1-2,  
up-regulated to 5-10 
2µ-type 1-2,  
up-regulated to 100 
Useful for production of proteins which are 
toxic to S. cerevisiae 
a autonomous replication sequence 
b centriomeric sequence 
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In connection to the introduction of a heterologous gene on a plasmid, maintenance of 
the plasmid in the host is a major concern. Two different types of instability exist in 
relation to plasmids: structural and segregational. Structural instability is caused by 
deletion, insertion or recombination at the level of DNA whereas segregational 
instability is caused by uneven partitioning of plasmids during cell division. Table 3.2 
lists examples of different methods to avoid segregational instability. 
 
The stability and copy number of the plasmid of four different selective markers were 
compared using 2µ-based plasmids containing the HIS3, LEU2, TRP1 and URA3 gene 
(Ugolini et al., 2002). A S. cerevisiae strain carrying deletions in the HIS3, LEU2, TRP1 
and URA3 genes was transformed with different plasmids coding one of the four 
deleted genes and the stability of the strains was followed for 50 generations. The 
stability of the plasmid containing the LEU2 gene (51% plasmid containing cells) was 
lower than the other plasmids. The plasmid containing the URA3 gene showed the 
highest stability (67% plasmid containing cells). The copy numbers of all the plasmids 
were between 5 and 30 per haploid genome, thus relatively low.  
It is believed that complementing the auxotrophy by introducing a plasmid results in a 
strain equal to the prototrophic counterpart; however, this is not always the case. 
Complementation of deletions in the leucine metabolism has been studied (Cakar et al., 
Table 3.2 Examples of methods to reduce segregational instability 
Selection 
method 
Selection principle Examples Advantages/ 
disadvantages 
Antibiotics 
resistance 
Cells containing plasmid which 
confers resistance to an 
antibiotic are able to grow in 
medium containing antibiotic 
whereas cells which does not 
contain the plasmid cannot 
grow 
G418 (geneticin), 
methotrexate and 
chloramphenicol 
Not suited for 
large scale 
production due to 
environmental 
conserns 
Auxotrophic 
selection 
Genes necessary for formation 
of a component essential for 
growth is deleted and the 
plasmid contains genes which 
make it possible to produce the 
missing component  
Deletion of LEU2, 
TRP1, URA3 or HIS3 
Defined growth 
medium is 
required 
Risk of cross-
feedinga 
Autoselection A gene encoding an essential 
enzyme activity is deleted and 
the activity is restored by a 
gene encoded on the plasmid 
Deletion of TPI1 and 
restoring the activity of 
the enzyme by 
including the gene 
encoding the enzyme 
from 
Schizosaccharomyces 
pombe. 
Does not require 
defined growth 
medium 
No risk of cross-
feeding 
a Auxotrophic cells feeding on the essential component produced by other cells in the 
population. 
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1999). The results showed that complementation of the deletion by expression of 
leucine marker from a plasmid resulted in strain specific differences. Depending on the 
host strain, the final cell densities were similar to those obtained with highest leucine 
supplementation of auxotrophs or much lower values. Based on the strain dependent 
results the authors recommended to avoide the use auxotrophic hosts in metabolic 
engineering studies to avoid artifacts (Cakar et al., 1999). Another problem associated 
with genetic complementation of a deletion is cross-feeding, which is due to leaking of 
the limiting compound from plasmid containing cells to the surrounding medium 
where it can be consumed by plasmid-free cells. Cross-feeding in the population 
therefore results in sub-populations without the genetic complementation and thus 
removes the selection of the expression vectors.  
In my Ph.D. study maintenance of the plasmid was ensured by autoselection. The 
triose phosphate isomerase gene (TPI) on the genome was deleted in the host cell and 
the activity was restored by using a 2µ derived plasmid containing the POT gene from 
Schizosaccharomyces pombe encoding a triose phosphate isomerase (POT) (Thim et al., 
1986). Triose phosphate isomerase is necessary for growth when glucose is the sole 
carbon source; selection for plasmid containing cells was therefore achieved by growth 
on glucose (Compagno et al., 1996). Furthermore, the POT gene is poorly transcribed 
resulting in a high copy number (Kawasaki and Bell, 1999). Heterologous protein 
production and copy number of the plasmid was determined after prolonged growth 
(up to 500 generations) at unlimited conditions. The results showed that the plasmid is 
maintained in the cells, but no general trend in the copy number in relation to time 
could be identified. In batch cultivations with the industrial strain the plasmid copy 
number was initially found to decrease followed by an increase. The opposite pattern 
was seen with the laboratory strain, but the fluctuations were much smaller with this 
strain. (Paper B). 
Protein production in S. cerevisiae 
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Adaptation to un-limited conditions influenced 
the yield of glycerol in strains containing the 
POT gene; the yield of glycerol in the aprotinin 
producing strains declined during the 
adaptation period (Paper A). The high glycerol 
yield found in the cultivations with the 
unadapted aprotinin producing strains could 
be due to insufficient levels of Pot to convert 
dihydroxyacetone phosphate (DHAP) to 
glyceraldehyde-3-phosphate (Figure 3.2). 
Incomplete conversion of DHAP would lead to 
a lowering of the maximal specific growth rate, 
which correlates well with the low specific 
growth rate determined for the unadapted 
strains. The glycerol yield of adapted strains 
was much lower than by the unadapted strains, 
and the maximal specific growth rate of the adapted strains were higher than the 
maximal specific growth rate of the unadapted strains, the adaptation probably 
resulted in a higher activity of the triose phosphate isomerase in the cells. The plasmid 
copy number (and thereby the copy number of the POT gene) did not increase during 
the adaptation period. An increase in the triose phosphate isomerase activity was 
therefore believed to be caused by an increase in the transcription of the TPI gene or an 
increased stability of the mRNA corresponding to TPI. Alternatively, the limitation of 
the triose phosphate isomerase activity may have been solved by a redirection of the 
carbon fluxes in the cell, even though this is less plausible. The adaptation of the 
industrial dummy strain (which contain a plasmid without the aprotinin gene, but the 
same selection system as the aprotinin producing strains) did not result in changes of 
neither the maximal specific growth rate nor the yield of glycerol (Paper A). 
The promoters used in heterologous protein production can either be homologous or 
heterologous, generally homologous promoters are preferred, as heterologous 
promoters often do not yield good efficiency of expression. Yeast promoters can be 
highly complex, extending over 500 bp containing several regulatory sites. Most 
promoters are regulated to some extent, but generally promoters have been divided 
into constitutive and inducible promoters. Inducible promoters have the advantage of 
enabling separation of the growth and production phase, and thus minimizing the 
stress in the cell caused by the production of the heterologous protein. However, 
complex fermentation strategies or addition of an inducer (adding cost to the overall 
process) have to be used when working with inducible promoters. Table 3.3 shows 
some examples of promoters used in S. cerevisiae. The heterologous protein was in the 
 Glucose
Fructose-1,6-diphosphate
Dihydroxyacetone
phosphate
Glyceraldehyde
3-phosphate
Pyruvate
Triosephosphate
isomerase
Glycerol  
Figure 3.2 Schematic overview of the 
reactions around the triose phosphate 
isomerase. 
Protein production in S. cerevisiae 
 
 18
present study expressed by the use of the TPI promoter, which is a strong glycolytic 
promoter. 
 
Improvement of the yield of heterologous proteins can be achieved by using high copy 
number plasmids in addition to strong promoters, thus generating a large amount of 
mRNA corresponding to the heterologous proteins. However, the degradation of the 
mRNA molecules has a significant influence on the level of mRNA found inside the 
cells and therefore on the potential templates for protein production (Raue, 1994). The 
flexibility of the cell to regulate the level of mRNA by both production and 
degradation is necessary for the changes in metabolism in response to different 
environmental changes, it is therefore lethal to the cell if the degradation is inactivated 
(Meyer et al., 2004). The half-life of mRNA’s vary between 1 min and 100 min (Raue, 
1994 and Meyer et al., 2004), but even though different factors influencing the stability 
of an mRNA molecule has been identified, it is not possible to predict the stability of an 
mRNA molecule on the basis of the sequence (McCarthy, 1998). 
Two different routes of mRNA degradation exist in S. cerevisiae; in both routes is the 
initial step in the degradation is a deadenylation. In the major pathway deadenylation 
is followed by decapping and finally degradation of the mRNA by a 5’-3’ exonuclease. 
In the other pathway deadenylation is followed by degradation of the mRNA by a 3’-5’ 
exonuclease (Meyer et al., 2004).  
More than 96% of the amino acids in S. cerevisiae are encoded by 25 codons (Bennetzen 
and Hall, 1982). Replacement of codons in the native PGK1 gene with less abundant 
Table 3.3 Examples of native promoters used in S. cerevisiae  
Promoter 
Regulatory 
stimulus 
Strengtha Description 
ADH2 
Glucose 
starvation 
++ 
Cannot be used with Crabtree-positive yeasts as sugar-
limitation has to be maintained to avoid alcoholic 
fermentation and the low sugar concentrations cause a 
partial derepression (Hensing et al., 1995). 
GAL Galactose +++ 
Repressed by glucose and induced by galactose. 
Galactose is expensive, however strains incapable of 
utilizing galactose have been constructed (Hensing et al., 
1995). 
PHO5 
Inorganic 
phosphor 
+/++ 
Difficult to obtain phosphor limitation, if limitation 
occurs this has an effect on the metabolism (Hensing et 
al., 1995). 
ADH1, 
PGK, 
GAP 
 ++++ 
The glycolytic promoters were the first promoters to be 
applied. The glycolytic promoters were initially thought 
to be constitutive, but later found to be induced by 
glucose. The strongest native promoters. 
CUP1 Copper + 
Induced by copper, tightly regulated and independent 
of culture parameters. 
a Romanos et al., 1992 
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codons resulted in a decline of the Pgk1 level. The data indicated that stability of the 
PGK1 mRNA was controlled by the translation elongation rate (Hoekema et al., 1987). 
Codon optimization of mouse IG kappa has been shown to increase the rate of protein 
synthesis more than 5-fold. The increased protein synthesis rate was not found to stem 
from increased steady state level of the mRNA or plasmid copy number (Kotula and 
Curtis, 1991). Figure 3.3 shows the codon usage in aprotinin including the leader 
sequence compared to the general usage of codons. The data in the figure shows that 
aprotinin contain both preferred and less abundant codons. Further optimization of the 
codon usage may improve the production of aprotinin. 
 
 
             
 
 
 
 
             
   
 
 
 
             
   
 
 
Figure 3.3 Comparison of the codon usage in aprotinin and leader (red) compared to the 
general codon usage of S. cerevisiae (black). The figure was generated by the use of the Graphical 
Codon Usage Analyser (www.gcua.de). Aprotinin does not contain any histidine, and this is the 
reason why the red bars corresponding to histidine do not add up to 100. 
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Other limitations than limitations in translation have, however also been proposed and 
this adds more dimensions to the complex picture of protein production:  
 Evidences exist for limitations in membrane translocation, signal sequence processing 
and folding within the endoplasmatic reticulum (Mattanovich et al., 2004), which is 
the theme of section 3.2.  
 Proof of control of translation by untranslated regions (UTR’s) also exits (Mazumder 
et al., 2003), both 5’- and 3’-UTR’s have been shown to be involved in the regulation 
of translation.  
Janes et al. (1990) investigated the influence of promoter strength on heterologous 
protein production and plasmid copy number. They proposed that plasmid copy 
number is determined by several factors: the plasmid, selection markers on the 
plasmid (and the promoter strength of these) and the promoter strength of the 
heterologous protein as well as the protein itself. Equilibrium between the different 
factors gives the plasmid copy number. 
3.2 Protein secretion 
Proteins resident in the endoplasmatic reticulum (ER) are responsible for correct 
protein folding, which is necessary for protein secretion and proper protein function. 
The polypeptides can be targeted to the ER by two routes: Signal Recognition Particle 
(SRP)-dependent or –independent routes. In the SRP-dependent route the mRNA is 
translated by free ribosomes and SRP binds to the polypeptides and a co-translation 
and transport into the ER is performed. On the SRP-independent route chaperones 
keep the polypeptide in an unfolded conformation in the cytoplasm while it is 
translated and afterwards the protein is transported into the ER (Conesa et al., 2001). 
Inside the endoplasmatic reticulum foldase and chaperones reside, which assist in the 
folding of the proteins, this includes formation of disulfide bridges, phosphorylation, 
subunit assembly and initial glycosylation (Figure 3.4). The major chaperone inside the 
ER is Kar2, which binds to the polypeptide and assist in the folding. When the proteins 
are correctly folded, they are transported in vesicles to the Golgi, where further 
glycosylation and peptide processing is performed. The proteins are subsequently 
packed in secretory vesicles and secreted. 
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It is favorable to have the heterologous protein secreted by S. cerevisiae both because 
the secretory pathway ensures correct folding of many proteins and in addition less 
than 0.5% of S. cerevisiae’s own proteins are secreted (Vasavada, 1995) which simplifies 
the process of purification. 
The native proteins secreted by S. cerevisiae typically feature a signal peptide at the N-
terminus. The signal peptide consists of charged amino acids followed by a 
hydrophobic core and a consensus amino acid sequence for enzymatic removal. Fusion 
of a signal peptide to a heterologous protein is not always enough to ensure secretion 
of the protein as the signal peptide only ensures translocation to the inside of ER. 
However, addition of a leader peptide to the heterologous protein has in many cases 
been shown to enhance secretion. A leader peptide consist of a signal peptide also 
denoted a prepeptide (which equals the signal peptide) and a propeptide (Figure 3.5 B) 
(Kjeldsen, 2000). The secretion signal most often used for heterologous protein 
production (even with “non-Saccharomyces” yeasts) is the S. cerevisiae α-mating factor 
(Porro et al., 2005) (Figure 3.5 A). The processing of the native prepro-α-factor during 
secretion is performed by four different enzymes: a signal peptidase removes the 
prepeptide, an endopeptidase cleaves off the glycosylated propeptide (encoded by 
KEX2), a dipeptidyl aminopeptidase removes dipeptides from the N-terminus 
(encoded by STE13) and a carboxypeptidase serine protease removes arginine and 
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proteins
Kar2 mediated 
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Pdi mediated disulphide 
bond formation
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Transport 
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Transport 
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glycoproteinAddition of glycans
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S
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6
1
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Figure 3.4 Schematic representation of protein folding in ER. The unfolded polypeptide enters 
ER through the Sec61 protein complex, Kar2 assists correct folding of the protein. Prolonged 
binding to Kar2 indicate misfolding of the protein and lead to degradation of the polypeptide 
by ERAD in the cytosol and induction of UPR (Unfolded Protein Response, quality control is 
discussed further in section 3.4). Pdi assists in correct disulfide bond formation.  Glycoprotein 
has the first part of the glyco-portion added in ER, the rest in Golgi. Only proteins which are 
correctly folded are transported to Golgi for further processing and secretion. 
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lysine from the C-terminus (encoded by KEX1). The activity of the dipeptidyl 
aminopeptidase has in several instances been shown to be rate limiting in the 
processing of a heterologous protein and therefore the spacer has been removed and 
the leader been fused directly to the heterologous protein (Kjeldsen et al., 2001). 
Since insulin production is well-studied, a large amount of information on the 
production of insulin is available. Omittance of the spacer sequence resulted in 
incomplete Kex2 processing (Kjeldsen et al., 1996). Different synthetic spacers have 
been used to enhance removal of the pro-peptide. Some of the investigated spacers 
were found to be partially removed by a native protease encoded by YAP3. However, 
as the proteolysis only was partial, spacers were designed to be resistant to in vivo 
proteolytic processing. The resistance to proteolytic cleavage resulted in an extra in 
vitro enzymatic step to remove the spacer (Kjeldsen et al., 1996). Synthetic leaders have 
been designed by rational design and semi random mutations, some of these 
significantly increased the yield of insulin compared to the native α-factor leader. The 
synthetic leaders have also been found to be effective for production of other proteins 
(Kjeldsen et al., 1997).  
 
Production of heterologous proteins containing hydrophobic patches (hydrophobic 
patches has been introduced in cutinase to increase the affinity to lipid stains) can lead 
to aggregation before the correct folding is achieved, which leads to the protein being 
retained in ER. Introduction of a N-glycosylation site (glycosylation will be discussed 
in more detail in section 3.3) has been shown to increase the secretion of heterologous 
protein (Sagt et al., 2000). The oligosaccharides are believed to hide the hydrophobic 
Leader
Heterologous proteinPre-peptide Pro-peptide
Signal peptidase Kex2
Spacer
Site for in vitro enzymatic removal of spacer
Pre-peptide Pro-peptide S1 α1 S2 α2 S3 α3 S4 α4
Signal peptidase Kex2 Kex2
Ste13 Kex1
 
Figure 3.5 A Structure and processing of the native prepro-α-factor, S: spacer, α: α-factor. B 
Schematic drawing of a heterologous protein secreted by S. cerevisiae.  
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patches. An N-terminal glycosylation site has been found to be more effective in 
enhancing secretion of cutinase than a C-terminal glycosylation site. It is possible that 
this approach also could increase secretion of other proteins which aggregate in ER and 
if no glycosylation site can be engineered in the protein perhaps a pro-sequence 
containing glycosylation site can help avoiding aggregation. 
The levels of ER resident enzymes have been the focus area of many studies trying to 
improve production of heterologous proteins from different microorganisms. 
However, no general rule can be formulated as the results are diverse; Table 3.4 gives 
an overview of some of the results obtained with alternation of the expression of ER-
resident chaperones. It has been suggested that an optimal level of Protein Disulfide 
Isomease (Pdi) exists, and that this is higher than wild-type levels at least for some 
proteins. On the other hand high overexpression has also been shown to have 
detrimental effects on protein secretion. The authors does not represent any data on 
this, but hypothesise this to be due to competition for ER membrane translocation sites 
(Robinson et al., 1994). Conesa and co-workers speculated on whether the observed 
differences stemmed from multiple cellular functions, which the investigated enzymes 
are implicated in, combined with different proteins being investigated (Conesa et al., 
2001). 
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DNA arrays of two Pichia pastoris strains, one producing a heterologous protein and a 
non-producing strain were compared (Gasser et al., 2007). Potential genes were selected 
(genes with higher expression in the producing strain and which in S. cerevisiae 
function in the secretion of proteins or stress regulation) and overexpressed in a strain 
producing another heterologous protein than the one used to identify the potential 
genes enhancing protein secretion. The analysis of the gene expression data resulted in 
a list with 13 potential secretion helpers including Pdi and Kar2. Analysis of secretion 
of strains overexpressing the different potential secretion helpers identified six novel 
secretion helpers: Bfr2 and Bmh2 involved in protein transport, Ssa4 and Sse1 both 
Table 3.4 Examples of effects of the level of different ER-resident chaperones  
Chaperone Heterologous Protein Effect Reference 
Kar2 Three heterologous 
proteinsa 
Lower Kar2 levels resulted in lower 
secretion levels, higher Kar2 levels 
did not increase secretion levels 
Robinson et al., 
1996 
Kar2 Chymosin and 
taumatin 
Kar2 overexpression increased level 
of secreted chyotrypsin; taumatin 
secretion was unaffected 
Harmsen et al., 
1996 
Kar2 Two G-protein-
coupled receptors 
Elevated levels of Kar2 did not 
increase functional receptors, in 
some instances lowered levels was 
found 
Butz et al., 2003 
Pdi PDGFb , 
Schizosaccharomyces 
pombe acid 
phosphatase and 
GCSFc 
PDI overexpressiond increased 
PDGF and S.  pombe acid 
phosphatase secretion and lowered 
intracellular accumulation, but 
secretion of GCSF was unaffected 
Robinson et al., 
1994 
Pdi Lysozyme PDI overexpression increased 
intracellular and secreted proteins 
levels 
Hayano et al., 
1995 
Pdi Antstasin PDI overexpression increased 
protein production 
Schultz et al., 
1994 
Pdi Two G-protein-
coupled receptors 
Elevated levels of PDI resulted in 
lower levels of functional receptors 
Butz et al., 2003 
Calnexin Two G-protein-
coupled receptors 
Overexpression of calnexin did not 
result in increased receptor levels 
Butz et al., 2003 
a The three proteins were: human granulocyte colony-stimulating factor, 
Schizosaccharomyces pombe  acid phosphatase and bovine pancreatic trypsin inhibitor 
b PDGF: Human platelet derived growth factor B homodimer 
c GCSF: Human granulocyte colony stimulation factor 
d Overexpression by placing a single copy of PDI under the GAPDH promoter was 
investigated, overexpression by a multicopy plasmid had detrimental effects in 
heterologous protein secretion. 
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chaperones and Cup5 and Kin2 both vacuolar proteins connected to exocytosis. Both 
Pdi and Kar2 were also found to enhance secretion (Gasser et al., 2007).  
Overexpression of proteins with functions later in the secretion has also been identified 
to increase secretions of proteins. The secretion of Bacillus α- amylase from S. cerevisiae 
was found to correlate with increased levels of the Sso2 protein (Ruohonen et al., 1997). 
The Sso2 protein is a plasma membrane t-SNARE involved in fusion of secretory 
vesicles at the plasma membrane, thus involved in the very last part of protein 
secretion. 
The results discussed in the paragraphs above clearly show that there is no simple 
answer to the question about neither what the bottleneck in the production of 
heterologous protein is nor how to circumvent this. The answer to the question seems 
to be protein and host dependent and thus needs to be dealt with in each single case. 
The elimination of a bottleneck probably just reveals another as the proteins involved 
in the secretion pathway are expressed in well-adjusted amounts; a method to analyse 
this would be application of MCA, metabolic control analysis. MCA analyses how the 
control of fluxes and metabolite concentrations in a metabolic pathway is distributed 
among the different enzymes in the pathway. 
3.3 Posttranslational modifications with emphasis on glycosylation 
The function and safety of glycoproteins depend on the composition of the 
glycosylation pattern. Non-human glycoforms can when administered to humans lead 
to different scenarios fast clearance from the blood stream and will thus have no effect 
or it can lead to severe allergic reactions. It is therefore desirable (and often necessary) 
to be able to control the glycosylation pattern. Glycoproteins represent 70 % of the 
approved therapeutic proteins (Porro et al., 2005) and the use of hosts providing a 
reproducible glycosylation pattern are thus needed. Even though glycosylation is 
widespread and has a large influence on heterologous protein production, other post-
translational modifications can have an effect on the final product Table 3.5 presents an 
overview of the different post-translational modifications. 
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Currently Chinese hamster ovary (CHO) cell lines are the preferred host for 
glycoprotein production, but there is still room for improvement with respect to cost 
and time associated with the production; heterogenic glycopattern makes the CHO cell 
line non-optimal. Other hosts are therefore being tested for their possible application in 
the production of glycoproteins. The glycopattern obtained on proteins produced in 
insect cell lines results in a very short half life and also in immunogenicity. 
Immunogenicity is also the major disadvantage when producing glycoproteins in 
plants. Transgenic animals has a glycopattern which is different from humans and this 
leads to a short serum half life (Sethuraman and Stadheim, 2006). At present a “new” 
human cell line denoted PER.C6 show promising results. The cell line was developed 
from a single, human retina-derived cell by Crucell (www.crucell.com, 20. May 2009). 
Yeasts have also been exploited in order to find a suitable host for production of 
glycosylated proteins; but the glycosylation pattern in yeasts and mammals is not 
equal. However, the first steps of N-glycosylation are equal in yeast and mammals, but 
the processing in Golgi varies (Porro et al., 2005). The first three steps in N-
glycosylation which are performed in ER are (Hamilton et al., 2003): 
Table 3.5 Main posttranslational modifications (Walsh and Jefferis, 2006) 
Modification Description 
Acetylation, acylation. ADP-
ribosylation 
Regulate various intracellular processes, including gene 
expression, endosomal vesicle trafficking and signal 
transduction. Rarely a characteristic of 
biopharmaceuticals. 
Amidation Characteristic of bioreactive peptides and of short 
polypeptides. Not a characteristic posttranslational 
modification of yeast or prokaryotes. The exact 
biological role remains to be explained. 
γ-carboylation and β-hydroxylation Characteristic of a few proteins, primarily proteins 
involved in blood coagulation. 
Disulfide bond formation Characteristic of many biopharmaceuticals and can 
influence product stability and biological activity. 
Glycosylation Oligosaccharides are attached to asparagine (N-linked) 
or serine/threonine (O-linked). Discussed in further 
detail below. 
Phosphorylation A mechanism for controlling the behavior of a protein, 
for instance activating or inactivating an enzyme. 
Proteolytic processing Necessary for production of biologically active insulin, 
can be introduced as a part of downstream processing. 
Sulfation Occurs in higher eukaryotes and in all mammalian cell 
lines, but not in prokaryotes or in yeasts. Sulfation 
functions in protein-protein interactions. 
PEGylation An engineered modification. Shields potential 
immunogenic epitopes, protects against proteolytic 
degradation and slows clearance from the blood stream. 
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− Site specific transfer of Glc3Man9GlcNAc21 all together from the ER lumen to the 
protein by an oligosaccharyltransferase complex 
− Trimming by glycosidase I and II to remove the three glucoses 
− Removal of one specific terminal mannose residue in ER resulting in a core N-
glycan: Man8GlcNAc2 
 
The protein is transferred to 
Golgi, where the further 
processing of the glycan 
structure differs significantly 
between humans and yeasts 
(Figure 3.6 and Gemmill and 
Trimble, 1999). In humans 
the glycan structure is 
trimmed further to 
Man5GlcNAc2 by action of 
several mannosidases, this 
precursor is used for N-
glycan formation (Hamilton 
et al., 2003). In S. cerevisiae 
numerous mannose residues 
are added to the glycan 
structure resulting in 
hypermannosylated glycans 
with more than 100 mannose 
residues (Hamilton et al., 
2003). Yeast do not add sialic 
acids to their glycans, instead 
phosphate or in rare cases 
glucuronic acid or pyruvate 
is used (Gemmill and 
Trimble, 1999). The function 
of addition of phosphate to 
the glycan is unknown. 
                                                     
1 Glc: glucose, Man: Mannose, GlcNAc: N-acetyl-glucosamine 
 
Figure 3.6 Comparison of N-linked glycosylation in homo 
sapiens and P. pastoris (Hamilton and Gerngross, 2007) 
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In the case of O-glycosylation differences are also identified between mammals and 
yeasts. Mammalian cells initiate synthesis by addition of GalNAc residues whereas 
yeast initially adds mannose to the protein. Mammalian cells elongate the glycan by 
addition of galactose, N-acetyl-glucosamine, fructose and N-acetyl-neuaminic acid 
whereas yeast add mannose or galactose to the glycan structure (Gemmill and Trimble, 
1999). 
Two different approaches have been followed in order to produce proteins with 
human glycosylation patterns in yeasts including S. cerevisiae. One was, in vitro 
processing of proteins produced in yeasts, the other was genetically engineering of the 
glycosylation pathway in yeast. In vitro processing of the proteins was found to be 
costly and cumbersome and genetically engineering was thus found to be the attractive 
choice (Gerngross, 2004). However, a number of requirements for successful human 
glycosylation in yeast exist. First of all, it is necessary to identify and delete the genes 
in the yeast genome responsible for the hypermannosylation. Secondly, it is necessary 
to express the genes involved in human glycosylation and to direct the enzymes to the 
right cellular compartment. Some work has been done on the glycosylation pathway in 
S. cerevisiae, but most progress has been observed in the work done on the 
glycosylation pattern of Pichia pastoris. It has been shown that it is possible to construct 
a P. pastoris strain capable of producing the most essential glycosylation pathways 
found in mammals. The genetically improved P. pastoris could be an alternative 
production platform for human therapeutic glycoproteins. Furthermore, the strain has 
the benefit of producing proteins with homogeneous glycosylation patterns. A library 
of antibodies with identical amino acid sequence, but different glycosylation patterns 
produced in P. pastoris has been shown to have a range of different activities (Li et al., 
2006).  
The heterologous protein investigated in the present study, aprotinin, is not 
glycosylated (Parekh and Wittrup, 1997). Glycosylation of the product was therefore 
not an issue. However, comparison of the transcription profile of the two investigated 
strains showed some differences in relation to mannosylation. Genes related to 
mannosylation were found to be expressed higher in the strain with industrial 
background than in the strain with laboratory background (Paper B). This suggests that 
the strain with the industrial background has a higher capacity of mannosylation, a 
feature that can be of large importance in production of other pharmaceuticals. 
3.4 ER quality control and protein degradation  
Only proteins with correct folding are allowed to exit ER and continue the secretion 
pathway to Golgi. Misfolded proteins are retained in ER; however, accumulation of 
unfolded protein in ER stresses the cells and there are several responses to minimize 
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this (Gasser et al., 2008). Misfolded proteins are initially bound by Kar2, but eventually 
the cell needs to get rid of the misfolded protein: 
− One way to minimize the stress is degradation of the misfolded protein by a 
pathway called ER-Associated Degradation (ERAD) (Figure 3.4). ERAD 
involves retranslocation of the misfolded protein to the cytosol and binding of 
ubiquitin to the protein. This targets the protein to the 26S proteasome where it 
is degraded (Mattanovich et al., 2004). 
− Another pathway to reduce the level of unfolded protein in ER is induction of 
the Unfolded Protein Response (UPR) (Figure 3.4) (Hampton, 2000). The 
amount of misfolded protein in the ER is sensed by the competitive binding of 
Kar2 to unfolded proteins and Ire1. Ire1 is a transmembrane kinase/nuclease 
which binds Kar2 when the level of unfolded protein is low and hence the level 
of free Kar2 is high. However, when unfolded protein accumulates in ER, Kar2 
is “pulled” away from Ire1 allowing self-association and activation. After 
activation Ire1 shows endonuclease activity on the cytoplasmic side which leads 
to removal of an intron from HAC1. HAC1 is more or less inactive until the 
intron is removed and the mRNA is translated. Hac1 is a transcription factor 
which has influence on the transcription of a large number of genes 
(Mattanovich et al., 2004).  
381 genes have been identified as targets of UPR, the targets are by Travers and co-
workers defined as genes which expression is induced by UPR (Travers et al., 2000). 
The targets were identified by using rather strict criteria on oligonucleotide arrays 
results, thus 381 genes might be an underestimation of the real number of target genes. 
Actually, KAR2 and INO1 were not identified in the study by Travers and co-workers 
(due to the strict criteria), even though they previously have been identified as targets 
of UPR. Functional information was obtained for 208 of the target genes, 103 of these 
were found to be involved in secretion or biogenesis of secretory organelles. The list of 
103 genes contained genes with different functions in secretion e.g. translocation, 
glycosylation, protein folding, protein degradation, vesicle trafficking, lipid/inositol 
metabolism, vacuolar protein sorting and cell wall biogenesis. The expression of genes 
involved in ERAD was found to be induced by UPR suggesting a linkage between the 
two routes. The authors hypothesise that the main function of UPR is to reduce the 
concentration of misfolded protein either by ensuring correct folding or removal from 
ER (Travers et al., 2000). 
The effects of deletion or constitutive expression of UPR (achieved by deletion or 
overexpression of HAC1 without the intron) on secretion of both heterologous and 
homologous proteins have been studied (Valkonen et al., 2003). The study showed that 
induction of UPR may be beneficial for production of some proteins and that deletion 
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of UPR resulted in reduced production of heterologous proteins. The growth rate did 
not decline as a result of the deletion of UPR and the results therefore also indicated 
that other mechanisms are able to cope with the misfolded protein produced in the 
cells; this could involve the ERAD pathway. The authors speculated if a selective 
decrease in the secretion of heterologous protein was caused by different secretion 
vesicle populations and that the UPR regulate the transport of these. The constitutive 
induction of UPR gave different results when testing different proteins, production of 
an α-amylase from Bacillus was increased whereas no effect on production of an 
endoglucanase from T. reesei was detected upon constitutive induction of UPR. This 
indicated that different proteins have different optimal levels of UPR induction. 
However, only three proteins of very different origins (one from B. amyloliquefaciens, 
one from T. reesei and a homologous yeast protein) were investigated and thus no 
systematic information could be retrieved about the optimal level of induction. As 
growth inhibition was observed equilibrium between the beneficial feature of 
increasing secretion and unwanted growth inhibition has to be found (Valkonen et al., 
2003). 
The onset of UPR was also studied in my project (Paper B), and transcriptome data 
from a chemostat cultivation with the laboratory aprotinin producing strain was 
compared to transcriptome data from a cultivation with a wild type laboratory strain 
(Usaite, 2008). The expression of the 381 genes identified by Travers and co-workers as 
being regulated by UPR were compared between the two strains. Only 78 genes were 
found to have significantly different expression, 27 genes were expressed at a higher 
level in the reference strain and the remaining 51 genes were expressed at a higher 
level in the strain producing the heterologous protein. The low number of genes with 
significantly different expression identified in the study indicated that UPR was not 
activated in the laboratory strain. 
3.5 Proteins produced in S. cerevisiae 
No universal super host for the production of heterologous protein production exist, 
the most suited organism depend on the product but also to a large extent on the 
inhouse knowledge of the different organisms. S. cerevisiae is the organism chosen by a 
number of different companies for production of biopharmaceutical compounds. These 
companies include Novo-Nordisk, Jansen-Cilag, Zymo-Genetics, GlaxoSmithKline and 
Aventis/Novartis (Schmidt, 2004). Currently a large range of therapeutic proteins are 
produced in S. cerevisiae, Table 3.6. 
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Table 3.6 Therapeutic proteins produced in S. cerevisiae (Gerngross, 2004; Walsh, 2003a) 
Recombinant protein Therapeutic indication Company Date approved 
Anticoagulant, recombinant hirudin 
(Refludan) 
Anticoagulant therapy for 
heparin-associated 
thrombocytopenia 
Hoechst Marion 
Roussel/ Behringwerke 
AG 
1997 (EU) 1998 
(US) 
Anticoagulant, recombinant hirudin 
(Revasc) 
Prevention of venous thrombosis Aventis 1997 (EU) 
Recombinant insulin formulated as short/ 
intermediate/ prolongedacting product 
(Actrapid/ velosulin/ monotard/ 
insulatard/ prophane/ mixtard/ 
actraphane/ ultratard) 
Diabetes mellitus Novo Nordisk 2002 (EU) 
Insulin aspart, short-acting recombinant 
insulin (Novolog) 
Diabetes mellitus Novo Nordisk 2001 (EU) 
Contains insulin aspart as one ingredient 
(Novolog mix 70/30) 
Diabetes mellitus Novo Nordisk 2001 (US) 
Contains insulin aspart as one ingredient 
(Novomix 30) 
Diabetes mellitus Novo Nordisk 2000 (EU) 
Insulin aspart (NovoRapid) Diabetes mellitus Novo Nordisk 1999 (EU) 
Recombinant insulin (Novolin) Diabetes mellitus Novo Nordisk 1991 (US) 
Recombinant glucagon (Glucagen) Hypoglycemia Novo Nordisk 1998 (US) 
Combination vaccine containing 
recombinant HBsAg (Ambrix) 
Immunization against hepatitis 
A and B 
GlaxoSmithKline 2002 (EU) 
Combination vaccine containing 
recombinant HBsAg (Pediarix) 
Immunization of children 
against various conditions 
inducing hepatitis B 
SmithKline Beecham 2002 (US) 
Recombinant HBsAg (HBVAXPRO) Immunization of children and 
adolescents against hepatitis B 
Aventis Pharma 2001 (EU) 
Combination vaccine containing 
recombinant HBsAg (Twinrix) 
Immunization against hepatitis 
A and B 
SmithKline Beecham 
(EU) GlaxoSmithKline 
(US) 
1996 (EU, adult)  
1997 (EU, 
pediatric), 2001 
(US) 
Combination vaccine containing 
recombinant HBsAg (Infanrix-hexa) 
Immunization against 
diphtheria, tetanus, pertussis, 
Haemophilus influenzae type B, 
hepatitis B and polio 
SmithKline Beecham 2000 (EU) 
Combination vaccine containing 
recombinant HBsAg (Infanrix-Penta) 
Immunization against 
diphtheria, tetanus, pertussis, 
hepatitis B and polio 
SmithKline Beecham 2000 (EU) 
Combination vaccine containing 
recombinant HBsAg (Hexavax) 
Immunization against 
diphtheria, tetanus, pertussis, 
Haemophilus influenzae type B, 
hepatitis B and polio 
Aventis Pasteur 2000 (EU) 
Combination vaccine containing 
recombinant HBsAg (Primavax) 
Immunization against 
diphtheria, tetanus and hepatitis 
B 
Aventis Pasteur 1998 (EU) 
Combination vaccine containing 
recombinant HBsAg (Infanrix Hep B) 
Immunization against 
diphtheria, tetanus, pertussis 
and hepatitis B  
SmithKline Beecham 1997 (EU) 
Combination vaccine containing 
recombinant HBsAg (Twinrix (adult and 
pediatric forms)) 
Immunization against hepatitis 
A and B 
SmithKline Beecham  1996 (EU, adult) 
1997 (EU) 
Combination vaccine containing 
recombinant HBsAg (Comvax) 
Vacination of infants against H. 
influenzae type B and hepatitis B  
Merck 1996 (US) 
Combination vaccine containing 
recombinant HBsAg (Tritanrix-HB) 
Vaccination against hepatitis B, 
diphtheria, tetanus and pertussis 
SmithKline Beecham 1996 (EU) 
Recombinant HBsAg (Recombivax) Hepatitis B prevention Merck 1986 (US) 
Recombinant urate oxidase (Fasturtec 
(Elitex in US)) 
Hyperuricaemia Sanofi-Synthelabo 2001 (EU) 2002 
(US) 
Recombinant platelet derived growth factor 
(Regranex) 
Lower extremity diabetic 
neuropathic ulcers 
Ortho-McNeil 
Pharmaceuticals (US), 
Janssen-Cilag (EU) 
1997 (US) 
1999 (EU) 
HBsAG hepatitis B surface antigen 
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Chapter 4 
Process considerations for heterologous protein 
production in S. cerevisiae 
In the previous chapter the intracellular aspects of heterologous protein production in S. 
cerevisiae was discussed. In the present chapter production conditions will be examined. 
This includes the influence of the cultivation method and reflections on the influence of 
different types of media on the protein production.  
4.1 Cultivation methods 
Heterologous proteins are produced by submerged fermentations, where the liquid 
surrounding the microorganisms contain all necessary components for cell growth and 
product formation. The medium composition is the topic of section 4.2. Three different 
cultivation methods are generally applied for the growth of microorganisms and for the 
production of heterologous proteins, the method chosen for a particular product largely 
depend on the production strain (S. cerevisiae is Crabtree positive which implies that it 
produces ethanol when it experiences high glucose concentrations) and the regulation of 
protein production (constitutive or regulated promoter) in question. Other factors such as 
the available equipment, the amount of material needed and the process economics also 
have a large influence on the cultivation method chosen. The three major cultivation 
methods have different characteristics: 
− Batch: In batch cultivation, everything is present from the beginning of the 
cultivation; nothing is added or removed from the cultivation vessel during the 
cultivation. Therefore the cells experience a high initial glucose concentration 
which leads to ethanol production if the host is Crabtree positive. The cells grow 
at their maximal specific growth rate until one of the nutrients become limiting. 
Another disadvantage is the osmotic stress caused by the high initial 
concentration of nutrients. 
− Continuous: Prior to continuous cultivation is a batch phase during which 
biomass is produced. Continuous cultivations can be divided into cultivations 
with (perfusion) and without (chemostats) cell retention. During chemostat 
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cultivation fresh medium is added and culture broth is removed at the same rate, 
thus keeping the volume constant and no accumulation of cells occurs. One 
nutrient will be the limiting and it is the rate at which this is added that 
determines the specific growth rate of the microorganism. The concentration of 
nutrients, metabolites and biomass reach a steady state.  
− Fedbatch: Fedbatch cultivations are initially run as batch cultivations to produce 
biomass. In fedbatch cultivation, a concentrated solution of nutrients is added to 
the cultivation vessel, but nothing is removed, thus the volume increases during 
the cultivation time. Just as in the case of continuous cultivation is one nutrient the 
limiting one, and it is the addition of this substrate that determines the specific 
growth rate. Oxygen limitation or heat transfer limits the applicable feed rate. 
Generally, fedbatch is the preferred method for large-scale production (Hensing et 
al., 1995).  
The optimal cultivation method should lead to high volumetric productivity, high final 
product concentration, stability and reproducibility of the process, and low-cost 
substrates can be used (Hensing et al., 1995). Most protein production processes are based 
on fedbatch protocols. Continuous cultures are generally not applied due to genetic 
instabilities and risk of contaminations (Porro et al., 2005). However, in the production of 
insulin by Novo Nordisk, continuous cultivation is applied, the fermentation is started as 
a fedbatch and after 72 hours it is run continuously for the next 3 weeks (Diers et al., 
1991).  
In my Ph.D. study, I have run both batch and chemostat cultivations, the cultivations 
were made with dual purposes: one purpose was investigation of the metabolism; the 
other purpose was utilization of the different cultivations as a method to reach a high 
number of generations of growth and to subsequently characterize the strains in relation 
to heterologous protein production. A high number of generations were achieved in batch 
cultivations by inoculating a new cultivation with cells from an old one before nutritional 
limitation occurred, thereby making repeated batch cultivations. Shake flasks were used 
for the repeated batch cultivations and it was possible to grow the cells for 500 
generations in unlimited conditions and thus at their maximal specific growth rate (Paper 
B). Prolonged growth at unlimited conditions (as in repeated batch cultivations) stresses 
the cells as a selection for faster growing cells occur as these will be able to outgrow the 
progenitor (This subject is the topic of Chapter 5). Heterologous protein production often 
results in a decrease in the maximal specific growth rate (the burden of protein 
production was discussed in further detail in section 5.1) and it is therefore obvious to 
expect some changes in heterologous protein production during prolonged growth at 
unlimited conditions. The maximal specific growth rate and yield of aprotinin in batch 
cultivations of strains grown for 250 and 500 generations in unlimited conditions are 
compared to the corresponding values of the initial strain in Table 4.1. After the first 250 
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generations of unlimited growth an increase in the maximal specific growth rate and a 
contemporary decrease in the yield of aprotinin yield were observed. 
 
During chemostat cultivations, the cells are not selected due to their maximal specific 
growth rate, as this is kept constant, but on their affinity for the limiting substrate. 
Intuitively this is believed to have a smaller effect on the production of a heterologous 
protein than selection for faster growth, as the affinity should not be directly related to 
protein production. However, the number of generations in chemostat cultivations was 
shown to have a large effect on the concentration of the heterologous protein in the 
fermentation broth (Paper C). 
4.2 Medium considerations 
The value of the product greatly influences the possibilities of improvement and 
refinement of the process. This results in large differences in the media and strain 
improvements possible for biopharmaceutical production and production of commodity 
chemicals. Cheap carbon and nitrogen sources used in the production of bulk chemicals 
often come from waste from other processes and are therefore not optimized for growth 
or product formation by microorganisms. For the production of high-value-added 
products a more expensive medium can be used. This results in better reproducibility and 
easier approval of the defined medium. The quality of the product is under influence of 
the medium and sometimes a complex medium is required to reduce product aggregation 
or proteolysis. Regardless of the economic aspects of the process, the cultivation medium 
has an effect on the phenotype of the strain, and the medium to be used in the final 
process should therefore be used during the strain development.  
During strain improvements it is often necessary to use auxotrophic strains. Auxotrophic 
strains are used for stable maintenance of expression vectors and for detection and 
Table 4.1 Maximal specific growth rate and yield of aprotinin on biomass in batch cultivation after 
0, 250 and 500 generations of unlimited growth. 
Straina µmaxb Yxpc Reference 
Industrial unadapted 0.16 ± 0.02 4.87 ± 0.61 Paper A 
Industrial adapted-250 0.33 ± 0.04 2.44 ± 0.24 Paper A 
Industrial adapted-500 0.27 ± 0.00 1.51 Paper B 
Laboratory haploid unadapted 0.23 ± 0.02 4.51 ± 0.74 Paper A 
Laboratory haploid adapted-250 0.31 ± 0.04 2.76 ± 0.16 Paper A 
Laboratory haploid adapted-500 0.27 ± 0.00 3.09 Paper B 
Laboratory diploid unadapted 0.23 ±  0.03  3.93 ± 0.28 Paper A 
Laboratory diploid adapted-250 0.29 1.08 Paper A 
a Strains with different genotypes, industrial and laboratory were used in the study. The 
strain with the laboratory genotype was investigated both as haploid and diploid 
(Paper A). 
b maximal specific growth rate (h-1) 
c yield of aprotinin on biomass (mg/g) 
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selection of transformed and deleted strains. Genetic or nutritional complementation is 
possible to restore growth of the strains. Genetic complementation is often applied to 
avoid loss of a plasmid, however, if high copy number plasmids are used the phenotype 
might not resemble the one of a prototrophic strain (Pronk, 2002) (Genetic 
complementation was discussed in more detail in section 3.1). Nutritional 
supplementation requires uptake and can have an effect on the specific growth rate of the 
strain. Genetic and nutritional supplementation has been shown to result in different 
specific growth rates (Pronk, 2002). 
Görgens et al. (2005) improved heterologous protein production from a prototrophic 
strain by supplementing specific amino acids. Comparison of the transcriptional profile of 
a strain producing a heterologous protein and a similar strain harbouring a plasmid 
containing neither the gene nor the promoter has been made (Hahn-Hägerdal et al., 2005). 
This comparison showed that yeast cells producing heterologous protein have an 
expression pattern resembling amino acid limitation, resulting in upregulation of amino 
acid transporters, synthesis of amino acids and onset of general stress responses (Hahn-
Hägerdal et al., 2005).  
Investigation of the influence of the medium on the maximal specific growth rate was 
made with the industrial strain, the results from measurements of the maximal specific 
growth rate on different media in shake flasks are shown in Table 4.2. In some of the 
experiments different growth phases with different maximal specific growth rates were 
observed. The specific growth rate was found to decrease during the cultivation. The 
decrease was believed to be due to either exhaustion of one medium component or a 
decrease of the pH in the broth. The defined minimal medium was buffered to pH 6.5 and 
had a high buffering capacity, and only one growth phase was observed with this 
medium. In Table 4.2 is given the highest growth rate measured with each medium, 
which in all cases was measured in the beginning of the cultivation. 
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The addition of five times the normal volume of vitamin solution resulted in a small 
increase of the maximal specific growth rate. The best way to increase the maximal 
specific growth rate of the strain with industrial background was to grow it in YPD 
medium (Yeast extract, peptone and dextrose). This medium contains a lot of building 
blocks readily available to the cells that are not present in the minimal medium, and it is 
thus not surprising that this resulted in a high maximal specific growth rate (0.31 h-1). The 
YG medium in Table 4.2 contain the same salts as the defined minimal medium, but 
instead of the vitamin and trace metal solutions yeast extract was added, this resulted in a 
maximal specific growth rate between the one obtained when growing the strain in 
defined minimal medium and YPG medium. Growing the strain in complex media (YPD 
and YG) resulted in an increase in the maximal specific growth rate when compared to 
the defined minimal medium; the component responsible for the increase is believed to be 
yeast extract.  
Compared to the minimal medium, the YNB medium contained some vitamins in other 
concentrations, and folic acid and riboflavin was only components in the YNB medium. 
YNB media both with and without amino acids were tested, the amino acids were 
histidine, methionine and tryptophane. The maximal specific growth rate was found to 
increase when YNB medium was used compared to the defined minimal medium, the 
increase was highest when the YNB medium contained amino acids and a maximal 
specific growth rate of 0.23 h-1 was measured. In order to test if any of the added amino 
Table 4.2 The maximal specific growth rate of the strain with industrial strain background in 
shake flasks using different kinds of media 
Medium 
Maximal specific 
growth rate, h-1 
Number of shake 
flask cultivations 
Defined medium   
DMMa 0.10 ± 0.01 2 
DMM + extra trace metal solution 0.11 1 
DMM + extra vitamin solution 0.18 ± 0.02 4 
DMM + Histidine 0.14 ± 0.01 2 
DMM + Methionine 0.16 ± 0.01 4 
DMM + Tryptophane 0.14 ± 0.02 4 
DMM + Folic acid 0.12 ± 0.00 2 
DMM + riboflavin 0.12 ± 0.00 2 
YNB – amino acidsb 0.20 ± 0.02 4 
YNB + amino acids 0.23 ± 0.03 4 
Complex medium   
YPDc 0.31 1 
YGd 0.23 ± 0.03 4 
a DMM: Defined minimal medium, (Paper A and Verduyn et al., 1992) 
b YNB: Yeast Nitrogen Base (Difco) 
c YPD: Yeast Peptone Dextrose (Dextrose 22 g/L, Peptone 20 g/L and Yeast extract 10 g/L) 
d YG: Contains the same salts as the DMM, but instead of the vitamin and trace metal 
solutions yeast extract was added 
 
Process considerations 
 
 42
acids of the YNB medium alone were responsible for the increased maximal specific 
growth rate these were added one at a time to the defined minimal medium. Single 
additions of the amino acids to the defined minimal medium resulted in slight increases 
in the maximal specific growth rate, but not increases as large as the one obtained with 
the YNB medium (data not shown). The experiments showed that it was possible to 
increase the maximal specific growth rate of the industrial strain by addition of a complex 
source of vitamins, trace metals and amino acids like yeast extract. 
After the initial characterization in shake flasks, the strain was investigated in batch 
cultivations. In a well-controlled batch cultivation with defined minimal medium the 
maximal specific growth rate of the industrial strain was higher than the one observed in 
shake flasks (0.16 ± 0.02, Paper A). The difference in the maximal specific growth rate 
between the two cultivation methods was believed to be caused by the lower degree of 
control in the shake flask cultivations, since both mixing, pH and temperature are 
controlled better in the batch cultivations.  
Other factors than the ones discussed in further detail in the following can also have 
influence on the production of a heterologous protein, e.g. temperature, pH, and aeration. 
Non-optimal growth conditions can lead to different stress responses, which generally 
have a negative effect on the productivity. On the other hand, another pH or a lower 
temperature different from the optimal for growth can be used to improve product 
formation or stability (Mattanovich et al., 2004). Cultivation at low pH values can result in 
inhibition of host cell proteases and can thus improve protein production. The osmolarity 
of the medium is in the beginning of a batch and fedbatch cultivation high and it 
decreases during the cultivation. High osmolarity results in accumulation of osmolytes, 
mainly glycerol, to increase the intracellular osmolarity (Mattanovich et al., 2004). 
Accumulation of glycerol results in a loss of carbon atoms and thus a lowering of the 
yield of the desired product. 
 
4.3 References 
Diers, I.V., Rasmussen, E., Larsen, P.H., and Kjaersig, I.L. (1991) Yeast fermentation 
processes for insulin production. Bioprocess. Technol. 13, 166-176. 
Görgens, J.F., van Zyl, W.H., Knoetze, J.H., and Hahn-Hägerdal, B. (2005) Amino acid 
supplementation improves heterologous protein production by Saccharomyces cerevisiae in 
defined medium. Appl. Microbiol. Biotechnol. 67, 684-691. 
Hahn-Hägerdal, ., Karhumaa, K., Larsson, C.U., Gorwa-Grauslund, M., Gorgens, J., and 
van Zyl, W.H. (2005) Role of cultivation media in the development of yeast strains for 
large scale industrial use. Microb. Cell Fact. 4, 31. 
Process considerations 
 
43 
Hensing, M.C., Rouwenhorst, R.J., Heijnen, J.J., van Dijken, J.P., and Pronk, J.T. (1995) 
Physiological and technological aspects of large-scale heterologous-protein production 
with yeasts. Antonie Leeuwenhoek 67, 261-279. 
Mattanovich, D., Gasser, B., Hohenblum, H., and Sauer, M. (2004) Stress in recombinant 
protein producing yeasts. J. Biotechnol. 113, 121-135. 
Porro, D., Sauer, M., Branduardi, P., and Mattanovich, D. (2005) Recombinant protein 
production in yeasts. Mol. Biotechnol. 31, 245-259. 
Pronk, J.T. (2002) Auxotrophic yeast strains in fundamental and applied research. Appl. 
Environ. Microbiol. 68, 2095-2100. 
Verduyn, C., Postma, E., Scheffers, W.A., and van Dijken, J.P. (1992) Effect of benzoic acid 
on metabolic fluxes in yeasts: a continuous-culture study on the regulation of respiration 
and alcoholic fermentation. Yeast 8, 501-517. 
Process considerations 
 
 44
 
 
 
 
  45 
Chapter 5 
Challenges in connection to protein production  
The metabolism of microbial organisms is optimized to the conditions which the 
organism experiences. A change in the environment will therefore lead to changes in 
the metabolism to account for the extracellular changes. Already in 1859 Darwin 
introduced the concept of “survival of the fittest” and evolution of the population. 
Evolution is caused by changes in the metabolism either by mutations or by different 
regulation. The use of evolution in strain improvement has been referred to as directed 
evolution or evolutionary engineering. Directed evolution has earlier been used to 
describe work done on protein engineering, where enzyme properties have been 
improved. Some of the properties which have been improved include stability, 
improving activity on a complex substrate and surface properties and many 
industrially important enzymes have been improved through protein engineering 
(Rubingh, 1997). Directed evolution is defined as repeated cell cycles resulting in 
genetic diversity and sifting pools of variants by immediate selection or screening 
(Sauer, 2001). Evolutionary engineering is generally applied to describe changes at 
cellular level rather than on single proteins (Butler et al., 1996 and Sauer, 2001). In 
literature the use of the two terms is not consistent with the above mentioned 
descriptions, however in the following the descriptions just mentioned will be applied. 
In strain improvement changes in the genome are regarded as a positive event, 
however, focus also needs to be put on some of the negative effects of the changes. 
Production of high amounts of different industrial relevant products is a burden to the 
host cell and causes a reduction in specific growth rate and biomass yield (Section 5.1), 
this unfortunately results in selection for cells which does not give the highest 
productivity. Therefore, from the view of the scientist, evolution is negative once an 
effective production strain has been generated, since this will result in changes away 
from the desired phenotype. On the other hand, evolution can be positive from the 
view of the microorganism, as lower production of heterologous protein result in a 
growth advantage. In my study, evolutionary engineering was used, not as a method 
to improve characteristics of a strain, but as a natural consequence of prolonged 
growth at constant conditions. Evolutionary engineering was thus not utilized as a 
tool, but studied more like a naturally occurring phenomena, which cannot be 
circumvented.  
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It has been shown that many factors have an effect on the rate of mutations; for 
instance metabolic stress, stationary phase and glucose repression has been shown to 
increase the rate of mutations (Sauer, 2001). 
Increasing the rate of mutations is the cellular 
tool for increasing the likelihood of adaptation to 
the new conditions (Figure 5.1). The rate of 
mutagenesis can be increased by various 
chemicals or radiation, however, when applying 
these methods one has to be aware of the 
biological specificity of the mutagen and 
preferably different mutagens should be used in 
different rounds of strain improvements 
(Rowlands, 1984). Recombination is another way 
of changing the genetic pool of a population. 
Recombination is a natural occurring event 
during meiosis, in which DNA is exchanged 
between a pair of chromosomes; it is an 
important source of new variation for natural 
selection to work upon. Recombination can be 
used to combine desired traits of two haploid 
strains in one diploid; afterwards the offspring 
can be tested for both of the desired traits. 
In batch cultivations the environment changes, whereas a constant environment is 
maintained in continuous cultivations (comparison of different cultivation methods are 
discussed in detail in section 4.1). The general trait selected for in continuous 
cultivations is the uptake rate of the limiting substrate; however, wall growth is also a 
selection parameter as this imposes a growth advantage (but usually not a trait that is 
sought after). Continuous cultivation can also be used to select for higher tolerance 
against a toxic compound (Adaptation in chemostat cultures will be further discussed 
in section 5.3). 
Evolutionary engineering used to improve desired strains has in several cases been 
shown to result in populations which were heterogenic (O'Kennedy and Patching, 
1999, Ferea et al., 1999, Sonderegger and Sauer, 2003 and Cakar et al., 2005). The 
different studies dealt with improving very different parts of the metabolism, e.g. 
xylose metabolism (Sonderegger and Sauer, 2003) and multiple-stress resistance (Cakar 
et al., 2005), but the trend about generation of heterogenic populations was general. 
Ferea and co-workers ran three similar aerobic glucose limited continuous cultivations 
with S. cerevisiae at a dilution rate of 0.2 h-1 for 250 – 500 generations and found similar 
changes of the metabolism (Ferea et al., 1999). The residual glucose concentration was 
 
Figure 5.1 Population fitness as a 
function of mutation rate. A stable 
environment without major changes 
will shift the optimal mutation rate to 
the left whereas a changing 
environment will shift the optimal 
mutation rate to the right (Radman, 
1999). 
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lower in cultivations with the evolved strains, the amount of ethanol produced was 
significantly reduced and the biomass yield was higher than in cultivations with the 
parental strain. Comparing the average gene expression in the three evolved strain 
with the gene expression of the parental strain showed that 3.0% of the genes had at 
least a two-fold difference in expression. Large differences were also detected between 
the three evolved strains, but this was not the main focus of the paper (Ferea et al., 
1999). The different studies highlight the fact, that adaptation occurs due to mutations 
which are more or less random even though a constant selection pressure is put on the 
cells. Generation of heterogenic populations could be seen as a problem for the 
approval of a process for industrial production as uniformity of the process has to be 
documented to assure the quality of the product.  
5.1 Burdens connected to heterologous protein production 
Production of a heterologous protein in Saccharomyces cerevisiae has been shown to 
have an effect on the metabolism of the host cell, the effect has been called the 
metabolic burden or protein burden (Görgens et al., 2001). In the following this 
negative effect on the metabolism will be denoted the burden. The burden has been 
shown to have an effect on the maximal specific growth rate, biomass yield and 
respiratory capacity. The burden increase with increasing production levels. However, 
the burden is not caused by the catalytic activity of the investigated protein. Different 
possible explanations of the observed changes of the cellular metabolism have been 
proposed: plasmid replication and protein production. The production of protein is 
energetically demanding and both plasmid replication and heterologous protein 
production competes with biomass synthesis for the available building blocks. 
Gopal et al. (1989) investigated homologous and heterologous protein production from 
2µ derived plasmids. The homologous protein was the yeast phosphoglycerate kinase 
(Pgk, an enzyme in the glycolysis) and the heterologous protein was the prochymosin. 
The production of protein from a plasmid resulted in lower biomass yield indicating 
that protein production from a plasmid occurs at the expense of host biomass 
production. Determination of the phosphorylation potential (which is defined as 
[ATP]/[ADP][Pi]) of the cell indicated that heterologous protein production imposed a 
higher energetic demand on the host than homologous protein production. The 
phosphorylation potential of the control and the strain producing Pgk were in the 
range of 0.1 to 5.2 103 mol-1 g dry wt whereas the phosphorylation potential of the 
strain producing the heterologous prochymosin was in the range of 1.1 to 7.0 102 mol-1 
g dry wt depending on the dilution rate applied. 
In a study of the influence of promoter strength on hirudin production and plasmid 
copy number an effect of the plasmid on the maximal specific growth rate was 
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observed as this decreased upon transformation with an empty plasmid (Janes et al., 
1990). This observation was in accordance with observations of a lower maximal 
specific growth rate by the native 2µ plasmid in both haploid and diploid cells (Mead 
et al., 1986). No clear correlation between plasmid copy number and protein production 
could be found in the study by Janes and co-workers. The burden was speculated to be 
caused by a competition between protein production and growth for metabolites and 
energy, but perhaps also in protein secretion as the heterologous protein was secreted. 
Production of β-D-glucuronidase was investigated by using six different promoters 
with three different types of plasmids: mono-copy, moderate copy number and high 
copy number (Nacken et al., 1996). The amount of β-D-glucuronidase increased with 
increasing plasmid copy number and there was a semiquantitative relation between 
the copy number and the production level. It is a large effort to measure copy numbers 
and the authors chose to use numbers from other papers. Not all changes in protein 
production could be explained by changes in plasmid copy number, and therefore 
other factors were believed to be involved, e.g. mRNA degradation and proteolysis. 
Görgens et al. (2001) studied the burden of the promoter system and heterologous 
protein production in S. cerevisiae. The heterologous protein investigated was a 
xylanase from Trichoderma reesei, the gene was inserted in the yeast cell on a 2µ derived 
plasmid. Different promoter systems were applied, a PGK1 and an ADH2 promoter, 
induced during growth on glucose and ethanol, respectively. Batch cultivations with 
cells transformed with empty plasmid and with plasmids containing only the promoter 
region were compared to cultivations with cells transformed with plasmids containing 
promoter and heterologous protein. It was concluded that maintenance and replication 
of the plasmid itself did not affect growth. However, the introduction of a promoter 
(without a protein) resulted in reduced maximal specific growth rate, lower biomass 
yield and a lower specific glucose consumption rate (Table 5.1). The application of 
inducible promoters made it possible to investigate the effect of the presence of the 
gene encoding the heterologous protein and protein production separately. The data 
indicated that the introduction of a gene encoding a protein only affected the 
phenotype of the cell during active gene expression (Table 5.1). The metabolic burden 
was found to be large compared to the amount of heterologous protein produced. 
Dilution of transcription factors can cause the essential transcription factors to become 
limiting thus affect the level of all genes including glycolytic enzymes and thereby 
growth. A competition for the transcription factors, biosynthetic precursors and energy 
can also be the cause of slower growth.  
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In my study introduction of an empty plasmid was found to have no effect on the 
maximal specific growth rate or yield of biomass on glucose. This is in accordance with 
the above mentioned findings by Görgens and co-workers. Introduction of a plasmid 
containing the expression cassette resulted in a decrease in the maximal specific 
growth rate, but no effect on the yield of biomass on glucose was observed (Paper A). 
The maximal specific growth rate of the industrial dummy strain (the industrial strain 
containing an empty plasmid) was determined to 0,35 h-1 in batch cultivations, and the 
maximal specific growth rate of the aprotinin producing industrial strain was 
determined to 0.16 h-1 (Paper A). 
5.2 Optimal level 
An optimal level of synthesis of heterologous protein has been shown to exist (Wittrup 
et al., 1994). The secretion of four different proteins; human granulocyte colony-
stimulating factor, human erythropoietin, human platelet-derived growth factor BB 
homodimer and bovine pancreatic trypsin inhibitor, was investigated by using both 
single copy and multicopy expression (Table 5.2).  
Table 5.1 Results from the investigation of the burden of promoter (PGK1 and ADH2) and 
heterologous protein production (XYN). The data originates from Görgens et al. (2001). 
Strain µmax, glucose h-1 Ysx, 
g DW/g glucose 
Glucose 
consumption 
rate, 
g glucose/(g 
biomass h) 
µmax, ethanol h-1 
Host 0.33 0.123 2.34 0.026 
PGK1a 0.28 0.114 2.10 0.035 
PGK1 + XYN 0.25 0.109 1.85 0.030 
ADH2 0.29 0.110 2.19 0.032 
ADH2 +XYN 0.27 0.122 2.13 0.028 
a PGK1 is induced by glucose 
b ADH2 is repressed by glucose and induced by ethanol 
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Secretion of bovine pancreatic trypsin inhibitor decreased as the copy number 
increased, further investigations showed this was to a high intracellular accumulation 
of unfolded protein (Wittrup et al., 1994). Similar results with expression of bovine 
pancreatic trypsin inhibitor (BPTI) were obtained by Parekh et al., 1995. The results 
illustrated that synthesis of BPTI was increased with increasing copies of the gene, but 
the secretory pathway was not capable to process the higher level of protein leading to 
intracellular accumulation. The expression of BPTI was investigated using a tunable 
integration vector (Parekh and Wittrup, 1997). In order to obtain higher levels of the 
heterologous protein the constitutive promoter was exchanged with an inducible 
promoter. At low expression levels a correlation between the mRNA level and secreted 
amount of BPTI was found, increasing the expression level did not result in increased 
secretion, in some instances the secretion actually decreased. The decrease in secretion 
was found to be associated with an intracellular accumulation of BPTI. The results of 
the above mentioned investigations show that the level of synthesis of a heterologous 
protein has to match the capability of the host cell to process the heterologous protein, 
and that the optimal level depend on the protein under investigation. 
Shusta et al. (1998) reported study of single-chain antibody fragments using inducible 
promoters. The use of an inducible promoter resulted in a decreased secreted amount 
and a simultaneous accumulation in Golgi, the protein was in an ER-processed pre-
Golgi form. This indicated that the expression was far beyond the optimal level of the 
cells. Kar2 and Pdi overexpression aided the secretion of single-chain antibody 
fragments (Shusta et al., 1998). 
This section underlines the significant importance of optimising the protein secretion 
as a whole rather than the individual steps in protein production, as optimisation of 
the individual steps most likely will result in a suboptimal overall process. For instance 
a higher level of mRNA does not always result in a higher secretion; sometimes 
actually the opposite is the case. 
Table 5.2 Relative expression of four different proteins from a single copy and a multi-copy 
plasmid (Wittrup et al., 1994). The expression from the single copy plasmids were for all the 
proteins set to 1. 
Protein Single copy Multi-copy 
Human granulocyte colony-stimulating factor 1 17 
Human erythropoietin 1 0.28 
Human platelet-derived growth factor BB homodimer 1 n.d. 
Bovine pancreatic trypsin inhibitor 1 0.67 
n.d. not determined, the level was below the detection limit 
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5.3 Adaptation to chemostat cultivation 
Wild type strains have been shown to change their metabolism during prolonged 
continuous cultivations. The changes are caused by the selective pressure put on the 
cell by the growth conditions; typically glucose limited conditions, and the 
accumulation of neutral mutations. The glucose limited conditions selects for strains 
capable of utilising the residual glucose. Ferea and co-workers measured the residual 
glucose concentration in chemostat cultivations, the residual glucose concentration in a 
cultivation with the parental strain was 0.17 g/L, in cultivations with strains evolved 
for 250 – 500 generations at glucose limited conditions the residual glucose 
concentration was reported to be between 0.04 and 0.06 g/L (Ferea et al., 1999). It has 
been stated that cells adapt to the continuous conditions if they are grown for more 
than 20 generations under the same conditions (Ferea et al., 1999). The changes thus 
occur rather fast when the cells experience constant conditions. 
Adaptation by S. cerevisiae to the conditions in a chemostat culture was studied using 
two independent chemostats, from a macroscopic point of view (based on biomass 
concentration, specific substrate uptake rate and carbon dioxide formation), the 
cultures were in steady state. However, a more thorough investigation of the 
cultivations revealed large variations with time (Mashego et al., 2005). The shape of the 
cells changed towards more elongated cells, which resulted in a higher surface to 
volume ratio. Both chemostats also showed a sharp decrease in the residual 
concentration of glucose after approximately 20 generations, after which the residual 
glucose concentration continued to decrease through the rest of the experiment, but at 
a lower rate. The decrease in extracellular glucose concentration resulted in lower 
intracellular glucose concentration, which again resulted in a decreased level of several 
primary metabolites. During the cultivation, a decrease in many of the activities of 
enzymes in the glycolysis was observed. The decreased activities were found to 
correspond to the reversible reactions of the glycolysis. The decrease in activity of 
enzymes in the glycolysis is believed to be caused by the shift from unlimited growth 
in the batch phase to glucose limited conditions in the chemostat and thus connected to 
the reduction of the specific growth rate.  
Another study on prolonged selection in chemostat cultures was done by Jansen et al., 
2005. Aerobic chemostat cultivations at a dilution rate of 0.1 h-1 were studied. As 
expected the residual concentration of glucose in the medium decreased sharply at the 
beginning of the cultivation, after hundred generations the level of glucose was 
constant during the rest of the cultivation. The fermentative capacity (defined as the 
mmol ethanol produced/(g biomass h) during anaerobic fermentation of glucose) of 
the cells was also found to decrease during the cultivation; this was found to correlate 
to a decrease in the activity of several enzymes in the glycolysis. The level of mRNA 
corresponding to glycolytic enzymes was not found to correlate with the changes in 
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enzyme activities, indicating that post-transcriptional modifications occurred. Genome 
wide transcription analysis revealed changed expression in a large number of genes, 
but it was not possible to detect which mutations caused the observed changes. 
Growing a micro-
organism in a 
constant environment 
over a large period of 
time has shown to 
lead to the 
accumulation of 
neutral mutations 
(Figure 5.2). As the 
neutral mutation does 
not give a growth 
advantage to the host 
cell, the number of 
mutant strains 
increase linearly with 
a slope dependent on 
the mutation rate. At 
some time point an 
advantageous 
mutation will occur, 
most probably in the original strain as this still constitutes the larger part of the 
population. This results in a sudden decrease in the number of cells carrying the 
neutral mutation as these cells are outgrown. However, mutations still occur in the 
new strain and therefore accumulation of neutral mutations will start over again. This 
scheme of increase and decrease in the number of neutral mutations continue during 
the whole cultivation period and is referred to as periodic selection (Berg, 1995 and 
Dykhuizen and Hartl, 1983).  
5.4 Ploidity 
Differences in the rate of fixation of adaptive mutations of strains with different 
ploidity have been the issue of several studies, but the conclusions of the studies differ. 
The diploid state has been found to give an advantage in relation to fixation of 
adaptive mutations in one study (Paquin and Adams, 1983). The advantage of the 
diploid state was believed to be due to a higher rate of mutation due to the larger size 
of the genome and the assumption that most adaptive mutations were dominant. Orr 
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Figure 5.2 The principle of periodic selection. During growth in a 
constant environment neutral mutations accumulate in the cells 
(the dotted line on the figure). The solid line shows percentage of 
the whole populations consisting of the consecutively evolving 
mutants. Once a mutation resulting in a growth advantage occurs, 
this mutant will take over the cultivation outgrowing the cells 
carrying neutral mutations. Adapted from Sauer (2001). 
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and Otto investigated the question whether haploid or diploid strains had an 
advantage in relation to fixation of adaptive mutations mathematically. Factors such as 
dominance of the mutations and the number of favourable mutations in a population 
influence the relative fitness of haploid and diploid strains. They found that small 
populations favour diploid strains, but in large populations diploid strains will adapt 
slower than haploid strains and thus be outgrown. Small populations are defined as a 
population in which a favourable mutation rarely arise whereas a large population is 
defined as a population in which a favourable mutation appear fairly often (Orr and 
Otto, 1994). These models were supported by later experiments by Zeyl et al., 2003. 
Adaptation of strains with different ploidity to unlimited conditions was investigated 
by the application of repeated batch cultures in my Ph.D study. The maximal specific 
growth rate of the unadapted haploid and diploid laboratory strain was found to be 
identical 0.23 h-1. In the repeated batch cultivations the maximal specific growth rate of 
the haploid strain was found to be constant whereas an increase in the maximal 
specific growth rate was observed of the diploid strain was observed. However, when 
the strains were grown in well-controlled batch cultivations an increase in the maximal 
specific growth rate of both strains identified, the maximal specific growth rate of the 
haploid and diploid strain was determined to 0.31 h-1 and 0.29 h-1, respectively (Paper 
A). Thus the present study did not indicate any advantage associated with either being 
haploid or diploid. 
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Chapter 6 
Evaluation of changes in the metabolism 
The present chapter contains an overview of the analytical methods, which have been 
used to evaluate the heterologous protein production and related changes of the 
metabolism. In the following sections some of the methods applied in the current study 
and the reason for application of these methods in particular will be discussed. The 
chapter contains detailed information on the development of a method for 
determination of aprotinin followed by an overview of analysis of the transcriptome 
data generated in my study and data analysis which complements the analyses 
reported in paper B and C. 
6.1 Measurement of the amount of aprotinin produced 
It is crucial to be able to determine the amount of heterologous protein produced. 
However, it is not trivial to design robust analytical methods that can determine the 
amount of protein in a complex sample matrix at high sensitivity and high accuracy. In 
the design of an analytical method the sample matrix presents a challenge because the 
cultivation broth contains different salts. Aprotinin, which was investigated in this 
study, has several characteristics which in principle should make it easy to design an 
analytical method: 
− HPLC is a proven method for analysis of proteins, although sensitive detection 
may be a challenge 
− Aprotinin could be detected by immunodetection by the use of specific 
antibodies against aprotinin. 
− The isoelectric point of aprotinin is 10.5, which is quite unusual for proteins 
produced by S. cerevisiae. This promoted the idea of using capillary 
electrophoresis for the determination of the amount of aprotinin secreted to the 
cultivation broth. 
− Aprotinin is an inhibitor of trypsin, the amount of aprotinin could thus be 
determined the ability of the cultivation broth to inhibit trypsin. 
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It would be informative to be able to analyse the amount of aprotinin produced by 
several different methods, e.g. a determination of the concentration and a 
determination of the activity of the aprotinin produced. Determination of both activity 
and concentration would give different kinds of information on the production, the 
concentration determination would detect all aprotinin produced, whereas the activity 
determination would detect the amount of the protein correctly folded for catalytic 
activity.  
A good method for determination of aprotinin was required to determine the amount 
of aprotinin in samples from shake flask, batch and chemostat cultivations preferably 
without any pretreatment of the samples. During my project, the aprotinin 
concentration was found to be approximately 1 mg/L in the first samples from batch 
cultivations, however, this was not known during the initial development of the 
analytical method.  
HPLC determination 
The HPLC method applied utilised gradient elution, which is characterised by a 
changing composition of the mobile phase with time. Two different solvents are used: 
a "weak" solvent, which allows the analyte to elute only slowly, and a “strong” solvent, 
which allows the analyte to elute rapidly from the column. Gradient elution has the 
advantage of resulting in sharper peaks than isocratic elution (constant composition of 
the mobile phase). 
Aprotinin can be detected by the HPLC method given in appendix A.1, aprotinin was 
detected after 9.0-9.1 minutes. Only standard solutions were analysed using this 
method, but problems with the detection limit were encountered. Standard samples 
containing 8.3 mg/L could be detected whereas 0.83 mg/L could not be detected. This 
problem could perhaps be eliminated by increasing the sample injection loop applied; 
however, this was not attempted due to limited HPLC capacity. 
Immunodetection analysis 
Another method for determination of aprotinin in cultivation samples was dot-blot 
analysis. This method was a simplification of traditional western blot; as no separation 
of the components in the samples were performed, but the samples were placed 
directly on a membrane, where the concentration was determined. The aprotinin 
concentration was detected by a cascade reaction between aprotinin (in mixture), 
primary antibody and secondary antibody. The protocol for determination of aprotinin 
by the dot-blot method is given in Appendix A.2. 
A linear correlation of the intensity and aprotinin concentration was found for 
aprotinin concentrations between 0 and 12 mg/L. The aprotinin concentration could 
also be determined in samples with a concentration above 12 mg/L, but another 
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correlation between the intensity and concentration had to be applied. However, 
determination of the spots was not trivial and different sizes were observed with 
different samples. Colouring of the spots was not found to be uniform in all instances, 
which was a problem for measurement of the concentration by determination of the 
intensity of the spots. The method was time consuming, as many washing steps had to 
be performed, which was found to be a limitation to the application of the method for 
determination of the aprotinin concentration in a high number of samples. Another 
limitation was the availability of the primary antibody. This method can be used to 
qualitatively rank many different samples. 
Capillary electrophoresis 
Several different ways to perform capillary electrophoresis exist, in the simplest form 
the capillary is filled with a buffer. When a sample is analysed the proteins in the 
sample are separated on the basis of their charge to size ratio. The proteins are detected 
by a UV detector after the separation. The charge of the proteins depends on the 
isoelectric point and the pH of the buffer solution. The charge of the capillary wall also 
depends on the pH of the buffer, at neutral pH the surface of the capillary is negatively 
charged whereas at very low pH values the negative charge is titrated off and thus the 
binding of positive proteins is avoided. An alternative to running at very low pH 
values is to add an ionic species to the buffer to create a dynamic coating of the wall or 
use a capillary with physical coating. Aprotinin has a high isoelectric point, which 
results in a positive net charge on the protein when it is analysed at neutral pH. Two 
different methods to avoid binding of aprotinin to the capillary wall was investigated, 
running at pH 2.5 to minimize the negative charge on the capillary wall and dynamic 
coating by addition of 1,3-diaminopropan.  
The amount of sample applied to the capillary introduced some variability and thus an 
internal standard was added to the samples. Different internal standards were tested, 
but imidiazol was found to be the most suited, it migrated faster than aprotinin and 
resulted in a narrow and symmetrical peak. Many different combinations of ionic 
strength and pH of the buffer and different concentrations of the dynamic coating 
compound were tested. Initially, the capillary was rinsed with a sodium hydroxide 
solution, as this was custom to do in our department (Jørgensen et al., 2003). However, 
it was found to result in a better analysis to rinse the capillary in the buffer between the 
samples. The best method is described in Appendix A.3. 
With a reliable method established, the range of detection had to be determined. 
Standard samples with an aprotinin concentration between 5 and 50 mg/L could easily 
be detected. Aprotinin in samples from a real cultivation was also successfully detected 
and validated by spiking with standard. A problem of the developed method was the 
detection limits, as the aprotinin concentration in the first part of a batch cultivation 
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was below 5 mg/L. Freeze-drying and ultrafiltration were tested as methods for 
concentrating the samples to be able to analyse the concentration of aprotinin. 
However, neither of these methods gave trustworthy analysis results.  
Determination by inhibition of trypsin 
Determination of the amount of aprotinin in the cultivation broth was done by a 
method developed by Parekh and co-workers, in which a manual determination of the 
aprotinin concentration was done using aprotinin’s ability to inhibit trypsin (Parekh et 
al., 1995). This method was combined with an established method in the department 
for determination of trypsin in whey using an analytical robot (Cobas Mira Robot). 
This resulted in a good semi-automated method for determination of the aprotinin 
concentration; the protocol for determination of the activity of aprotinin by the trypsin 
inhibition method can be seen in Appendix A.4. The method can be used for aprotinin 
concentrations in the range of 1-10 mg/L, thus samples from the beginning of batch 
cultivations could be analysed using this method.  
Comparison of the different methods investigated for the determination of aprotinin 
An overview of the different methods investigated in my study is given in Table 6.1. 
The most optimal analysis method for determination of the amount of aprotinin in the 
cultivation broth was found to be the measurement of the ability of the cultivation 
broth to inhibit trypsin. This method was used for all the determinations of aprotinin 
concentration reported in papers A, B and C.  
 
6.2 Overview of the array data 
Determination of the expression of single genes can be performed by Northern analysis 
whereas determination of the expression of the entire genome in yeast usually is 
performed by array techniques. In my study, I have used arrays manufactured by 
Table 6.1 Comparison of the different analytical methods 
Method Advantages Disadvantages 
HPLC Automated The detection limit is too high  
Immunodetection 
analysis 
Linear correlation between 
intensity and concentration of 
aprotinin between 0 and 12 mg/L 
Manual and time consuming 
Poor availability of the primary 
antigen 
Determination of the spots 
Capillary 
electrophoresis 
Automated Detection range 5-50 mg/L 
Trypsin inhibition Detection range 1-10 mg/L Partly manual 
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Affymetrix; they have a high degree of reproducibility. As the expression of the genes 
is highly dependent on the conditions, the microorganism “experience” care has to be 
taken in the design of a transcriptome experiments, both with respect to cultivation 
method and thus the surrounding environment, but also the time points for sampling. 
The results of a transcriptome analysis give insight into the expression pattern at the 
time point of sampling. Often replicates are taken in order to be able to evaluate the 
variance in the experiment. One distinguishes between technical and biological 
replicates; technical replicates involve multiple testing of one RNA sample, whereas 
biological replicates involve several independent RNA isolations. I have used arrays to 
investigate the expression profile at different time points during prolonged chemostat 
cultivations. Two different principles of withdrawal of the samples were applied:  
− Sampling at different time points during a prolonged continuous cultivation, 
one sample was analysed from each time point (Figure 6.1 A). Thus no 
replicates in the normal sense were made. However, the obtained results gave 
insight into the dynamic changes of the transcription profile with time (Paper 
C). 
− Sampling at the beginning and the end of a prolonged continuous cultivation 
(Figure 6.1 B), three samples were analysed from each time point, which gave 
technical replicates, which could be used to determine the deviations of the 
measurements. However, the results obtained did not result in any information 
about how the changes occurred.  
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Figure 6.1 Overview of sampling for transcriptome analysis during prolonged continuous 
cultivations. The x-axis shows the time in generations after connection of the continuous feed, 
10 generations correspond roughly to 3 days. The y-axis shows the normalised aprotinin 
concentration in the broth. In both cultivations, the industrial strain was investigated. The 
vertical lines represent time points of sampling. 
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The two different methods for sampling gave different information and the optimal 
sampling procedure thus depends on the information one wants to obtain from the 
analysis. Sampling at different time points without any replicates makes it possible to 
obtain information about the dynamic changes which occurred. The obtained gene 
expression data is highly suited for cluster analysis whereas traditional statistical 
analysis will be biased by the variation within the samples. If one is interested in the 
gene expression at the start and end of the cultivation sampling with replicates will 
result in a much stronger analysis. Table 6.2 shows all the different analyses made on 
the different data sets and also where to find the results of the analyses. 
Several of the analyses include t-tests, and Excel was well suited for this purpose. T-
test is applied to the huge amount of data generated in transcriptome analysis in order 
to identify the genes with significantly different expression. Different types of t-tests 
are available, depending on whether the test should be performed pair wise, if the 
samples have equal or unequal variance. Usually it is safest to assume unequal 
variance, if the number of replicates is limited; however, the test is more conservative 
resulting in less number of significant genes. In all the analyses performed in the 
present study unequal variance was assumed.  
When performing a statistical test a cut-off value also has to be chosen in order to 
identify the significant genes. Often a p-value of 0.05 has been used as the cut-off value. 
However, when transcriptome data is analysed, multiple testing is performed, 
resulting in a large number of false positives. A p-value of 0.05 correspond to 1 of 20 
tests resulting in a false positive and when 6000 tests are performed in parallel this 
correspond to 300 false positives. One way to decrease the number of false positives is 
to use the Bonferroni correction, where the p-value is divided with the total number of 
tests. With 6000 parallel tests this results in a cut-off value of 8.3·10-6(0.05/6000). The 
Bonferroni correction is a stringent method to reduce the number of false positives; 
however, the method also increases the number of false negatives. In the analyses 
performed in the present study no correction of the p-value was performed, which 
means one has to bear in mind the risk of a number of false positives. 
Table 6.2 Overview of the analysis of the array data 
Sampling method Analysis Location of results 
Sampling at different time 
points (Figure 6.1 A) 
 Comparison of strains (laboratory and 
industrial) using the first three arrays 
Paper B 
  2-way ANOVA (grouping of the arrays in 
young and old, three arrays in each 
group) 
Paper C 
  Analysis of the time response in each 
separate strain 
Section 6.4 
Sampling at the beginning 
and the end (Figure 6.1 B) 
 Analysis of changes with time in the 
industrial strain 
Section 6.3 
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The following sections (Section 6.3, 6.4 and 6.5) show analyses of the transcriptome 
data, which are complementary to the results shown in the Papers B and C. The 
analyses reported in the papers are more thorough than the one given here, and the 
analyses given in this chapter primarily stem from questions raised during the writing 
of the papers. One concern was the use of sampling at different time points which 
resulted in analysis without replicates in the normal sense (replicates were “generated” 
in the analysis as the arrays were pooled). Another concern was the differences in the 
time profile of the aprotinin concentration and dealt with the question of whether or 
not the two strains were suited for comparison. The final concern was on the analyses 
method applied in paper C (2-way ANOVA) and the results were therefore compared 
to results obtained by using normal t-tests. 
6.3 Analysis of transcription data from the beginning and end of a 
cultivation 
Comparison of the gene expression at the beginning and the end of a continuous 
cultivation was done with the industrial strain. Samples for array analysis were 
withdrawn after 33 and 86 generations after connection of the continuous feed. Four 
samples were withdrawn at each time point and three of these were analysed in order 
to obtain replicates (the fourth sample was backup). A t-test was used to compare the 
expression at the beginning and the end of the cultivation.  
Using a cut-off p-value of 0.001 resulted in 993 genes which changed expression 
significantly during the cultivation. The SGD Term Finder identified genes in lipid 
metabolic processes and in particular ergosterol metabolism to be highly represented 
among the genes. Of the 993 genes with significantly changed expression 460 were up-
regulated and 533 were down-regulated during the cultivation. Each of these groups 
was used as input to the SGD Term Finder (http://www.yeastgenome.org/) to 
identify if genes in any specific part of the metabolism were overrepresented when 
compared to the occurrence in the whole genome. Among the genes with increasing 
expression were identified sterol metabolic process, cellular metabolic lipid process, 
ribosome biogenesis and amino acid metabolic process as significant. Among the genes 
with decreasing expression were protein refolding, protein catabolic processes and 
fatty acid metabolic process identified as significant. It was interesting to identify gene 
ontologies involved in protein refolding and protein catabolic processes as significant 
as these changes probably are related to the changes in production of the heterologous 
protein. Protein refolding is the process of restoring biological activity of unfolded or 
misfolded protein and protein catabolic processes is breakdown of proteins. 
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6.4 Analysis of the transcription profile of the two strains separately 
Samples for transcriptome analysis were withdrawn from cultivations with the 
industrial and laboratory strains at different time points after connection of the feed. 
The profiles of aprotinin and biomass are along with the sampling times shown in 
Figure 6.2. 
 
 
The aprotinin concentration in the cultivation broth with the industrial strain showed a 
clear maximum around 20 generations (Figure 6.2 A), whereas the aprotinin 
concentration in the cultivation broth with the laboratory strain does not have a clear 
maximum, a maximum aprotinin concentration was estimated around 58 generations 
(Figure 6.2 B). The differences between the time points at which the aprotinin 
concentration in the cultivation broth reached a maximum led to the hypothesis that 
the gene expression of the young industrial strain was more similar to the old 
laboratory strain than the young laboratory strain. A t-test comparing the gene 
expression at the time points of the two first arrays of the industrial strain with the 
gene expression at the time points of the two first and two last arrays of the laboratory 
strain, respectively, was performed. The test revealed that the gene expression pattern 
of the industrial strain had the largest similarity to the gene expression pattern in the 
samples from the beginning of the cultivation with the laboratory strain.  
T-tests comparing the gene expression determined with the three first arrays (the ones 
denoted young in Figure 6.2) with the gene expression determined with the three last 
arrays (the ones denoted old in Figure 6.2) were made with each of the strains 
individually. Using a cut-off p-value of 0.05 resulted in 235 and 388 significant genes 
with the industrial and laboratory strain, respectively (Paper C). Even though a much 
less stringent cut-off was chosen than in the analysis of the data from sampling in 
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Figure 6.2 Comparison of the dynamic changes in gene expression during prolonged 
chemostat cultivations was obtained by sampling at different time points. The vertical lines 
indicate time points for sampling during cultivations, the sample corresponding to the dotted 
line was taken from an other cultivation run at identical conditions. Squares show the OD of 
the cultivation broth and triangles show the aprotinin concentration. A the industrial strain and 
B laboratory strain. (Paper C) 
A B 
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beginning and the end of a cultivation fewer significant genes were identified (a cut-off 
value of 0.001 resulted in 993 genes when analysing the data from the arrays shown in 
Figure 6.1 B). This stressed the fact that sampling with replicates result in a statistically 
much stronger dataset, as the arrays treated as replicates in the present analysis cover a 
lot of biological variation.  
The 235 genes identified as significantly changed in the cultivation with the industrial 
strain were used as input to the SGD Term Finder, but only the gene ontology cellular 
process was identified as significant. This is a very broad gene ontology, which is 
defined as any process that is carried out at the cellular level. Among the 388 genes 
identified as significantly changed in the cultivation with the laboratory strain no 
significant gene ontologies were identified when using the SGD Term Finder. A more 
systematic analysis of the data obtained by sampling at different time points can be 
found in paper C. 
6.5 Comparison of the analyses of transcriptome data 
The gene expression pattern of the laboratory and industrial strains were compared 
during prolonged continuous cultivations different kinds of analyses were applied 
(Table 6.2). The information obtained from the analyses depended both on the data set 
used as input and the method applied. 
In paper C, the gene expression data was obtained from the samples from the 
prolonged continuous cultivations used as input to a 2-way ANOVA, which identified 
genes with changed expression over time, strain and other factors. The output from the 
2-way ANOVA was used as input to the reporter algorithms. It was chosen to analyse 
the data by the 2-way ANOVA as the aim of the study was to identify global changes 
in relation to time. However, strain specific changes might not be identified. In order to 
identify strain specific reporter features a t-test was done comparing the gene 
expression for each of the strains compared between the young and old strains (Section 
6.4). This provided a strain specific p-value for each gene, which could be used as input 
to the reporter algorithm. Table 6.3 shows the reporter metabolites with a p-value 
below 0.01 in either of the analyses. Similar results are obtained if the reporter gene 
ontologies or reporter transcription factors were used for comparison. 
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Table 6.3 shows that different reporter metabolites are identified when the output from 
the different statistical analyses are used as input emphasizing the importance of 
choosing the statistical method relevant for the question of interest.  
The analysis clearly shows that the two strains have some strain specific responses to 
the prolonged continuous cultivations. Metabolites involved in “biosynthesis of 
steroids” are identified as significant when using the p-values obtained from analysing 
Table 6.3 Reporter metabolites with a p-value below 0.01 when analysing either the output 
from one of the t-tests (analysis of the gene expression separately for the two strains) or the 2-
was ANOVA. The p-values below 0.01 are shown in bold 
 
Groupa 
Metabolite p-value_LAB p-value_IND 
2-way 
ANOVA, 
time 
Allantoin 
degradation 
Urea 0.026 0.155 0.001 
Biosynthesis of 
steroids 
 
4,4-Dimethylzymosterol 0.071 0.040 0.004 
Biosynthesis of 
steroids 
 
Zymosterol 0.002 0.579 0.013 
Biosynthesis of 
steroids 
 
all-trans-Nonaprenyl 
diphosphate 
0.009 0.742 0.907 
Fructose and 
mannose 
metabolism 
 
alpha-D-Mannose 1-
phosphate 
0.001 0.015 0.180 
Fructose and 
mannose 
metabolism 
 
Mannan 0.141 0.004 0.115 
TCA cycle and 
glyoxylate cycle 
Fumarate 0.277 0.004 0.016 
Ubiquinone Q 
prenylation 
4-Hydroxybenzoate 0.007 0.781 0.809 
Phospholipid 
synthesis 
CDPdiacylglycerol 0.008 0.714 0.387 
- 
Ethanolamine 
phosphate 
0.005 0.651 0.125 
- NADPH 0.007 0.604 0.046 
- NAxt 0.335 0.008 0.139 
- Sodium 0.335 0.008 0.139 
- THRxt 0.195 0.111 0.007 
a The term group refers to the manual part of the metabolism in which the identified 
metabolite is involved in . 
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the data from only the laboratory strain and when analysing the output from the 2-way 
ANOVA, but not when analysing data from the cultivation with the industrial strain. 
Even though a part of the metabolism is identified in the 2-way ANOVA it may only be 
relevant for one of two strains compared. On the other hand, parts of the metabolism, 
are identified containing significantly changed metabolites in the analysis of the two 
strains separately, whereas not necessarily identified by the analysis of the output from 
the 2-way ANOVA, e.g. “fructose and mannose metabolism”. This underlines the need 
for a trained eye and manual curation when applying the different analyses. 
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Abstract 
Little is known about the effect of different strain backgrounds and ploidy of 
Saccharomyces cerevisiae on gene expression level and productivity of heterologously 
expressed proteins. Therefore, a comprehensive comparison between a haploid 
laboratory strain (LAB-HAP) and a diploid industrial strain (IND); both strains 
producing aprotinin, was performed. Gene expression data from glucose-limited 
chemostats with the two strains were compared revealing differences with relation to 
ubiquitination, fatty acid β-oxidation, ergosterol biosynthesis and mannosylation. Also 
the expression of transcription factors related to glucose repression (Adr1, Mig1 and 
Snf1) was identified as being significantly different, which led to a further comparison 
of the behaviour of the strains under conditions which induced glucose repression. The 
strains were adapted to nutrient unlimited conditions by repeated batch cultivations 
and the phenotypes were compared. Growth under nutrient unlimited conditions for 
500 generations was found to result in adaptation to the culture conditions. When the 
adapted strains were grown at restricted conditions, e.g. carbon-limited chemostat, 
only minor differences in the metabolism were detected. The study highlighted several 
differences and similarities between the two strain backgrounds and pointed out that 
processing and degradation of mRNA has a large effect on the yield of aprotinin. 
Keywords: heterologous protein production, adaptation, batch, chemostat, 
transcription analysis 
 
Introduction 
Saccharomyces cerevisiae is widely exploited in both industry and academia. Some of the 
reasons for the extensive use of this microorganism are the availability of methods to 
genetically manipulate it, its ability to produce and secrete glycosylated heterologous 
proteins and its ease of large scale cultivation (Buckholz and Gleeson, 1991). 
Traditionally, strain improvements have been achieved by repeated rounds of 
mutagenesis and selection. In more recent years metabolic engineering has been 
applied as an alternative for strain improvement, for example for optimization of small 
metabolite production. However, repeated rounds of mutagenesis often lead to 
crippled strains and metabolic engineering requires a gene to protein knowledge, 
which is not always available (Sauer, 2001). In the recent years a method for strain 
improvement referred to as evolutionary engineering has been described. Evolutionary 
engineering is composed of two sub-methods: directed evolution and metabolic 
engineering. Directed evolution has been defined as repeated cell cycles resulting in 
genetic diversity and selection of the fitter strain from the pool of variants by 
immediate selection or screening (Sauer, 2001). In the case of directed evolution the 
work is performed on populations and not on single cells, the cells with the most 
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advantageous phenotype will dominate the population, but the population is most 
likely heterogeneous. It has been demonstrated that S. cerevisiae adapt to the prevailing 
growth conditions and the changes depend on the genetic setup of the strains 
(Guimaraes et al., 2008; Kuyper et al., 2004). One obstacle in the application of 
evolutionary engineering is the design of the selection scheme. Some traits are 
relatively easy to select for e.g. strains with a high specific growth rate or with higher 
tolerance to toxic compounds whereas other traits e.g. increased productivity, which is 
desirable in the industrial applications, is more difficult to design a selection scheme 
for.  
Prolonged growth in a constant environment has, besides positive adaptive mutations, 
been shown to result in accumulation of neutral mutations in the cells (Berg, 1995). As 
the neutral mutations do not result in a growth advantage for the host cell, the number 
of mutant strains increases linearly with the number of generations. At some time 
point an advantageous mutation will occur, most probably in the original strain as this 
still constitutes the major part of the population. As the mutation is advantageous, it 
results in a sudden decrease in the number of cells carrying the neutral mutation as 
these cells now will be outgrown. However, mutation events will still occur in the new 
strain and therefore accumulation of neutral mutations will start over again. This 
scheme of increase and decrease in the number of neutral mutations continue during 
the whole adaptation period and is referred to as periodic selection (Berg, 1995 and 
Dykhuizen and Hartl, 1983). The mutations, which during the selection period are 
neutral, might have an effect on the phenotype if the strains are grown at another set of 
conditions than those prevailing during the selection scheme. To gain understanding of 
the mutations accumulating in a population during prolonged growth it is therefore 
beneficial to study the metabolism in different kinds of cultivations, e.g. batch 
(unlimited growth, high specific growth rate) and continuous (limited growth, fixed 
specific growth rate). 
Clonal analysis of strains after pro-longed growth in a chemostat has shown that the 
population is heterogeneous (Cakar et al., 2005; Sonderegger and Sauer, 2003). Plasmid 
stability in S. cerevisiae during continuous cultivation with selective pressure has been 
studied (O'Kennedy and Patching, 1999). The strain under investigation was deleted in 
the URA3 gene; a plasmid containing the URA3 gene ensured growth in minimal 
medium. The strain was grown for 420 generations and the ability of the strain to 
retain the plasmid was determined at different time points. This analysis revealed a 
polymorphic population in respect to plasmid retention. Actually both cells with 
increased and decreased plasmid retention were isolated, due to the possibility of cross 
feeding of uracil. Cross feeding is possible as the selection system is based on 
auxotrophic strains and a plasmid-free population can thus co-exist by utilization of 
the auxotrophic marker produced by the plasmid-containing cells. 
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In the current study, the effect of genetic background on heterologous aprotinin 
production was investigated. Bovine aprotinin is a small protein (6.5 kDa) with three 
disulfide bridges that act as a serine protease inhibitor. The investigated strains carried 
the gene encoding aprotinin on a plasmid. A strong selection for the plasmid is 
achieved by a complementation of a TPI1 deletion with a plasmid borne POT. TPI1 and 
POT  encode a triose phosphate isomerase from S. cerevisiae and S. pombe, respectively 
(Thim et al., 1986). The influence of differences in genetic background (laboratory and 
industrial) and in ploidy (haploid and diploid) was investigated. The gene expression 
levels were compared in the strains by whole-genome transcription analysis. This 
analysis was performed to analyse if the different genetic backgrounds had an effect on 
the transcriptome as the different genetic backgrounds result in different phenotypes. 
The transcription analysis was also used to investigate if differences in gene expression 
of genes related to heterologous protein production could be detected.  
Furthermore, the influence of the genetic background on heterologous protein 
production was investigated through an adaptation study. During the adaptation 
period the strains were selected for faster growth, which poses stress on the cells and 
also affects the production of the heterologous protein. The effect on the production of 
heterologous proteins is most often negative as production of the heterologous protein 
is a burden to the host cell and not necessary for growth. Important questions to raise 
when working with adaptation are: in which time scale do the adaptations occur and is 
it possible to reach a fully stable adapted strain or will the phenotype change 
continuously? To answer these questions, strains producing aprotinin, which were 
adapted to unlimited conditions by growth for 250 generations (Krogh et al., 2008), 
were grown in sequential shake flasks to push the adaptation further. Strains at 
different adaptation levels (unadapted, adapted for 250 and 500 generations, 
respectively) were compared in aerobic batch and continuous cultivations. The two 
cultivation methods were chosen in order to obtain insight into two different regimes 
of metabolism: the respiro-fermentative (batch cultivation) and fully respiratory 
(chemostat cultivation) metabolism. The two types of metabolism were characterised 
by different specific growth rates and glucose uptake rates and the effects of these 
differences on the production of a heterologous protein were investigated by 
measurement of the aprotinin concentration in the cultivation broth, the plasmid copy 
number and the level of mRNA corresponding to aprotinin.  
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Materials and Methods 
Strains 
Strains of Saccharomyces cerevisiae with two different genotypic backgrounds were 
investigated (Table 8.1). All strains carried a deletion in the chromosomal TPI1 gene 
(encoding triose phosphate isomerase) and have been transformed with a 2-µ-derived 
plasmid. The plasmid contains the POT gene from Schizosaccharomyces pombe (encoding 
triose phosphate isomerase) and an expression cassette for aprotinin (BPTI, Swiss-Prot 
P00974) with the TPI1-promoter and terminator. The POT gene was transcribed at 
relatively low levels in S. cerevisiae leading to a high copy number of the plasmid 
(Kawasaki and Bell, 1999). All the investigated strains were stored at -80°C in a 15% 
(v/v) glycerol solution.  
 
The strains were adapted to unlimited growth conditions in sequential shake flasks, i.e. 
the cells were not restricted in any nutrients and could grow at maximal specific 
growth rate. The strains were during the whole experiment grown exponentially on 
glucose (Krogh et al., 2008). 
 
Table 8.1 Strains used in this study 
Name Description Construction of the strains 
IND Industrial unadapted 
∆TPI1 transformed with plasmid (Bjørn et 
al., 1996) 
IND.adapt250 Industrial adapted-250 
Industrial unadapted grown for 243 
generations in sequential shake flasks 
(Krogh et al., 2008) 
IND.adapt500 Industrial adapted-500 
Industrial adapted-250 grown for 239 
generations in sequential shake flasks 
(current study) 
LAB-HAP 
Laboratory haploid 
unadapted 
∆TPI1 transformed with plasmid 
LAB-
HAP.adapt250 
Laboratory haploid 
adapted-250 
Laboratory haploid unadapted grown for 
265 generations in sequential shake flasks 
(Krogh et al., 2008) 
LAB-
HAP.adapt500 
Laboratory haploid 
adapted-500 
Laboratory haploid adapted-250 grown for 
264 generations in sequential shake flasks 
(current study) 
LAB-DIP 
Laboratory diploid 
unadapted 
∆TPI1 transformed with plasmid 
LAB-DIP.adapt250 
Laboratory diploid 
adapted-250 
Laboratory diploid unadapted grown for 
253 generations in sequential shake flasks 
(Krogh et al., 2008) 
REF Laboratory haploid CEN.PK 113-7D 
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Growth conditions and culture conditions 
The media used for adaptation and batch cultivation as well as the culture conditions 
are described elsewhere (Krogh et al., 2008). 
Chemostat cultivations 
Inoculation conditions 
A 500 mL shake flask with two baffles and 100 mL of medium was inoculated with one 
vial of cells from the -80°C-stock. A defined minimal medium containing vitamin and 
trace metal solution was used (Verduyn et al., 1992). The medium had the following 
composition: 7.5 g L-1 (NH4)2SO4, 14.4 g L-1 KH2PO4, 0.5 g L-1 MgSO4 7H2O, 2 mL L-1 
trace metal solution, 50 µL L-1 antifoam and 1 mL L-1 vitamin solution with an initial 
glucose concentration of 10 g L-1. Initial pH was 6.5 and the temperature was kept at 30 
°C. 
Medium and growth conditions 
Continuous cultivations were carried out in 1.5 L fermentors (Biostat, Braun Biotech 
International) with a working volume of 1 L. The fermentor was inoculated with cells 
growing exponentially and the cultivation was run in batch-mode until approximately 
80% of the initial glucose was consumed (initial glucose concentration 20 g L-1 using 
the same media composition as in the batch cultivation) and thereafter the feed was 
connected. The cultivations were run at a dilution rate of 0.1 h-1. A defined minimal 
medium containing vitamin and trace metal solution was used in the cultivations 
(Verduyn et al., 1992). The medium had the following composition: 10 g L-1 (NH4)2SO4, 
3 g L-1 KH2PO4, 1 g L-1 MgSO4 7H2O, 2 mL L-1 trace metal solution, 50 µL L-1 antifoam 
and 1 mL L-1 vitamin solution with a glucose concentration of 10 g L-1. Agitation, 
aeration rate and temperature were kept constant at 800 rpm, 1 vvm, and 30 °C, 
respectively. The pH was kept at 5.0 by automatic addition of 2 M NaOH.  
Analytical methods 
Determination of biomass concentration (dry weight and optical density) as well as 
concentration of metabolites was performed as described earlier (Krogh et al., 2008). 
The concentration of the metabolites glucose, glycerol, ethanol, pyruvate, succinate and 
acetate were determined by HPLC. 
Northern analysis and plasmid copy number determination by real-time PCR 
Samples from batch cultivations and steady state cultures were withdrawn for 
determination of the level of mRNA corresponding to aprotinin and plasmid copy 
number. The culture was considered in steady state when the dry weight 
determinations and the CO2 content in the exhaust gas varied less than 5 and 2 percent, 
respectively, in samples taken with an interval of 1 day. The sample treatment and 
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procedure for the northern analysis and copy number determination by real time PCR 
has been described elsewhere (Krogh et al., 2008). 
Probe preparation and hybridization to arrays 
Biomass samples for investigation of gene expression were withdrawn from 
continuous cultivations cultivating the IND and LAB-HAP strains. Two continuous 
cultivations were run with each strain. From one of the cultivations with each strain a 
sample was withdrawn as soon as a steady state was established. In the cultivation 
with the industrial strain this was achieved 15 generations after the connection of the 
continuous feed and in the cultivation with the strain with laboratory strain 
background steady state was achieved 10 generations after connection of the 
continuous feed. From the other cultivation two biomass samples were taken. The 
samples from the cultivation with the strain with industrial strain background were 
taken at 23 and 32 generations, respectively, after connection of the continuous feed 
and the samples from the cultivation with the strain with laboratory strain background 
were taken at 24 and 34 generations after connection of the continuous feed. Every time 
samples for transcriptome analysis were withdrawn four times 20 mL were swiftly 
taken from the cultures and transferred to 50 mL tubes containing approximately 30 
mL of crushed ice. The tubes were centrifuged at 4000 rpm for 2.5 min and the 
supernatant was discarded. The tube containing the pellet was submerged in liquid 
nitrogen and stored at -80 °C until further analysis. 
Total RNA was isolated from biomass samples using the RNeasy kit (Qiagen). The 
further processing of the samples was performed in accordance with “Affymetrix 
GeneChip® Expression Analysis Technical Manual”; the One-Cycle Target Labelling 
and Control Reagents kit (Affymetrix) was used. Briefly, cDNA was prepared from the 
isolated total RNA, the cDNA was biotin labelled, fragmented and hybridised to the 
GeneChip® Yeast Genome 2.0 Array. After the hybridisation the arrays were washed 
and stained followed by scanning (all in accordance with the above mentioned 
manual). The raw data was acquired from the array images by the use of the 
Affymetrix software (GCOS). The arrays were normalised using the dChip software 
(modified 5. march 2007). This software utilises the Invariant Set Normalisation 
Method for normalisation (Li and Wong, 2001). A heteroscedastic two-tailed t-test was 
used to identify genes with different expression in the two strains.  
Reporter algorithm 
The transcriptome data was analysed by using the reporter algorithm as described in 
(Patil and Nielsen, 2005 and Oliveira et al., 2008). This analysis helped in identifying 
key regulatory and metabolic processes that significantly differ between the two 
genetic backgrounds. The reporter algorithm uses a systems approach were the p-
values for all the genes identified by the transcriptome analysis are mapped on a 
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network describing the connection of the genes to the ‘features’, viz., Gene Ontologies, 
Transcription Factors or Metabolites, respectively. Each of the gene ontology terms, 
transcription factors and metabolites were then scored based on the significance of the 
transcriptional changes in the genes connected to them. High scoring features 
represent reporter gene ontology/transcription factors/metabolites. This way, 
significant reporter features were identified without prior decision of significance level 
at the level of transcription.  
 
Results and discussion 
This study investigated strains with different genetic backgrounds, a laboratory and 
industrial background. The gene expression levels of the strains during growth in 
carbon-limited chemostats were compared by transcriptome analysis to identify the 
differences caused by the two genetic backgrounds. Following the transcriptome 
analysis comparison of the strains was performed in batch and continuous cultivations. 
The comparison included measurements of the amount of protein secreted to the 
medium, the level of mRNA corresponding to the heterologous protein and the 
plasmid copy number. The current study includes strains, which have earlier been 
adapted to growth at unlimited conditions (these conditions selects for higher specific 
growth rate, which have a negative effect on the production of the heterologous 
protein) (Krogh et al., 2008). The already adapted aprotinin producing strains 
(IND.adapt250 and LAB-HAP.adapt250, Table 8.1) were further studied under growth 
in sequential shake flasks in order to investigate if the metabolism continues to change 
during such a directed evolution process. Figure 8.1 summarises the experimental 
design.  
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Physiological comparison and transcriptome analysis of unadapted strains  
Earlier conducted experiments have revealed many similarities between the two 
unadapted strains (IND and LAB-HAP) during batch cultivations (Krogh et al., 2008); 
the yield of aprotinin, the level of mRNA corresponding to aprotinin and the plasmid 
copy number were similar. The only major difference between the strains has been 
found to be a significant higher maximal specific growth rate of LAB-HAP compared 
to IND. However, adaptation to nutrient-unlimited conditions led to the same 
phenotypic changes: a decreased yield of aprotinin and an increased maximal specific 
growth rate, but different factors were found to be responsible for these phenotypic 
changes (Krogh et al., 2008). A thorough investigation of the two strain backgrounds 
was therefore motivated; this included continuous cultivation and global 
transcriptome analysis of the two strains.  
The global transcriptome analysis was performed in order to identify differences in the 
gene expression caused by the two different strain backgrounds (IND and LAB-HAP 
were compared). However, besides the general differences due to the different strain 
backgrounds also differences caused by the burden of the production of heterologous 
protein were expected to be detected. Clustering of the gene expression data showed 
that the variation between the data from two strains was larger than the variation of 
the gene expression data within the samples from each strain (Figure 8.2). The 
expression patterns of the IND and LAB-HAP strains were compared by t-test; using a 
Adaptation to 
unlimited conditions
and comparison of
the strains in batch 
cultivation
Unadapted Adapted 250 
generations
Adapted 500 
generations
Short continuous
cultivations
Continuous
cultivation for 
transcriptome 
analysis
 
Figure 8.1 Overview of the different kind of cultivations performed with the IND and LAB-
HAP strain (the whole figure). The LAB-DIP strain was only adapted for 250 generations and it 
was not grown in continuous cultivation for transcriptome analysis (the LAB-DIP strain was 
subjected to the different cultivations shown inside the dotted line). 
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cut-off value of 0.05 resulting in identification of 927 genes with different expression 
between the two strains. 
 
Gene Ontology analysis 
To get a global overview of the transcriptional differences between two strains, it was 
investigated whether specific cellular processes/functions were significantly different 
in the two investigated strains (IND and LAB-HAP). This analysis was performed by 
applying a reporter gene ontology algorithm (Oliveira et al., 2008). The gene ontologies 
describe how gene products are placed in a global cellular context. The input to the 
algorithm was all genes and their corresponding p-values (the output from the t-test) 
and therefore no pre-selection of significantly changed genes was performed. Table 8.2 
shows the 10 gene ontologies with the lowest p-value. Along with the gene ontologies 
is given the “number of neighbours”, which is the number of genes associated with the 
gene ontologies and the “significance count” which is the number of genes associated 
with the gene ontologies that are found to be significant in the t-test (p-value<0.05) 
with highest expression in the IND and LAB-HAP strains respectively. 
Taking a closer look at the different gene ontologies listed in Table 8.2, connections 
between some of the entries can be identified. When looking at the genes related to 
“endopeptidase activity” and “ubiquitin-dependent protein catabolism” a large 
majority of the genes are found in both gene ontologies. Ubiquitination of proteins 
marks the protein to proteasomal degradation and “ubiquitin-dependent protein 
LAB-HAP IND
 
Figure 8.2 Hierarchical clustering of the gene expression data from continuous cultivations with 
LAB-HAP and IND, respectively. Clustering was performed by using single linkage method 
and {1 - correlation coefficient} as a distance measure. Numbers 1 to 3 correspond to the gene 
expression data from the cultivation with the IND strain and the numbers 4 to 6 to the gene
expression data from the cultivation with the LAB-HAP strain. 
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catabolism” is therefore also related to “proteasome core complex, β-subunit complex 
(sensu Eukaryota)” and “proteasome core complex, α-subunit complex (sensu 
Eukaryota)”. One of the genes among the 21 identified as significant and belonging to 
the gene ontology “endopeptidase activity” is PEP4. It was expected to identify this 
gene as having significant different expression between the two strains as the gene 
encoding the proteinase has been deleted in the strain with the industrial background. 
Another group of related gene ontologies include “Fatty acid β-oxidation” and 
“Peroxisomal matrix”, as β-oxidation is performed in the peroxisomes. 
 
Ergosterol is an essential component of yeast plasma membrane; it influences fluidity, 
permeability and the activity of membrane-bound enzymes. In S. cerevisiae, ergosterol 
is also a major component of secretory vesicles and it has an important role in the 
mitochondrial respiration (Bammert and Fostel, 2000). Heterotrimeric G-protein 
complex is a molecular switch, which is involved in the mating of two haploid strains. 
When haploid cells of opposite mating types are brought together large changes in 
Table 8.2 The 10 gene ontologies with the lowest p-value identified by the reporter algorithm. 
The input to the algorithm was the p-value from the t-test comparing the gene expression level 
of the IND and LAB-HAP strains. 
Feature 
Number of 
neighborsa 
Significance 
countb, 
highest 
expression in 
the IND 
strain 
Significance 
countb, 
highest 
expression 
in the LAB-
HAP strain 
P-valuec 
Endopeptidase activity 29 0 21 1.37E-10 
Ubiquitin-dependent protein 
catabolism 
62 1 27 1.85E-07 
Proteasome core complex, β-subunit 
complex (sensu Eukaryota) 
7 0 7 1.14E-06 
Proteasome core complex, α-subunit 
complex (sensu Eukaryota) 
7 0 7 4.18E-06 
Fatty acid β-oxidation 9 1 8 6.32E-06 
Peroxisomal matrix 13 0 9 2.76E-04 
Ergosterol biosynthesis 25 1 10 4.52E-04 
Heterotrimeric G-protein complex 3 0 3 7.52E-04 
Dolichyl-phosphate-mannose-
protein mannosyltransferase 
activity 
6 4 0 7.66E-04 
Lagging strand elongation 16 7 2 8.37E-04 
a The number of genes associated with the feature 
b The number of genes associated with the feature and with a p-value below 0.05 in 
the t-test 
c The probability of the observed transcriptional response to be random 
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their physiology is observed. These changes are mediated by the heterotrimeric G-
protein, when a cell senses another cell of different mating type the GDP bound to the 
heterotrimeric protein is exchanged with GTP and the complex dissociates and it is one 
of the dissociation products which mediates the downstream activation of the 
physiological changes (Hirsch and Cross, 1992). The complex consists of an α, β and γ 
subunit, encoded by GPA1, STE18 and STE4. All three genes were expressed higher in 
the strain with the laboratory genetic background. However, this is believed to be a 
result of the two strains having different ploidity, the strain with laboratory genetic 
background is haploid whereas the strain with industrial genetic background is 
diploid.  
Dolichyl β-D-mannosyl phosphate is the donor of mannose in O-mannosylation of 
proteins. The mannose is transferred to the serine or threonine residues of the protein. 
Six genes are related to this gene ontology, all the genes are expressed higher in the 
IND strain. The higher expression in the IND strain suggests a higher degree of O-
mannosylation in this strain. Lagging strand elongation is the discontinuous synthesis 
of DNA in the direction 3’ to 5’ through the synthesis of small fragments named 
Okazaki fragments. However, this is not expected to be related to the production of the 
heterologous protein, but only a difference between the two genetic backgrounds. 
The results suggested that improvements of the industrial background primarily 
depend on gene deletions rather than up regulation of genes, as the genes with 
significant different expression resulting in differences in the gene ontologies listed in 
Table 8.2 were higher expressed in the LAB-HAP strain than in the IND strain. 
Reporter metabolite analysis 
The reporter algorithm was also applied to identify reporter metabolites (the 10 
metabolites with the lowest p-value are shown in Table 8.3). The reporter metabolites 
identified were based on the significance of the differential expression of the genes that 
encode enzymes catalyzing reactions involving a particular metabolite as a substrate or 
product (Patil and Nielsen, 2005). 
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3-Indoleacetonitrile, Indoleacetate, α-Aminopropiononitrile and γ-Amino-γ-
cyanobutanoate all has one neighbour and as the four reporter metabolites have equal 
Z-score and P-value it is the same neighbour. The gene involved in the conversion of 
the four reporter metabolites is NIT2; Nit2 has hydrolase activity acting on carbon-
nitrogen (but not peptide) bonds. Nit2 catalyses the release of NH3 from 3-
Indoleacetonitrile, α-Aminopropiononitrile and γ-Amino-γ-cyanobutanoate, 
respectively and the formation of Indoleacetate, L-alanine and L-glutamate, 
respectively. NIT2 is not found to have any other substrates than the metabolites just 
mentioned and the expression was highest in the LAB-HAP strain. 
Another group of the reporter metabolites were related to mannosylation of proteins, 
these include: Mannan, Dolichyl β-D-mannosyl phosphate, Dolichyl phosphate and α-
D-Mannose 1-phosphate. The mannose is transferred to the serine or threonine 
residues of proteins. Ten enzymes are identified which are related to the 4 reporter 
metabolites, all but one, was higher expressed in the IND strain than the LAB-HAP 
strain. The higher expression in the IND strain suggested a higher capacity of O-
mannosylation in this strain. The heterologous protein produced by both strains, 
aprotinin, is not glycosylated (Parekh and Wittrup, 1997), thus the different 
glycosylation patterns does not affect the production of this protein. However, the 
higher degree of glycosylation in the IND strain might be an important factor in the 
production of other proteins and therefore a main parameter in the selection of a 
production strain. 
Table 8.3 The 10 metabolites with the lowest p-value identified by the reporter algorithm. The 
input to the algorithm was the p-value from the t-test comparing the gene expression level of 
the IND and LAB-HAP strains. 
Feature 
Number of 
neighboursa 
Z-scoreb P-valuec 
Mannan 6 2.873 0.0020 
UDPglucose 12 2.577 0.0050 
P1,P4-Bis(5'-adenosyl) tetraphosphate 2 2.543 0.0055 
Dolichyl β-D-mannosyl phosphate 7 2.413 0.0079 
3-Indoleacetonitrile 1 2.310 0.0105 
Indoleacetate 1 2.310 0.0105 
α-Aminopropiononitrile 1 2.310 0.0105 
γ-Amino-γ-cyanobutanoate 1 2.310 0.0105 
Dolichyl phosphate 8 2.286 0.0111 
α-D-Mannose 1-phosphate 2 2.253 0.0121 
a The number of genes associated with the feature 
b The Z-score indicates how many standard deviations an observation is above or 
below the mean. 
c The probability of the observed transcriptional response to be random 
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Pre-selected genes 
Besides the analysis of general changes in the gene expression, a special focus was put 
on genes related to heterologous protein production. In order to focus on the genes 
related to the production of heterologous proteins a subset of genes was selected and 
analysed. This subset contained genes related to protein secretion, protein folding, 
chaperone and stress. The genes belonging to each subgroup were identified by using 
the group name as input in the “quick search” option on the SGD database (the list of 
genes was last updated Feb. 2008 and can be found in Appendix B). Table 8.3 
summarizes the number of genes in each subgroup as well as the number in each 
group which have significant different expression. 
 
The p-values of the different subgroups indicated that the number of genes which were 
significantly changed and belong to “protein secretion” was not significant, and could 
stem from random selection of the genes, as the p-value was above 0.05. However, the 
last three subgroups had low p-values as a result of a positive selection of these genes. 
The subgroup with the lowest p-value was “chaperone” group; the percentage of genes 
which was significantly differently expressed in the two strains was lower than the 
percentage belonging to the whole genome. The genes belonging to the subgroup 
“chaperone” was therefore regulated in the same manner in the two strains even 
though they have different strain backgrounds. The subgroups “protein folding” and 
“stress” both had low p-values and the percentage of genes in the groups were higher 
than in the whole genome, this suggested that these areas were effected by the 
different strain backgrounds. Taking a closer look at the 28 genes which transcript 
levels were significantly changed between the two strain backgrounds and belonged to 
Table 8.4 Subsets, which are believed to be related to the production of a heterologous protein, 
the number of genes in each subset and the number of genes in each subset which are 
significantly changed. The number of genes with significant different expression was identified 
by a t-test comparing the IND and LAB-HAP strains. 
Subset 
Number of genes in 
subseta 
Number of genes with 
significant different 
expressiona 
P-valueb 
Protein secretion 10 (0.17%) 0 0.170 
Protein folding 124 (2.17%) 28 (3.02%) 0.015 
Chaperone 408 (7.14%) 44 (4.75%) 0.0003 
Stress 416 (7.26%) 79 (8.52%) 0.015 
Genes in total 5716 927  
a The numbers in parenthesis in column 2 and 3 are, respectively, the percentage of the 
total number of genes and the total number of genes with significant changes in 
expression. 
b The hypergeometic probability, which is the probability of a given number of sample 
successes, given the sample size, population successes, and population size. The 
HYPGEOMDIST function in excel was used for the calculations 
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the subgroup “protein folding” revealed differences between the two strain 
backgrounds. Of the 28 genes, 24 were higher expressed in the LAB-HAP strain. Also 
in the subgroup of “stress” there was an overrepresentation of genes with higher 
expression in the LAB-HAP strain. Of the 79 genes which had different transcript 
levels, 51 had higher expression in the LAB-HAP strain. The subgroup “stress” is very 
broad and contains both genes which are directly related to heterologous protein 
production and genes which is not expected no be affected in the present study. The 
genes with significant different expression which belong to the subgroup stress were 
used as input in the SGD Term Finder. Gene ontologies related to DNA repair and 
response to osmotic stress were identified.  
In relation to the production of heterologous protein, the analysis of the pre-selected 
genes showed some differences between the two strain backgrounds in relation to 
genes belonging to the subgroup “protein folding”. On the other hand were genes in 
the subgroup “chaperone” regulated in the same way. This suggests that protein 
folding is a bottleneck in the production for the LAB-HAP strain, but not for the IND 
strain. Further investigations would be required to confirm this. 
Activation of the unfolded protein response takes place through removal of an intron 
in the HAC1 mRNA, which is then transcribed more efficiently and subsequently 
activates the genes involved in the unfolded protein response (Kaufman, 1999). The 
onset of the unfolded protein response is therefore not related to an elevation of the 
level of mRNA. It is thus more appropriate to look at genes known to be regulated by 
the protein unfolded response than directly at the expression of the genes activating 
the unfolded protein response. 381 genes have been identified to be regulated by the 
unfolded protein response (Travers et al., 2000). A reference dataset from the literature 
containing the results from a global transcription analysis of a reference laboratory 
strain without the gene encoding the heterologous protein and TPI deletion (Usaite, 
2008) was used to investigate if the unfolded protein response was activated in the 
laboratory aprotinin producing strain (LAB-HAP). Of the 381 genes regulated by the 
unfolded protein response, 78 genes with different expression in the two laboratory 
strains were identified (t-test, cut-off p-value 0.05). Of the 78 genes, 27 had highest 
expression in the reference strain and the remaining 51 genes had highest expression in 
the LAB-HAP strain. Among the 78 genes the GO component Endoplasmic Reticulum 
and related ontologies were found to be significant (SGD Term Finder). 
Transmembrane proteins and proteins synthesized for secretion and for transfer to 
other organelles are synthesized at the Endoplasmic Reticulum, and it is therefore not 
surprising to find differences in this area when comparing a strain producing a 
heterologous protein with a non-producing strain. However, the finding of only 78 
genes with significant different expression of the 381 genes regulated by the unfolded 
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protein response indicated that the unfolded protein response was not activated in the 
LAB-HAP strain. 
Reporter transcription factor analysis 
Differences between the regulatory network of the two genetic backgrounds were 
investigated by identifying reporter transcription factors (Oliveira et al., 2008). The 
algorithm uses the connection between each known yeast transcription factor to all the 
genes known to be regulated by these proteins. Since many transcription factors are 
themselves regulated at post-transcriptional level, the expression level of the 
transcription factors themselves may not differ between two genetic backgrounds even 
though their activity may differ. Thus, reporter scores for the transcription factors are 
good indicators of their relative activity. Table 8.4 shows the 10 reporter transcription 
factors with the lowest p-values. 
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The analysis of gene ontologies showed that genes involved fatty acid β-oxidation was 
expressed at a higher level in the LAB-HAP strain compared to the IND strain (Table 
8.1). The analysis of reporter transcription factors showed that transcription factors 
Table 8.5 The transcription factors with the lowest p-value identified by the reporter algorithm. 
The input to the algorithm was the p-value from the t-test comparing the gene expression level 
of the IND and LAB-HAP strains. 
Feature Descriptiona P-valueb 
Pip2 
Autoregulatory oleate-specific transcriptional activator of 
peroxisome proliferation, contains Zn(2)-Cys(6) cluster domain, 
forms heterodimer with Oaf1, binds oleate response elements 
(OREs), activates β-oxidation genes 
4.33E-06 
Oaf1 
Oleate-activated transcription factor, acts alone and as a heterodimer 
with Pip2; activates genes involved in β-oxidation of fatty acids and 
peroxisome organization and biogenesis 
4.38E-05 
Adr1 
Carbon source-responsive zinc-finger transcription factor, required 
for transcription of the glucose-repressed gene adh2, of peroxisomal 
protein genes, and of genes required for ethanol, glycerol, and fatty 
acid utilization‘ 
2.07E-03 
Paf1 
RNAP II-associated protein; defines large complex biochemically 
and functionally distinct from the Srb-Mediator form of Pol II 
holoenzyme; required for full expression of a subset of cell cycle-
regulated genes; homolog of human PD2/hPAF1 
2.19E-03 
Mig1 
Transcription factor involved in glucose repression; sequence 
specific DNA binding protein containing two Cys2His2 zinc finger 
motifs; regulated by the Snf1 kinase and the Glc7 phosphatase 
5.47E-03 
Snf1 
AMP-activated serine/threonine protein kinase found in a complex 
containing Snf4p and members of the Sip1/Sip2/Gal83 family; 
required for transcription of glucose-repressed genes, 
thermotolerance, sporulation, and peroxisome biogenesis 
5.67E-03 
Fzo1 
Mitochondrial integral membrane protein involved in mitochondrial 
fusion and maintenance of the mitochondrial genome; contains N-
terminal GTPase domain 
5.79E-03 
Oxa1 
Mitochondrial inner membrane insertase, mediates the insertion of 
both mitochondrial- and nuclear-encoded proteins from the matrix 
into the inner membrane, interacts with mitochondrial ribosomes; 
conserved from bacteria to animals 
5.79E-03 
Rds1 
Zinc cluster transcription factor involved in conferring resistance to 
cycloheximide 
5.79E-03 
Tim17 
Essential constituent of the mitochondrial inner membrane 
presequence translocase; interacts with Pam18 to recruit the 
presequence translocase-associated motor (PAM complex) and also 
required for protein sorting during import 
5.79E-03 
a Description according to the SGD database 
b The probability of the observed transcriptional response to be random 
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responsible for this difference in the metabolism probably were Pip2, Oaf1, Adr1 and 
Snf1. The transcription factors Fzo1, Oxa1, Rds1 and Tim17 have the same p-value (and 
also Z-score) and are all related to the gene PDR5. PDR5 encodes a multidrug 
transporter that is involved in the pleiotropic drug response, but this does not seem to 
be related to heterologous protein production. 
Also transcription factors related to glucose repression, which have not been identified 
directly by any of the other analyses, were identified; these include Adr1, Mig1 and 
Snf1. The identification of significant differences in the activity of transcription factors 
related to glucose induced regulation was very interesting, as both the glycolytic 
promoter, TPI1, and the triose phosphate isomerase have central roles in the 
production of the heterologous protein and in maintenance of the plasmid in the cells. 
The TPI1promoter is driving the production of the heterologous protein, and thus 
differences in glucose repression could have a direct effect on transcription of the gene 
encoding the heterologous protein. In addition to the effect directly on the 
transcription of the heterologous protein the autoselection of the plasmid is also based 
on a glycolytic enzyme. Differences in the glucose repression therefore have an effect 
on the plasmid copy number and thus the gene dosage of the heterologous protein. 
 
Adaptation and batch cultivations 
The finding of transcription factors related to glucose induced regulation led to the 
second part of the study, where the influence of cellular adaptation to glucose rich and, 
in general, nutrient unlimited conditions on protein production was investigated. The 
adapted-250 strains (IND.adapt250 and LAB-HAP.adapt250) were grown for around 
250 generations more in sequential shake flasks. It should be noted that one adaptation 
cultivation was run with each of the strain, as adaptation is based on random events it 
is not certain that exactly the same phenotype will occur during another adaptation 
even though the same selection pressure is applied. Following the adaptation period, 
the strains were cultivated in batch cultures in order to be able to compare their 
phenotypes with the earlier adapted strains. A comparison of the IND, IND.adapt250, 
IND.adapt500, LAB-HAP, LAB-HAP.adapt250 and LAB-HAP.adapt500 strains in batch 
cultivations showed some interesting differences (Table 8.6). The maximal specific 
growth rate of the IND.adapt250 strain was twofold of the maximal specific growth 
rate of the IND strain, whereas the maximal specific growth rate of the IND.adapt500 
strain was 80% of the corresponding value for the industrial adapted-250. Comparison 
of the maximal specific growth rate of the LAB-HAP and LAB-HAP.adapt250 strains 
showed that the LAB-HAP.adapt250 strain grew with a maximal specific growth rate 
35% higher than the LAB-HAP strain. The maximal specific growth rate of the LAB-
HAP.adapt500 was 85% of the LAB-HAP.adapt250 strain. 
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The yield of aprotinin decreased with the number of generations in the cultivations 
using the industrial strain background. The aprotinin yield resulting from the 
cultivation of the IND.adapt250 and IND.adapt500 was 50 and 30 percent of the IND 
strain, respectively. The yield of the aprotinin resulting from the cultivation of the 
LAB-HAP.adapt250 and LAB-HAP.adapt500 was roughly 60 and 70 percent of the 
yield resulting from cultivation of the LAB-HAP strain. The influence of the adaptation 
on the yield of glycerol was different in the two genetic backgrounds, the yield of 
glycerol was similar in the cultivations with the IND.adapt250 and IND.adapt500 
strains, but during the second round of adaptation, the yield of glycerol doubled in the 
cultivation using the strain with laboratory genetic background. The yields of biomass 
and ethanol were not affected during the adaptation in either strain (data not shown). 
The plasmid copy number and the level of mRNA of aprotinin were determined in the 
adapted and unadapted strains. Both the mRNA level and plasmid copy number was 
determined relative to the amount of actin mRNA and DNA, respectively, therefore 
Table 8.6 Maximal specific growth rate and yield coefficients during batch cultivations. The 
level of mRNA and plasmid copy number was determined in triplicate in a sample withdrawn 
at OD 5 from one cultivation with each strain. 
 µmaxa Yxpb Ysgc 
mRNA 
leveld 
Plasmid 
copy  
number 
No. of  
cultivatio
ns 
IND (Krogh et al., 
2008) 
0.16 ± 0.02 4.87 ± 0.61 
0.11 ± 
0.01 
2.4 ±0.3 11.8 ±1.8 6 
IND.adapt250 
(Krogh et al., 
2008) 
0.33 ± 0.04 2.44 ± 0.24 
0.06 ± 
0.00 
1.9 ±0.0 2.4 ±0.3 3 
IND.adapt500 
(this study) 
0.27 ± 0.00 1.51 0.07 1.1 ±0.1 11.2 ±1.9 1e 
LAB-HAP 
(Krogh et al., 
2008) 
0.23 ± 0.02 4.51 ± 0.74 
0.08 ± 
0.01 
2.1 ±0.1 12.2 ±1.6 6 
LAB-
HAP.adapt250 
(Krogh et al., 
2008) 
0.31 ± 0.04 2.76 ± 0.16 
0.04 ± 
0.01 
2.4 ±0.2 16.9 ±2.0 4 
LAB-
HAP.adapt500 
(this study) 
0.27 ± 0.00 3.09 0.09 1.4 ±0.1 15.4 ±1.4 1e 
a maximal specific growth rate (h-1), 
b yield of aprotinin on biomass (mg g-1), 
c yield of glycerol on glucose (g g-1), 
d level of mRNA corresponding to aprotinin, 
e two cultivations were used for calculation of the maximal specific growth rate, but 
only one was used for yield determinations 
Paper B 
 
 96
comparisons should only be made within strains with the same genetic background. 
The decline in the yield of aprotinin obtained in the cultivations with the industrial 
strains with increasing number of generations in sequential shake flasks was linked to 
a significant (One-way ANOVA, α =0.05) decline in the level of mRNA corresponding 
to aprotinin. The changes in the level of mRNA could, however, not be related to 
changes in the plasmid copy number as this increased after the last round of 
adaptation. The plasmid copy number in the IND and IND.adapt500 strain was 
actually similar.  
In the laboratory haploid strain, the yield of aprotinin decreased during the first round 
of adaptation and it was constant during the second, however, this picture can not be 
seen in the level of mRNA corresponding to aprotinin; which was significantly 
different in the cultivation with the LAB-HAP.adapt250 and LAB-HAP.adapt500 
strains (One-way ANOVA, α=0.05). The level of mRNA corresponding to aprotinin 
was constant during the first round of adaptation and declined during the second 
round of adaptation. The plasmid copy number of the laboratory haploid strain 
increased during the first round of adaptation and decreased during the second round 
of adaptation, the plasmid copy number of the LAB-HAP.adapt500 strain still being 
higher than the plasmid copy number of the LAB-HAP strain. 
Short continuous cultivations 
The strains were also compared in continuous cultivations as these cultivations 
provide insight into another part of the metabolism than batch cultivations. During the 
continuous cultivations the specific growth rate was kept at 0.1 h-1 (equalling the 
dilution rate), which was lower than the critical specific growth rate for all the 
investigated strains and the metabolism was fully respiratory (which was also 
confirmed by metabolite analysis). During these conditions no glucose repression is 
taking place. The results from the continuous cultivations are summarized in Figure 
8.3. 
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Comparison of the continuous cultivations with the strain with industrial background 
showed, contrary to the results obtained in batch cultivation, an increase in the yield of 
aprotinin during the second round of adaptation. The level of mRNA is constant (One-
way ANOVA, α =0.05) throughout the adaptation period even though the plasmid 
copy number decreased during the first adaptation round. Adaptation of the 
laboratory haploid strain resulted in a slightly increased yield of aprotinin on biomass 
in chemostat cultivations. The increase is coupled to a significant (One-way ANOVA, α 
=0.05) increase in the level of mRNA, corresponding to aprotinin during the first 
adaptation period, but the level of mRNA does not change during the last adaptation 
period. The plasmid copy number of the haploid laboratory strain remained constant 
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Figure 8.3 The yield of aprotinin on biomass, the level of mRNA corresponding to aprotinin and 
the plasmid copy number in the continuous cultivations at steady state. The level of mRNA and 
plasmid copy number was determined in triplicate from a sample withdrawn from a 
continuous cultivation with each strain. 
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during the whole adaptation period. The continuous cultivation of the LAB-
DIP.adapt250 resulted in a lower yield of aprotinin on biomass than the similar 
cultivation with the unadapted strain. In contrast to this significant (One-way ANOVA, 
α =0.05) increase was detected in the amount of mRNA corresponding to aprotinin. 
The plasmid copy number was constant during the adaptation period. 
Comparison of the batch cultivations and short steady states revealed some 
differences. The yield of aprotinin on biomass was in the same range for the two types 
of cultivations, but differences were found in the level of mRNA corresponding to 
aprotinin and also in the plasmid copy number. Apparently, the continuous cultivation 
promotes a higher plasmid copy number than the batch cultivation does, but the level 
of mRNA corresponding to aprotinin was lower in continuous cultivation than in 
batch. This discrepancy between the level of mRNA and plasmid copy number relates 
to the activity of the tpi1 promoter (as this is responsible for the production of mRNA 
corresponding to aprotinin) and mRNA degradation. Looking at the ratio of the level 
of mRNA and plasmid copy number in the batch cultivations did not show any clear 
trend between the different strains during the adaptation period. However, looking at 
the same ratio in the chemostat cultivations some similarities could be detected. The 
ratio of the unadapted, adapted-250 and adapted-500 strain with industrial and 
laboratory haploid backgrounds had the same profile as function of adaptation time. 
During the first round of adaptation the ratio doubled or tripled and during the second 
round of adaptation the ratio decreased to a value between the two first. This suggests 
that the activity of the tpi1 promoter is regulated in the same way in the strain with the 
industrial and laboratory haploid backgrounds when grown in chemostats. 
 
Conclusion 
Differences in the global gene expression of two aprotinin producing S. cerevisiae 
strains were identified. Application of the gene ontology algorithm (on a dataset 
comparing the IND and LAB-HAP strains in continuous cultivation) identified several 
significant gene ontologies which were related to protein production; ubiquitin-
dependent protein catabolism, ergosterol biosynthesis and mannosyltransferase. 
Different expression of the genes in these gene ontologies combined with the variation 
observed in aprotinin mRNA level were the cause of the different yields of aprotinin 
observed in the continuous cultivations. 62 genes belonged to the gene ontology 
ubiquitin-dependent protein catabolism, 28 of these genes were significantly different 
expressed in the two genetic backgrounds, all but one of the significant differently 
expressed genes were found to be expressed higher in the LAB-HAP strain. The total 
number of genes related to ergosterol biosynthesis was 25 and 11 of these had 
significant different expression. Again 10 of the significant different expressed genes 
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were expressed at a higher level in the LAB-HAP strain. Analysis of the pre-selected 
sub-groups of genes pointed to that protein folding and not protein secretion were a 
bottleneck in the protein production in the strain with the LAB genetic background 
suggesting that the genes involved in ubiquitin-dependent protein catabolism had a 
larger influence on the yield of aprotinin than did the genes related to the gene 
ontology ergosterol biosynthesis. 
The aprotinin producing strains were adapted to nutrient unlimited conditions for 
both 250 and 500 generations. These strains were compared in batch and continuous 
cultivations with the unadapted strains. The comparison showed that the phenotypes 
of the adapted strains are highly dependent on the cultivation conditions, as the 
difference in phenotype is less pronounced when the strains are grown in chemostat 
cultivation than when grown in batch cultivations. This means that it is not possible to 
achieve a large number of generations in e.g. batch cultivations and in this way change 
the phenotype under other conditions. 
It was investigated how prolonged growth at unlimited conditions affected the 
production of aprotinin. The determination of the yield of aprotinin, plasmid copy 
number and level of mRNA corresponding to aprotinin in batch and continuous 
cultivations revealed no clear correlation. Thus processing of mRNA has a large effect 
on the yield of aprotinin. The adaptation to unlimited conditions is also believed to 
have an effect on the processing. 
The identification of reporter transcription factors highlighted some interesting 
differences between the two genetic backgrounds; the recognition of transcription 
factors involved in fatty acid β-oxidation (Pip2, Oaf1, Adr1 and Snf1) and glucose 
repression (Adr1, Mig1 and Snf1) was significant. At present it is unknown if and how 
the expressions of these transcription factors affect the production of heterologous 
protein in S. cerevisiae. However, the influence of glucose repression on heterologous 
protein production has been evaluated in Kluyveromyces lactis (Donnini et al., 2004). In 
K. lactis the production of heterologous protein was affected by deletion of genes 
involved in glucose repression. Deletion of RAG1 (a low affinity glucose permease) and 
KlMIG1 (a component of the repressor complex) resulted in lower secretion of the 
heterologous protein whereas deletion of DGR151 (the single hexokinase) increased the 
production. Consequently, it could be interesting to investigate how the production of 
aprotinin is affected by changes in the transcription factors Adr1, Mig1 and Snf1. 
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Abstract 
Heterologous protein production in Saccharomyces cerevisiae using continuous 
cultivations is of substantial industrial interest due to the possibility of achieving high 
productivity. One of the major problems during a continuous process is the time-
dependent variability and eventual drop in the productivity. In order to identify the 
cellular processes underlying this variability, we investigated the physiological and 
global gene-expression changes during prolonged chemostat cultivations (70-150 
generations which corresponds to 490-1050 hours of cultivation) of two different 
strains, a diploid industrial (IND) and a haploid laboratory (LAB) strain. 
The cultivations of both strains reached a steady state level of biomass, whereas the 
concentration of the heterologous protein in the cultivation broth changed with time. 
In all the cultivations with the IND strain, the concentration of the heterologous protein 
in the cultivation broth reached a maximum after 20 generations after connection of the 
feed. In the cultivations with the LAB strain, the maximal concentration of the 
heterologous protein was reached later. The decline in heterologous protein 
concentration was not linked to loss of the expression cassette, indicating cellular 
reprogramming during prolonged continuous cultivations as a cause for the decreased 
production of heterologous aprotinin.  
Global gene expression analysis was used to identify genes with altered expression 
during prolonged continuous cultivations. One hypothesis for the decrease in protein 
production was that the decline in heterologous protein production was linked to a 
general down-regulation of the genes in the glycolysis; the heterologous protein was 
placed under a glycolytic promoter. Another hypothesis was recirculation of protein; 
the hypothesis was based on observed changes in the metabolism of amino acids. A 
third hypothesis was that the decline in aprotinin production was caused by the 
catalytic activity of aprotinin; aprotinin is a serine protease inhibitor.  
Keywords 
Transcription analysis, long-term continuous cultivation, adaptation, heterologous 
protein production 
Background 
Saccharomyces cerevisiae is widely used in the production of various pharmaceutical 
products. Generally three different cultivation methods can be used for the production 
of heterologous proteins: batch, fed-batch and continuous cultivation. In batch 
cultivations the cells experience high initial concentration of the nutrients and varying 
conditions throughout the cultivation. S. cerevisiae is characterised as a Crabtree 
positive yeast, which means that it produces ethanol when it experiences high glucose 
concentrations even though oxygen is present. A threshold value of glucose exists 
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above which ethanol formation occurs resulting in low biomass yields on glucose in 
the batch phase. During fed-batch cultivations a highly concentrated solution of 
nutrients is added in a feed to the cultivation vessel. There is no withdrawal of 
fermentation broth from the vessel leading to a prolonged growth phase and a very 
high cell mass concentration can be achieved. Continuous cultivations are 
characterised by the possibility of maintaining a constant environment for a prolonged 
period of time, feeding the culture with fresh medium and withdrawal of cultivation 
broth at the same rate. It is possible in both fed-batch and continuous cultivations to 
maintain a low glucose concentration in the broth by controlling the feed rate and 
thereby avoiding ethanol production. Most industrial processes are currently fed-batch 
processes, which is partly caused by the risk of genetic instability and contamination 
during continuous cultivation. Furthermore, the approval procedure of continuous 
cultivations is unclear, due to difficulties defining the process lifetime (Porro et al., 
2005). However, it is less labour intensive to run the process continuously as the labour 
intensive parts of cultivations are the upstart and cleaning of the equipment. The 
continuous cultivation is also easier to automate than batch and fed-batch cultivation. 
It is therefore economically attractive to run certain types of processes in a continuous 
manner. Novo Nordisk produces insulin in S. cerevisiae using a continuous set-up. The 
cultivation starts with an initial batch phase (20 h) followed by fed-batch phase during 
which the cell mass concentration increases. After 72 h of cultivation the continuous 
part begins and it can run for the next 3 weeks (Diers et al., 1991). Continuous 
cultivations could in principle run for an infinite length of time. However, running a 
cultivation for a long period of time results in many cell divisions and each cell 
division involves a risk of alterations in the genetic material. Changes in the genetic 
material can in some cases have an effect on the productivity or product quality, which 
both are important parameters in the production of heterologous proteins. Many 
factors influence the risk of changes in the genetic material of a strain expressing a 
heterologous protein in continuous culture, e.g. the heterologous protein itself, the 
expression system and the host strain (Beretta et al., 1991).  
Cultivation of wild type S. cerevisiae in prolonged continuous cultivation has been 
shown to have an effect on the central metabolism (Mashego et al., 2005, Jansen et al., 
2005 and Wu et al., 2006). These investigations have all been performed below the 
threshold of aerobic ethanol formation and thus the cells experienced a constant low 
glucose concentration. At low glucose concentrations in the broth the uptake rate 
depend on the cell’s affinity towards glucose, and increased glucose affinity is a 
growth advantage to the cell. A decline in the residual glucose concentration, 
indicating increased affinity, has been found to occur as a function of the cultivation 
time. Furthermore, a decrease in the activity of most glycolytic enzymes during 
prolonged cultivations has been identified; however, this decrease could not be 
recognized in the levels of mRNA suggesting post-translational control of the 
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glycolytic enzymes (Jansen et al., 2005). It has been hypothesized that the glycolytic 
enzymes have an overcapacity in the beginning of prolonged continuous cultivations 
which is caused by the need to be able to cope with large fluctuations in glucose 
concentration (Mashego et al., 2005). This ability is partly lost during the prolonged 
continuous cultivations as the cells experience a constant low glucose concentration. 
The production of some heterologous proteins has been shown to be toxic to the host 
cell, e.g. human alpha-synuclein, human REP1 and three cyclins from Drosophila 
(Maya et al., 2008). These proteins therefore have a negative effect on the production 
stability e.g. by enhancing the risk for plasmid loss or recombination or simply 
impairing growth of the host or interfering with some metabolic reactions. If toxicity of 
the heterologous protein is the main cause of decline in protein production an 
inducible promoter may be used to separate the growth and the production phases. 
Decreasing production by time in continuous cultivations has also been reported when 
proteins, which have not been identified as toxic to S. cerevisiae, were produced. An 
example of a non-toxic protein is hirudin (Janes et al., 1990). The expression of hirudin 
from a 2µ plasmid in S. cerevisiae has been studied during continuous cultivation (Ibba 
et al., 1993). Different dilution rates were investigated (two below and one above the 
threshold of aerobic ethanol production, all cultivations were investigated for 75 
generations). After 75 generations only 5 to 10 % of the population did not contain the 
expression plasmid. Although the plasmid copy number was almost constant during 
the continuous cultivations it was not possible to establish a true steady state as the 
yield of hirudin never stabilised completely. In the beginning of the cultivations the 
yield of hirudin was fluctuating around a constant level. However, between 45 and 65 
generations, the yield of hirudin started to decline. The yield of hirudin had after 75 
generations decreased to 45-75 % of the maximum yield (depending on the dilution 
rate).  
A general burden on the host metabolism due to heterologous protein production 
resulting in, e.g. lowered maximal specific growth rate (Da Silva and Bailey, 1991) or 
lowered biomass yield (Gopal et al., 1989) has earlier been demonstrated. Also for the 
current setup the protein production has been found to result in a lowering of the 
maximal specific growth rate compared to a dummy strain containing an empty 
plasmid (Krogh et al., 2008). Growing the cells in sequential shake flasks (repeated 
batch cultivations) for 250 generations led to a partial relief of the burden, which 
resulted in a lower protein production and a higher maximal specific growth rate 
(Krogh et al., 2008). The growth in sequential shake flasks was characterised as being 
un-limited in regard to all nutrients, and therefore selected for cells with higher 
maximal specific growth rate. The results showed that the strains adapt to the growth 
conditions when they were grown for a large number of generations under the same 
growth conditions. The transcriptional profile of the two hosts has been investigated 
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during short term chemostat cultivation (Krogh et al., 2009), the focus area was 
investigation of differences between the transcriptional profile of the two strains. 
Differences linked to the cellular processes involved in heterologous protein 
production; e.g. the genes involved in gene ontologies (GO’s) such as ubiquitin-
dependent protein catabolism, ergosterol biosynthesis and mannosyltransferase were 
identified. The results also indicated that processing of mRNA has a large effect on the 
yield of heterologous protein (Krogh et al., 2009).  
As, batch cultivations rarely are used in industry for protein production it was chosen 
to analyse the changes observed during prolonged continuous cultivations in the 
present study. S. cerevisiae strains expressing the heterologous model protein, 
aprotinin, were studied in prolonged continuous cultivations. Aprotinin is a basic 
protein consisting of 58 amino acids with three disulfide bridges, it is a serine protease 
inhibitor and the production is therefore troublesome to the host. Two different hosts 
were included in the study; one strain with industrial and one with laboratory 
background, respectively. The cultivations in the current study were run at a dilution 
rate of 0.07-0.10 h-1 for 70-155 generations. The focus of this study was the influence of 
cultivation time on the production of aprotinin and host cell metabolism. In order to 
determine the cellular processes leading to changes in the production of aprotinin as a 
function of time, the transcriptional profile of the strains were determined at different 
time points during the prolonged continuous cultivations. This made it possible to 
evaluate changes in the expression of the genes (both related and unrelated to protein 
production) as a function of the age of the cultivation. 
 
Materials and methods 
Strains and growth conditions 
Two different strain backgrounds were investigated in this study, a haploid laboratory 
(LAB) and a diploid industrial (IND) strain background. The LAB strain was 
constructed from the CEN.PK 113-7D strain (Overkamp et al., 2002). Construction of 
the IND strain has also been described elsewhere (Bjørn et al., 1996). Both strain 
backgrounds carried deletions in the chromosomal TPI1 gene (encoding triose 
phosphate isomerase) and have been transformed with a 2µ-derived plasmid (Bjørn et 
al., 1996). The plasmid contains the POT gene from Schizosaccharomyces pombe 
(encoding triose phosphate isomerase) (Thim et al., 1986) and an expression cassette for 
aprotinin (BPTI, Swiss-Prot P00974) with the TPI1 promoter and terminator. The POT 
gene has been shown to be transcribed at relatively low levels in S. cerevisiae and this 
leads to a high copy number of the plasmid (Kawasaki and Bell, 1999). All the 
investigated strains were stored at -80 °C in a 15 % (v/v) glycerol solution.  
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The strains were investigated in aerobic glucose limited continuous cultivations at a 
dilution rate of 0.07 - 0.1 h-1 for 70-155 generations. The pre-cultures performed in 
shake flasks were inoculated with one vial of cells from the -80 °C stock, and 
exponentially growing cells from the shake flasks were used to inoculate the 
cultivations. The initial glucose concentration in the batch phase was 20 g/L, when 
approximately 80% of this was metabolised the continuous feed was started. A 
minimal medium with a glucose concentration of 10 g/L in the feed was used (Krogh 
et al., 2009), agitation, aeration rate and temperature were kept at 800 rpm, 1 vvm and 
30 °C, respectively. The pH was kept at 5.0 by automatic addition of 2 M NaOH. 
Analytical methods 
Biomass concentration 
During the cultivations the concentration of biomass was followed by measurements of 
the optical density at 600 nm. Two different methods were used for the determination 
of dry weight, but no difference was observed between the two methods. In some 
cultivations the dry weight of biomass were determined by centrifugation of 10 mL of 
fermentation broth in a pre-weighed tube, after centrifugation the tube with pellet was 
dried at 100 °C for 24 hours and weighing was repeated. In other cultivations the dry 
weight of biomass was determined by the use of a Gelman Supor®-450 membranes, 
0.45 µm. A known volume of cultivation broth was filtered on a dry pre-weighed filter. 
After filtration the filter was dried in a microwave oven at 150 W for 15 min. Finally the 
filter was weighed again. 
Aprotinin activity 
Samples from the cultivations were centrifuged and the supernatant kept at -20 °C 
until analysis. The amount of heterologous protein, aprotinin, was determined by 
measuring the ability of the cultivation broth to inhibit the activity of trypsin. 250 µL 
cultivation broth was incubated with 250 µL of trypsin solution (100 mg/L) at 30 °C for 
30 minutes. Hereafter the activity of trypsin was measured by a Cobas Mira robot 
using BAPNA (N-α-benzoyl-DL-arginin-p-nitroanilide, Sigma no. B4875) as a substrate 
(Krogh et al., 2008 and Parekh et al., 1995). 
Plasmid copy number 
The plasmid copy number was determined by the use of realtime-PCR, the exact 
procedure has been described elsewhere (Krogh et al., 2008). 
Expression level determination 
The expression level of pot and aprotinin were determined by quantitative Real-Time 
Reverse Transcription PCR. Total RNA was isolated using the FastRNA Pro Red Kit 
(Qbiogene, France). The samples were treated with TURBO DNAfree (Ambion) to 
remove potential DNA contamination. The analysis was performed using a Chromo4 
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Real-time PDR System (Bio-RAd Laboratories Inc) and a DyNAmo SYBR Green 2 step 
qRT-PCR kit (Finnzymes). The same primers as for determination of the plasmid copy 
number and the same calculation method was applied.  
Probe preparation and hybridization to arrays 
Samples for transcriptome analysis were withdrawn at different time intervals after 
connection of the continuous feed. A number of different cultivations were performed 
with each strain. All samples for gene expression analysis, but one, stem from one 
cultivation with each strain. However, it was necessary to use a sample withdrawn 
from another cultivation run at identical conditions due to degradation of the mRNA 
in one of the samples. Every time samples for transcriptome analysis were withdrawn, 
four times 20 mL were swiftly taken from the cultures and transferred to 50 mL tubes 
containing approximately 30 mL of crushed ice. The tubes were centrifuged at 4000 
rpm for 2.5 min and the supernatant was discarded. The tube containing the pellet was 
submerged in liquid nitrogen and stored at -80 °C until analysis. 
Total RNA was isolated from biomass samples using the RNeasy kit (Qiagen). The 
further processing of the samples was performed in accordance with “Affymetrix 
GeneChip® Expression Analysis Technical Manual”; the One-Cycle Target Labelling 
and Control Reagents kit (Affymetrix) was used. Briefly, cDNA was prepared from the 
isolated total RNA, the cDNA was biotin labelled, fragmented and hybridised to the 
GeneChip® Yeast Genome 2.0 Array. After the hybridisation, the arrays were washed 
and stained, followed by scanning (all in accordance with the above mentioned 
manual). The raw data was acquired from the array images by the use of the 
Affymetrix software (GCOS). The arrays were normalised using the dChip software 
(modified 5. march 2007). This software utilises the Invariant Set Normalisation 
Method for normalisation (Li and Wong, 2001). 
Data analysis 
The normalized expression data was used both as input for the clustering and for the 
two-way ANOVA. Before performing the clustering a selection of interesting genes 
had to be made, and genes which had a ratio of 2 or higher between the highest and 
lowest expression in all the arrays were included in the clustering. The transcripts were 
clustered into groups of transcripts with the same profile over time using the 
ClustreLuster algorithm (Grotkjaer et al., 2006).  
The purpose of the two-way ANOVA was dual; one goal was to identify the genes 
with significantly different expression in relation to differences with strain and time, 
the other goal was to generate the input to the reporter algorithms (Patil and Nielsen, 
2005 and Oliveira et al., 2008). The reporter analysis helped in identifying key 
regulatory and metabolic processes. The reporter algorithm used a systems approach 
where the p-values for all the genes identified by the transcriptome analysis are 
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mapped on a network describing the connection of the genes to the ‘features’, viz., 
Gene Ontologies, Transcription Factors or Metabolites, respectively. Each of the gene 
ontology terms, transcription factors and metabolites were then scored based on the 
significance of the transcriptional changes in the genes connected to them. High 
scoring features represent reporter gene ontology/transcription factors/metabolites. 
This way, significant reporter features were identified without prior decision of 
significance level at the level of transcription.  
 
Results and Discussion 
The application of continuous cultivation as the production method necessitates a high 
stability of the production strains to ensure constant productivity and product quality. 
In the present study strains producing aprotinin were used to evaluate the stability of 
heterologous protein production during continuous cultivations. The strains were 
grown for a large number of generations (70-155 generations) under constant 
cultivation conditions. Two different strain backgrounds were included in the study, a 
laboratory (LAB) and an industrial (IND) strain background. In the present study, we 
attempt to gain further knowledge about strain adaptation by elucidating the cellular 
processes responsible for the loss of productivity in prolonged nutrient limited 
chemostat cultivations. Initially a physiological characterization of the prolonged 
continuous cultivations was made; this was followed by an analysis of the gene 
expression of the two strains during the prolonged continuous cultivations. The 
analysis of the transcriptome data was data-driven, and thus not performed to test a 
specific hypothesis, but rather to investigate the changes in gene expression with 
cultivation time. 
Characterization of prolonged continuous cultivations  
The two genetic backgrounds were characterized in glucose limited continuous 
cultivations. The yield of biomass (both measured by OD determinations and dry 
weight measurements) was constant during the cultivations and equal to the expected 
yield of 0.5 g biomass/g glucose prevailing during aerobic respiratory growth of S. 
cerevisiae. However, the concentration of aprotinin in the cultivation broth did not 
reach a steady state in any of the cultivations (Figure 9.1).  
In the cultivations with the IND strain, the concentration of aprotinin in the cultivation 
broth increased until 20 generations after the connection of the continuous feed. After 
20 generations, the concentration of aprotinin started to decrease and towards the end 
of the cultivation the concentration approached a constant level. The concentration of 
aprotinin also reached a maximum in the cultivations with the LAB strain. The 
maximal aprotinin concentration was generally reached later in the cultivation with the 
LAB strain than with the IND strain. It was surprising to find that the IND strain 
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responded in the same manner in all the cultivations as adaptation is believed to be 
caused by random events. The randomness of the adaptation process typically leads to 
different genetic changes although the same selection pressure is put on the strains in 
all cultivations and hence a difference in adaptation pattern between cultivations was 
expected.  
 
 
It is relevant to use the generation time as a measurement-unit of time in adaptation 
studies, however sometimes it might also be beneficial to reflect about the time aspect 
in real time. The time point of the maximal aprotinin concentration in the cultivation 
broth, which was determined to be approximately 20 generations after the connection 
of the continuous feed correspond to 140 hours or just below 6 days. The longest 
cultivations lasted 155 generations, which correspond to 1070 hours or almost 45 days. 
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Figure 9.1 The normalized aprotinin concentration as a function of the number of generations. 
The aprotinin concentration was normalised to have a maximal value of 1 in each cultivation. 
The time is the generation time calculated from the connection of the continuous feed. The thick 
line represents the average of the measured aprotinin concentrations in all the cultivation 
broths. A Results from 5 independent cultivations with the strain with IND strain. B Results 
from 4 independent cultivations with the LAB strain. The cultivations marked with solid black 
squares were used for the subsequent transcriptome analysis. 
B 
A 
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The cultivations were thus much longer than most other laboratory cultivations. 
However, the decline in the protein production occurs in the time span of the 
continuous cultivations run by Novo Nordisk for the production of insulin (Diers et al., 
1991). 
The cultivations performed in this study were laboratory scale cultivations, which are 
characterised as well-controlled and the yeast cells will thus experience constant 
environmental conditions. This might not be the case in industrial cultivations where 
longer mixing times might lead to different gradients in the cultivation medium and 
therefore an inhomogeneous environment. The selection pressure on the cells during 
laboratory and industrial cultivations could thus be different and the adaptations to the 
constant conditions might not occur in an identical way as in industrial scale 
cultivations. 
The gene encoding aprotinin was present on a plasmid in the aprotinin producing 
strains. It was therefore natural to look at the plasmid copy number in order to find an 
explanation of the decline observed in the aprotinin concentration during prolonged 
cultivations. In a cultivation with the IND strain the copy number of the plasmid was 
determined by using probes for both POT and aprotinin. The investigated strains had 
deletions in the chromosomal TPI1 gene and thus the plasmid borne POT gene is 
necessary to ensure growth on glucose, thus the POT gene is the part of the plasmid 
which is necessary for the cells to maintain. Comparison of the copy number 
determined by the two different probes can reveal if aprotinin is excised from the 
plasmid resulting in non-producing cells still able to grow on glucose as the sole 
carbon source. The copy numbers resulting from the two methods had the same time 
course and it was therefore concluded that the aprotinin gene was not lost from the 
plasmid (Figure 9.2). Furthermore, the variations in the plasmid copy number that 
were observed did not coincide with the changes in aprotinin concentration in the 
cultivation broth. It was therefore concluded that plasmid loss was not the main cause 
of decline in aprotinin concentration. As changes in the plasmid copy number was not 
the main cause of the decline in aprotinin concentration, the level of mRNA was 
determined. The levels of mRNA corresponding to both aprotinin and POT fluctuated 
during the cultivation (Figure 9.2). Due to the fluctuating results of the determination 
of the expression level of both aprotinin and pot the analysis was repeated with 
samples from another cultivation with the IND strain run at identical conditions. This 
analysis gave the same time profile of the expression level, high expression until 
approximately 50 generations, after 50 generations the expression level was lower than 
the expression level at 10 generations (data not shown). However, the changes did not 
coincide with the changes in aprotinin concentration and the Pearson correlation 
between aprotinin concentration and the mRNA corresponding to aprotinin and POT 
were 0.65 and 0.23, respectively.  
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The activity of the triose 
phosphate isomerase 
fluctuated during the 
cultivation (data not 
shown). The measurements 
were performed to support 
the data in Figure 9.2, as 
triose phosphate only is 
expressed from the 
plasmid. During the first 30 
generations the activity 
increased, hereafter it 
decreased, reaching a 
minimum at 65 generations 
where after the activity 
increased to the maximal 
level again. 
Transcriptome analysis  
In order to elucidate what was causing the varying concentration of the heterologous 
protein, aprotinin, in the cultivation broth, transcriptome analysis was applied. In 
addition to investigate the cause of the changes in heterologous protein production the 
transcriptome analysis could map gene expression changes following the adaptation to 
glucose limited conditions. Samples taken at different time points during prolonged 
continuous cultivations were analysed. Figure 9.3 shows the time points of sample 
withdrawal and the profile of the aprotinin concentration during the cultivations. 
Single samples were withdrawn throughout the cultivation, rather than as samples 
with replicates, in order to be able to follow the gene expression over time. The 
dynamic changes in gene expression was analysed by clustering of the expression data. 
In total 6-7 samples were withdrawn per cultivation. One has to keep in mind that 
during prolonged continuous cultivations the strains adapt to the low glucose 
concentration and low specific growth rate (a dilution rate of 0.07 to 0.1 h-1 was used). 
This might include an adjustment of the cellular machinery at the transcriptional level, 
and will hence also be detected in the transcriptome analysis. 
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Figure 9.2 Results from a continuous cultivation with the 
IND strain. The time course of normalised aprotinin 
concentration ( ), the normalised plasmid copy number 
determined using probes for aprotinin ( ) and POT ( ) 
and the relative level of mRNA corresponding to aprotinin 
( ) and POT ( ) are shown. All results were normalised to 
the values obtained in the sample withdrawn at 10 
generations. 
Paper C 
 
 114 
 
0
5
10
15
20
25
30
0 10 20 30 40 50 60 70 80
Generations
Ap
ro
tin
in
 
(m
g/
L)
0
1
2
3
4
5
6
7
8
Bi
o
m
as
s 
(g/
L)
0
5
10
15
20
25
30
0 10 20 30 40 50 60 70 80
Generations
Ap
ro
tin
in
 
(m
g/
L)
0
1
2
3
4
5
6
7
8
Bi
o
m
as
s 
(g/
L)
young old old young 
Figure 9.3 Continuous cultivations with the IND and LAB strains, the vertical lines indicate 
sampling for transcriptome analysis. The dotted line represents a sample taken from another 
cultivation (see Material and Methods for details). Above the diagrams the grouping of the 
arrays for the two-way ANOVA analysis is shown. The time shown is the generation time 
calculated from the connection of the continuous feed.  Aprotinin concentration in the 
cultivation broth (mg/L) and  Dry weight (g/L). A The IND strain B The LAB strain. 
Plasmid retention was obtained by deletion of the chromosomal Triose Phosphate 
Isomerase (TPI1) gene and re-establishment of the activity by including the triose 
phosphate isomerase enzyme from S. pombe (POT) on the plasmid. As the cells cannot 
grow on glucose as the sole carbon source without triose phosphate isomerase activity 
this is a very good method to achieve plasmid stability. It was possible to determine 
the expression level of both TPI1 and POT by the application of the yeast 2.0 array by 
Affymetrix as both Saccharomyces cerevisiae and Schizosaccharomyces pombe probes were 
present on the array. Neither of the investigated strains expressed the TPI1 gene and 
both strains were found to express the POT gene, just as expected. However, the level 
of expression of the pot gene was different; the LAB strain expressed the gene 3 to 17 
times higher than the IND strain. 
The analysis of the transcriptome data was dual: one part analysed the dynamic time 
aspect of each of the strains (cluster analysis) whereas the other part of the analysis was 
performed to find general changes in the gene expression of the two strains over time 
(two-way ANOVA). The analysis of the dynamic time aspect was performed by 
clustering of the expression data of the two strains separately thus identifying groups 
of genes with comparable time profiles. In the second part of the analysis changes, 
which were common to the two strains, were identified. For this purpose the reporter 
algorithm was applied, which enabled the identification of reporter metabolites, GO’s 
and transcription factors. Comparison of the IND and LAB strains has been reported 
earlier (Krogh et al., 2009), however, the comparison was only based on samples from 
short term cultivations (the arrays denoted young in the current study). The focus of 
the former investigation was the differences in gene expression pattern between the 
two strains whereas the current study primarily focuses on the time aspect of 
prolonged continuous cultivations. 
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Cluster analysis 
The ClustreLuster algorithm (Grotkjaer et al., 2006) was used to identify groups of 
genes with similar profiles over time. The input for the clustering algorithm contained 
the expression levels of the genes, which had a ratio of 2 or higher between the highest 
and lowest expression in all the arrays. Therefore the list contains both genes with an 
increase, a decrease and a fluctuation in expression with time. In the cultivation with 
the IND strain 1761 genes were identified to have a ratio above 2 and in the cultivation 
with the LAB strain 844 genes were identified to a ratio above 2. Figure 9.4 shows the 
profile of the normalized average expression of genes in the different clusters with 
both strains. 
 
The clustering was applied in order to be able to identify the biological signal in the 
huge amount of expression data. However, the transcription profiles in some of the 
clusters in Figure 9.4 are difficult to interpret in a biological sense. Clusters containing 
genes with a fluctuating expression is intuitively more difficult to understand than 
clusters containing genes with either increasing or decreasing expression as the strain 
 
Figure 9.4 The average normalized gene expression in the different clusters when the genes 
with a ratio between the maximal and minimal expression over time are at least 2 were used as 
input. The expression was normalised to values between -1 and 1, where 0 indicates the average 
expression. A The 14 clusters obtained when the 1761 transcripts for the IND strain was used as 
input. B The 14 clusters obtained when the 844 transcripts for the LAB strain was used as input. 
A B 
Paper C 
 
 116 
are grown under constant conditions. However, fluctuations in gene expression can be 
speculated to stem from several subsequent adaptation events. None of the clusters for 
either strain showed a time profile similar to the aprotinin concentration found in the 
cultivation broth. The SGD Term Finder (www.yeastgenome.org) has been used to 
search for significant Gene Ontologies (GOs) within each cluster. 
Cluster analysis of the cultivation with the IND strain 
The genes in cluster 4 on Figure 9.4A show an increasing expression, this cluster 
contains 102 genes. Using the 102 genes as input in the SGD Term Finder identified 
hexose transporters to be significantly represented in this group. The hexose 
transporters identified are both glucose transporters with high and low affinity and 
genes involved in galactose metabolism.  
The expression of the genes belonging to cluster 11 in Figure 9.4A decreased with 
increasing cultivation time. The SGD Term Finder found the GO “post-translational 
modifications” to be the only significant GO among the genes, 22 of the 130 genes in 
this cluster were assigned to this GO. The definition by SGD of “post-translational 
modifications” is “The covalent alteration of one or more amino acids occurring in a 
protein after the protein has been completely translated and released from the 
ribosome”. The term is thus rather broad and looking into the specific genes identified 
in our study, these are related to protein de-ubiquitination, protein ubiquitination, 
attachment of GPI anchor to protein and protein amino acid phosphorylation. The 
results found in the present study suggest that there is an overcapacity in the activity 
of the post-translational reactions in the strain at the beginning of the cultivation. In the 
beginning of the cultivation aprotinin is produced and the cells have rather recently 
been growing at a higher specific growth rate during the batch phase. The decreasing 
expression of genes related to post-translational modifications could both be a 
secondary response to the decline in aprotinin production or a result of the recent 
change in growth conditions and thus be an adjustment to the new conditions. 
Actually, post-translational modifications has earlier been identified as an area where 
the IND and LAB strains differed (Krogh et al., 2009). 
Gene expression profiles that correlate to the aprotinin concentration profile were 
searched for. This was done in order to spot genes, which could be potential targets for 
deletion or over expression aiming at enhancing the protein production. Table C.1 in 
Appendix C shows the ten genes with lowest and highest correlation to the aprotinin 
concentration. The genes in the table with a negative correlation to the aprotinin 
concentration, which have been clustered, all belong to cluster number 6, however no 
significant GO’s have been identified among the genes belonging to this cluster. The 
genes in the table with the highest positive correlation to aprotinin belong to cluster 12, 
however looking beyond the ten genes given in the table reveal that the highly 
Paper C 
117 
correlated genes belong to both cluster 8 and 12. Among the genes in cluster 12 no 
significant GO’s have been identified (but there might be single genes, which have 
influence on the production), but in cluster 8 GO’s within nitrogen compound 
metabolism have been identified as significant. Neither among the positively or 
negatively correlated genes any significant GO’s were identified by the SDG Term 
Finder when genes with a correlation equal or higher than 0.900 (absolute value) were 
used as input.  
Cluster analysis of the cultivation with the LAB strain 
The expression of the genes belonging to cluster 2 (Figure 9.4B) generally increase 
during the cultivation time. The SGD Term Finder identifies GO’s within allantoin 
catabolic process and reproduction as significant. Allantoin is an intermediate in the 
degradation of adenine and guanine (purines), allantoin is degraded to ammonia and 
carbon dioxide. Within the genes belonging to cluster 8 (Figure 9.4B), another cluster 
with increasing expression, was siderophore transport and iron assimilation identified 
as significant GO’s. However, none of these GO’s seems directly related to 
heterologous protein production.  
The expression of the genes in the clusters 5, 12, 13 and 14 decreased as a function of 
the cultivation time (Figure 9.4B). No significant GO’s could be detected in cluster 5. 
The genes in cluster 12 and 13 were assigned to ribosome biogenesis and RNA 
processing. Actually, all the significant GO’s in cluster 12 was also found as the GO’s 
with the lowest p-value within the genes in cluster 13. Cluster 14 contained genes 
related to the cell cycle process. The decrease in the expression of genes related to 
Ribosomes and RNA processing does not influence the concentration of aprotinin in 
the cultivation broth, as no decline in aprotinin concentration can be found (Figure 
9.3B). 
The expression pattern of the different genes was correlated to the aprotinin 
concentration in the cultivation broth with the laboratory strain background (Table C.2 
in Appendix C). The genes that correlate negatively to the aprotinin concentration are 
in cluster number 14, which primarily contains genes related to cell cycle. The genes, 
which correlate positively with the aprotinin concentration, belong mainly to cluster 2. 
In cluster 2, allantoin catabolic process and reproduction have been identified as 
significant GO’s. 245 genes correlates negatively with aprotinin and has a correlation 
factor with an absolute value equal to or above 0.9, and using these as input to the SGD 
Term Finder identified mRNA processing and related GO’s as significant. A group of 
123 genes correlate positively with the aprotinin concentration with a correlation value 
above 0.9. Among these 123 genes was membrane lipid metabolic process and related 
GO’s identified as significant.  
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Two-way ANOVA 
The transcription data was analysed by two-way ANOVA to determine the number of 
genes with significantly changed expression; the out-put from the two-way ANOVA 
analysis was subsequently used as input to the reporter algorithms in order to 
investigate changes in a global context. The choice of using two-way ANOVA to 
analyse the data was based on a wish to analyse the general response and not a strain 
specific response, which would be the case if the data from each strain was analysed 
separately. The transcription profiles from different time points during the cultivations 
were divided into four groups: industrial young, industrial old, laboratory young and 
laboratory old. In the young category the three first samples from the continuous 
cultivation with each strain was collected and in the old category the three last samples 
with each strain was collected (Figure 9.3 A and B). It was necessary to put the samples 
into groups to obtain some kind of replicates in order to be able to calculate the 
variation within each group. P-values for the differences with cultivation time and 
strain background were calculated. A third p-value describing the changes caused by 
other variations than time or strain alone was also calculated, this was denoted as 
interaction effect. The variations in gene expression within this group can be caused by 
factors outside the focus of this study, the genes belonging to this group will therefore 
not be considered in any detail. A cut-off P-value of 0.05 was applied and resulted in 
2478 genes significantly changed with strain, 343 genes significantly changed with time 
and 525 genes significantly changed with interaction. It was investigated how many 
genes are present in more than one of the groups (time, strain and interaction); the 
results are shown in Figure 9.5.  
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The results from the two-way ANOVA were used as input to three different reporter 
algorithms Oliveira et al., 2008. This meant no pre-selection of significantly changed 
genes was performed. The algorithms were used on both the p-value related to time 
and strain. The reporter algorithms applied were: Reporter Gene Ontologies, Reporter 
Metabolites and Reporter Transcription Factors.  
Analysis of the changes with time 
During the time span of the cultivation the strains will adjust their metabolism to a 
constant low specific growth rate and restricted carbon availability. This will probably 
lead to modifications in many parts of the metabolism. These changes will, at least in 
the cultivation with the IND strain be intertwined with the changes resulting in the 
lower production of the heterologous protein. In Table 9.1 is shown the ten gene 
ontologies with the lowest p-value when the p-values describing differences related to 
time were used as input. From the information given in Table 9.1 it is not possible to 
directly say anything about the significance of the gene ontologies in each of the 
strains, as Table 9.1 is based on a combined analysis of both strains. 
Time
Interaction
Strain
91 genes
191 genes
20 genes
84 genes
147 genes
230 genes
2003 genes
 
Figure 9.5 Comparison of the genes identified as significant by the two-way ANOVA analysis 
(cut-off p-value 0.05). The number of genes and overlap of genes between the three different 
groups (time, strain and interaction) is shown in the figure. 
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The two gene ontologies “extrinsic to endoplasmic reticulum membrane” and 
“palmitoyltransferase complex” each contain one significant gene. It is the same gene 
that is significant in both gene ontologies, SHR5, a subunit of a palmitoyltransferase, 
composed of Shr5 and Erf2. The expression of SHR5 decreased during the cultivations. 
Palmitoylation contributes to membrane association and plays a significant role in 
subcellular trafficking of proteins between membrane compartments. Palmitoylation is 
reversible and can thus regulate location of proteins. 
An interesting finding was the identification of the gene ontology “gluconeogenesis” as 
a reporter gene ontology. Gluconeogenesis is the formation of glucose from 
noncarbohydrate precursors, such as pyruvate, amino acids and glycerol. Four genes 
related to this gene ontology changed expression significantly during the time span of 
the cultivation; all four genes were found to be expressed highest in beginning of the 
cultivation suggesting a tightening of the glucose repression.  
The p-values describing differences with time were also used as input to the reporter 
metabolite algorithm. Among the 30 metabolites with the lowest p-value was a large 
group of metabolites related to amino acids. Metabolites in the allantoin metabolism, 
ergosterol metabolism, glycolysis and metabolites in relation to mitochondria were also 
identified (the list of metabolites can be found in Appendix C, Table C.3). 
The reporter transcription factors shown in Table 9.2 are the ones with the lowest p-
value when the p-values for time are used as input. The algorithm utilises information 
about the connection of transcription factors to all genes to determine a p-value for 
each transcription factor. Many transcriptional factors are regulated at the post-
translational level and differences in activity might thus not be recognized when 
looking directly at the gene expression data. 
Table 9.1 The 10 gene ontologies with the lowest p-value. The input was the result from the 
two-way ANOVA describing the changes with cultivation time (p-values for time). 
Gene Ontology 
Number of 
neighborsa 
Significance 
countb 
P-valuec 
extrinsic to endoplasmic reticulum membrane 2 1 1.26E-04 
chromatin assembly or disassembly 19 3 1.75E-04 
palmitoyltransferase complex 2 1 1.81E-04 
septin ring (sensu Saccharomyces) 9 2 3.75E-04 
structural constituent of ribosome 208 8 3.82E-04 
cell wall (sensu Fungi) 85 16 6.42E-04 
gluconeogenesis 14 4 6.98E-04 
extracellular region 19 6 8.53E-04 
transmembrane receptor activity 5 2 9.68E-04 
D-lactate dehydrogenase (cytochrome) activity 3 2 1.59E-03 
a The number of genes associated with the feature 
b The number of genes associated with the feature and with a p-value below 0.05 in 
the two-way ANOVA (p-time) 
c The probability of the observed transcriptional response to be random 
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Table 9.2 The 10 transcription factors with the lowest p-value. The input was the result from the 
two-way ANOVA describing the changes with cultivation time (p-values for time). 
Feature Descriptiona 
Numbe
r of 
neighb
ors 
Signific
ance 
count 
P-value 
Ste7 
Signal transducing MAP kinase kinase involved in 
pheromone response, where it phosphorylates Fus3p, 
and in the pseudohyphal/invasive growth pathway, 
through phosphorylation of Kss1p; phosphorylated by 
Ste11p, degraded by ubiquitin pathway 
39 11 0.00067 
Aro80 
Zinc finger transcriptional activator of the Zn2Cys6 
family; activates transcription of aromatic amino acid 
catabolic genes in the presence of aromatic amino acids 
2 2 0.00071 
Cln3 
G1 cyclin involved in cell cycle progression; activates 
Cdc28p kinase to promote the G1 to S phase transition; 
plays a role in regulating transcription of the other G1 
cyclins, CLN1 and CLN2; regulated by 
phosphorylation and proteolysis 
6 3 0.00089 
Tec1 
Transcription factor required for full Ty1 epxression, 
Ty1-mediated gene activation, and haploid invasive 
and diploid pseudohyphal growth; TEA/ATTS DNA-
binding domain family member 
38 10 0.00224 
Cdc42 
Small rho-like GTPase, essential for establishment and 
maintenance of cell polarity; mutants have defects in 
the organization of actin and septins 
3 2 0.00436 
Slt2 
Serine/threonine MAP kinase involved in regulating 
the maintenance of cell wall integrity and progression 
through the cell cycle; regulated by the PKC1-mediated 
signaling pathway 
14 4 0.00475 
Bck2 
Protein rich in serine and threonine residues involved 
in protein kinase C signaling pathway, which controls 
cell integrity; overproduction suppresses pkc1 
mutations 
2 2 0.00620 
Cad1 
AP-1-like basic leucine zipper (bZIP) transcriptional 
activator involved in stress responses, iron metabolism, 
and pleiotropic drug resistance; controls a set of genes 
involved in stabilizing proteins; binds consensus 
sequence TTACTAA 
1 1 0.00924 
Far1 
Cyclin-dependent kinase inhibitor that mediates cell 
cycle arrest in response to pheromone; also forms a 
complex with Cdc24p, Ste4p, and Ste18p that may 
specify the direction of polarized growth during 
mating; potential Cdc28p substrate 
2 2 0.01182 
Pip2 
Autoregulatory oleate-specific transcriptional activator 
of peroxisome proliferation, contains Zn(2)-Cys(6) 
cluster domain, forms heterodimer with Oaf1p, binds 
oleate response elements (OREs), activates beta-
oxidation genes 
24 2 0.01346 
a Description according to the SGD database 
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Looking at the list several transcription factors related to the pheromone response and 
cell cycle progression was identified. The pheromone response is the response of a 
haploid cell when it senses a cell of opposite mating type. The changes include 
significant changes in the expression of about 200 genes and arrest in the G1 phase of 
the cell-cycle (Bardwell, 2004). The transcription factors related to these events are: 
Ste7, Cln3, Slt2, Bck2 and Far1. In the present study both haploid and diploid strains 
were used, the LAB strain is haploid whereas the IND strain is diploid, however 
mating have not been performed and it is thus surprising to identify this group of 
transcription factors when the input to the reporter algorithm was the p-values 
describing differences in relation to time. Looking at the 11 significant neighbours of 
Ste7 differences between the two strain backgrounds were identified. The average 
expression of the 11 genes at each time point was manually compared; in the 
cultivation with the IND strain the average gene expression was constant, whereas an 
increase in the average gene expression was observed in the cultivation with the LAB 
strain. 
Identification of the transcription factor Aro80, which is involved in the degradation of 
aromatic amino acids promoted a comparison of the amino acid composition of 
aprotinin and the leader sequence with the usage of amino acids in the 3,222 ORFs 
which have been assigned a gene name by the community as listed within SGD as of 
January 1999 (ftp://genome-ftp.stanford.edu/pub/codon/ysc.gene.cod). The 
percentages of aromatic amino acids were found to be similar. The degradation of 
aromatic amino acids could thus stem from degradation of the heterologous protein, 
aprotinin, or homologous proteins.  
Analysis of the changes with strain 
In this part of the study differences between the two strains regardless of the number 
of generations, in continuous cultivation were evaluated. Table 9.3 shows the ten gene 
ontologies with the lowest p-value when the p-values describing strain differences 
were used as input. In line with the strain differences observed when looking into the 
genes regulated by the transcription factor Ste7 (discussed above) the gene ontology 
“heterotrimeric G-protein complex” was identified as a reporter gene ontology. 
Heterotrimeric G-protein is a molecular switch involved in mating of two haploid 
strains. 
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The genes belonging to the gene ontologies “retrotransposon nucleocapsid”, 
“transposition, RNA-mediated” and “RNA-directed DNA polymerase activity” are 
identical beside that the two first gene ontologies has more significant neighbours than 
the last. Retrotransposons are genetic elements that can amplify themselves in a 
genome; they are a subclass of transposones which copy themselves via RNA. 
Retrotransposons can cause mutations in the genome if they are inserted into a gene. 
Half of the significant genes belonging to “retrotransposon nucleocapsid” showed 
higher expression in the LAB strain whereas the other half had higher expression in the 
cultivation with the IND strain. Thus no conclusion of either strain being more likely to 
experience mutations caused by retrotransposons can be drawn. 
Five of the ten gene ontologies with the lowest p-values were also among the ten gene 
ontologies identified earlier (Krogh et al., 2009). The five gene ontologies are: 
endopeptidase activity, fatty acid β-oxidation, proteasome core complex, α-subunit 
complex (sensu Eukaryota), heterotrimeric G-protein complex and ubiquitin-
dependent protein catabolism. The genes belonging to the gene ontologies fatty acid β-
oxidation and heterotrimeric G-protein complex are not directly related to protein 
production. The genes belonging to the gene ontologies endopeptidase activity, 
proteasome core complex and ubiquitin dependent protein catabolism are more 
directly involved in protein production or perhaps more correctly put: in the 
intracellular degradation of proteins. 
The 30 metabolites with the lowest p-value after applying the reporter metabolite 
algorithm were investigated and several metabolites in relation to both synthesis and 
Table 9.3 The 10 gene ontologies with the lowest p-value. The input was the result from the 
two-way ANOVA describing the changes with strain background (p-values for strain). 
Gene Ontology 
Number 
of 
neighbors
a 
Significan
ce countb 
P-valuec 
endopeptidase activity 29 24 9.51E-08 
fatty acid β-oxidation 9 9 5.40E-06 
proteasome core complex, α-subunit complex (sensu 
Eukaryota) 7 7 3.38E-05 
heterotrimeric G-protein complex 3 3 9.28E-05 
NAD biosynthesis 7 7 9.50E-05 
ubiquitin-dependent protein catabolism 62 36 1.22E-04 
retrotransposon nucleocapsid 11 9 1.28E-04 
transposition, RNA-mediated 11 9 1.28E-04 
cellular component unknown 762 376 1.57E-04 
RNA-directed DNA polymerase activity 7 6 2.01E-04 
a The number of genes associated with the feature 
b The number of genes associated with the feature and with a p-value below 0.05 in 
the two-way ANOVA (p-strain) 
c The probability of the observed transcriptional response to be random 
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metabolism of amino acids were identified. Primary metabolites in the synthesis of 
phenylalanine, tyrosine and tryptophane and metabolites of tryptophane were 
identified. The aromatic amino acids phenylalanine, tyrosine and tryptophane are all 
synthesised from the metabolite chorismate. 11 of the 30 metabolites with lowest p-
value could be connected to the synthesis and metabolism of amino acids. No general 
trend in relation to strain background could be identified among the significantly 
changed genes related to the reporter metabolites (the list of metabolites is shown in 
Appendix C, Table C.4). Aprotinin was found to be very rich in cysteine and rich in 
alanine, arginine, glycine and methionine compared to the general amino acid 
composition of S. cerevisiae proteins. However, the content of phenylalanine, tyrosine 
and tryptophane varied around the average composition.  
An earlier study has by comparison of the transcriptional profile of two isogenic strains 
of S. cerevisiae, one harbouring a multicopy plasmid containing a gene encoding a 
heterologous protein and another containing an empty plasmid (neither promoter nor 
gene) found differences in relation to amino acid production and transport (Hahn-
Hägerdal et al., 2005). The transcriptional profile of the strain producing the 
heterologous protein showed amino acid limitation and both amino acid synthesis and 
transport were found to be up-regulated (Hahn-Hägerdal et al., 2005). In the present 
study, changes in amino acid metabolism were identified during the cultivation. 
Supplementation of amino acids to the cultivation medium of a prototrophic S. 
cerevisiae has been investigated (Görgens et al., 2005). Screening of addition of single 
amino acids to shake flask cultures and determination of the effect on both xylanase 
and biomass formation has been performed. The effect of addition of amino acids was 
evaluated at pH 3.0 and 5.0, pH 3.0 is characterised by an increased extracellular 
protease activity whereas pH 5.0 is characterised by a reduced activity. At both pH-
values amino acids that inhibited biomass formation and/or xylanase formation were 
identified. However, also a group of amino acids enhancing xylanase production was 
identified. At pH 3.0 Arg, Ala, Asn, Glu, Gln and Gly were found to retard proteolysis, 
at pH 5.0 addition of Ala, Arg, Asn, Asp, Gln, Gly and Lys improved xylanase 
formation without interfering with cell growth. Addition of amino acids to steady state 
cultures was also found to have a large effect on the production of xylanase, addition 
of casamino acids was found to inhibit xylanase formation. Addition of a mixture of 
Arg, Asn, Gly, Ala, Gln and Glu resulted in the highest yield of xylanase on glucose. 
The study highlighted that heterologous protein production can be increased by 
addition of amino acids, but the amino acids giving the best result should probably be 
determined experimentally in each separate case. No attempts to identify the best-
suited mixture of amino acids were made in the present study, but the production of 
aprotinin could probably be increased by additions of amino acids. 
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Metabolites in the synthesis of ergosterol and in β-oxidation of fatty acids were also 
identified along with a large group of what seems to be unrelated metabolites. Of the 
30 metabolites with the lowest p-value 4 were related to the synthesis of ergosterol. The 
4 metabolites related to ergosterol were connected to 9 genes which all were highest 
expressed in the LAB strain. 2 of the 30 metabolites with the lowest p-value were 
related to β-oxidation of fatty acids and these metabolites were related to 3 genes 
which were all expressed highest in the LAB strain. 
The expression profile of the young samples for the two strains has earlier been 
compared and reporter metabolites have also been analysed (Krogh et al., 2009). Three 
of the top-ten reporter metabolites found in the present study was also found among 
the ten reporter metabolites earlier reported. The metabolites identified in both studies 
are: P1,P4-Bis(5'-adenosyl) tetraphosphate, 3-Indoleacetonitrile and Indoleacetate. 
P1,P4-Bis(5'-adenosyl) tetraphosphathate has two neighbours, apa1 and apa2. apa1 has 
higher expression in the LAB strain whereas apa2 has higher expression in the IND 
strain. Both genes are diadenosine 5',5''-P1,P4-tetraphosphate phosphorylases involved 
in catabolism of bis(5'-nucleosidyl) tetraphosphates. Both apa1 and apa2 were identified 
as significantly changed by the ANOVA analysis. 3-Indoleacetonitrile and 
Indoleacetate are both metabolites which can be found in the tryptophane metabolism. 
Table 9.4 shows the 10 reporter transcription factors with the lowest p-value when the 
p-values describing differences between the two strain backgrounds are used as input. 
Analysis of the samples denoted young in the present study and identification of the 
reporter transcription factors has earlier been performed (Krogh et al., 2009). Two of the 
ten transcription factors shown in Table 9.3 are also identified in the earlier study. The 
two common transcription factors are: Adr1 and Paf1. 
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 Table 9.4 The 10 transcription factors with the lowest p-value. The input was the result from 
the two-way ANOVA describing the changes with strain background (p-values for strain). 
Feature Descriptiona 
Num-
ber of 
neigh-
bors 
Signifi
cance 
count 
P-
value 
Alpha2 
Homeobox-domain protein that, with Mcm1p, 
represses a-specific genes in haploids; acts with A1p to 
repress transcription of haploid-specific genes in 
diploids; one of two genes encoded by the MATalpha 
mating type cassette 
8 7 0.0002 
Adr1 
Carbon source-responsive zinc-finger transcription 
factor, required for transcription of the glucose-
repressed gene ADH2, of peroxisomal protein genes, 
and of genes required for ethanol, glycerol, and fatty 
acid utilization 
11 10 0.0006 
Aro80 
Zinc finger transcriptional activator of the Zn2Cys6 
family; activates transcription of aromatic amino acid 
catabolic genes in the presence of aromatic amino 
acids 
2 2 0.0014 
Sin3 
Component of the Sin3p-Rpd3p histone deacetylase 
complex, involved in transcriptional repression and 
activation of diverse processes, including mating-type 
switching and meiosis; involved in the maintenance of 
chromosomal integrity 
18 14 0.0015 
Sds3 
Component of the Rpd3p/Sin3p deacetylase complex 
required for its structural integrity and catalytic 
activity, involved in transcriptional silencing and 
required for sporulation; cells defective in SDS3 
display pleiotropic phenotypes 
3 3 0.0040 
Rho1 
GTP-binding protein of the rho subfamily of Ras-like 
proteins, involved in establishment of cell polarity; 
regulates protein kinase C (Pkc1p) and the cell wall 
synthesizing enzyme 1,3-beta-glucan synthase (Fks1p 
and Gsc2p) 
2 2 0.0042 
Spt14 
UDP-GlcNAc-binding and catalytic subunit of the 
enzyme that mediates the first step in 
glycosylphosphatidylinositol (GPI) biosynthesis, 
mutations cause defects in transcription and in 
biogenesis of cell wall proteins 
3 3 0.0043 
Tup1 
General repressor of transcription, forms complex with 
Cyc8p, involved in the establishment of repressive 
chromatin structure through interactions with histones 
H3 and H4, appears to enhance expression of some 
genes 
46 28 0.0063 
Paf1 
RNAP II-associated protein; defines large complex 
biochemically and functionally distinct from the Srb-
Mediator form of Pol II holoenzyme; required for full 
expression of a subset of cell cycle-regulated genes; 
homolog of human PD2/hPAF1 
15 12 0.0070 
Hda1 
Putative catalytic subunit of a class II histone 
deacetylase complex that also contains Hda2p and 
Hda3p; Hda1p interacts with the Hda2p-Hda3p 
subcomplex to form an active tetramer; deletion 
increases histone H2B, H3 and H4 acetylation 
12 9 0.0073 
a Description according to the SGD database 
Paper C 
127 
The role of Alpha2 is dual; in haploid strains it represses expression of MATa genes 
whereas it in diploid strains represses the expression of haploid specific genes. In order 
to investigate which of the two was the main cause of identifying this transcription 
factor as a reporter transcription factor the ratio of the expression between the 
significantly differently expressed genes was calculated. 7 of 8 related genes were 
found to be significantly differently expressed in the two strains. Five of these had 
highest expression in the haploid strain suggesting the Alpha2 is identified due to its 
function in haploid strains. However, the LAB strain used in the present study initially 
had mating type a, and the question about a mating type switch was therefore obvious. 
Looking at the other reporter transcription factors gave further hints pointing in the 
same direction: Sin3 which is directly involved in mating type switching and Paf1 
which is involved in expression of some cell cycle regulated genes. Sin3 had 14 genes 
assigned, which were significant differently expressed genes. Two of these were 
highest expressed in the IND strain, whereas 12 were highest expressed in the LAB 
strain. Actually the HO-gene (YDL227C, Site-specific endonuclease required for gene 
conversion at the MAT locus) was identified as being expressed 22 times higher in the 
strain with laboratory background than in the strain with industrial background.  
Conclusion 
The production of a heterologous protein was studied in prolonged continuous 
cultivations and two different strain backgrounds were compared. To the best of our 
knowledge this kind of studies have not been published before, and the data presented 
here is thus unique and provide new insight to heterologous protein production in 
prolonged continuous glucose limited cultivations. The present study showed that 
even though a steady state at the level of biomass and metabolites was achieved, this 
was not coupled to a constant production rate of the heterologous protein, and a true 
steady state was not achieved. The two different strain backgrounds showed some 
differences in relation to the production of the heterologous protein. Identical selection 
pressure was put on the cells in all cultivations, but this lead to varying responses 
when the LAB strain was cultivated, which stressed the fact that adaptation is caused 
by random events. In contrast, the different cultivations with the IND strain displayed 
similar time profiles of protein concentration. The changes in protein concentration 
could not be related to loss of the plasmid carrying the gene coding for the 
heterologous protein nor in the level of mRNA corresponding to the heterologous 
protein. A global approach was therefore taken in order to investigate the changes in 
gene expression during the prolonged continuous cultivations.  
The analysis of the transcriptome data was data-driven in order to provide insight into 
the large changes in gene expression during production of a heterologous protein in 
glucose limited chemostats. The analysis of the prolonged continuous cultivations 
(both transcriptome data and protein concentration data were analysed) resulted in the 
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generation some hypotheses for the decline in aprotinin production. One hypothesis 
was that a general decrease in the transcription of glycolytic promoters was part of the 
adaptation process. The gene encoding aprotinin was placed under the glycolytic triose 
phosphate isomerase promoter (TPI1). Several other studies have shown that the 
expression of glycolytic enzymes decrease during long continuous cultivations 
(Mashego et al., 2005and Jansen et al., 2005). It was observed that the concentration of 
aprotinin per copy of the gene encoding aprotinin decreased during the cultivation 
(Figure 9.1). In contrast to this the triose phosphate isomerase activity did not decrease 
during the cultivation, but the triose phosphate isomerase was placed under a 
promoter from S. pombe, which might not be regulated as native S. cerevisiae promoters.  
Analysis of the transcriptome data resulted in identification of changes in the 
expression of genes with relation of degradation of aromatic amino acids and 
membrane components. Identification of genes related to degradation of amino acids 
resulted in the second hypothesis on the cause of decline in protein production to be 
recirculation of protein, however it could not be determined if the turn-over of 
aprotinin was increased or not. Recirculation of protein could be caused by insufficient 
levels of chaperones or other protein necessary for the folding process resulting in 
improper folding of the protein. The identification of membrane lipid components and 
ergosterol could be caused by the higher secretion of proteins and thus the need for 
trafficking of proteins in vesicles. 
The third hypothesis was that the serine protease inhibitory activity of aprotinin also 
played a role and result in the decline in the aprotinin production. Serine proteases are 
present in several different cellular components; e.g. nucleus, vacuole and trans-golgi. 
KEX2 is a serine protease present in the trans-golgi where it is involved in the 
activation of pro-proteins in the secretory pathway; this activity could be inhibited by 
the production of aprotinin. Thus the decrease in aprotinin production could be a way 
to restore the normal activity of the serine proteases of the cell.  
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Chapter 10 
Concluding remarks and future perspectives 
The aim of my Ph.D. study was to increase the knowledge of the mechanisms 
controlling the production of a heterologous protein during prolonged growth under 
respiratory conditions. A model protein, aprotinin, was used for the investigations; it is 
a protein, which is difficult for S. cerevisiae to produce. It was chosen to include two 
different strains in my study, an industrial and a laboratory strain. This was done to 
test if the observed changes in productivity were strain specific or a global 
phenomenon, changes in the productivity by time have previously been observed with 
the industrial strain. The main results of my Ph.D. study were reported in the papers 
A, B and C (Chapter 7, Chapter 8 and Chapter 9), and the more general conclusions 
and perspectives will be given in the following text. 
The investigations revealed similarity of the yield of aprotinin in cultivations with the 
strains with industrial and laboratory background. In batch cultivations the yield was 
determined to 0.56 mg aprotinin/g glucose for both strains (Paper A). In chemostat 
cultivations a difference was detected between the two strains, the yield of aprotinin in 
a chemostat cultivation with the industrial strain was determined to 2.2 mg 
aprotinin/g glucose whereas the yield of aprotinin in a cultivation with the strain with 
laboratory background was determined to 1.0 mg aprotinin/g glucose. The low yield 
of aprotinin is believed to be due to the application of a defined minimal medium. The 
defined minimal medium also resulted in a low maximal specific growth rate of the 
industrial strain (it was determined to 0.1 h-1 in shake flask cultivations and to 0.16 h-1 
in well-controlled batch cultivations). Growth in complex medium resulted in an 
increase in the maximal specific growth rate (0.31 h-1 was measured in a shake flask 
cultivation of the industrial strain on YPD medium). Another way to increase the 
maximal specific growth rate was to use prolonged growth at unlimited conditions. 
After 250 generations of unlimited growth the maximal specific growth rate of the 
laboratory and industrial strains were 0.31 h-1 and 0.33 h-1, respectively and after 500 
generations the maximal specific growth rate was determined to 0.27 h-1 for both 
strains (Paper A and B). 
Heterologous protein production has been found to have an influence on the host 
metabolism, e.g. by a lowering of the maximal specific growth rate or by a lower 
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biomass yield. The negative effect of heterologous protein production in host 
metabolism is denoted either protein or plasmid burden. In literature, it has been 
discussed if the burden of heterologous protein production from a plasmid is 
predominantly due to the presence of the plasmid or due to the production of the 
heterologous protein. In my study the burden (which resulted in a lowering of the 
maximal specific growth rate) was identified as being caused by the protein production 
and not by the presence of an empty plasmid. The maximal specific growth rate was 
determined to 0.35 h-1 for the industrial strain containing an empty plasmid whereas 
introduction of a plasmid containing the expression cassette lowered the maximal 
specific growth rate to 0.16 h-1 (Paper A). In order to investigate this matter further, the 
effect of the promoter region and protein secretion on the maximal specific growth rate 
should be investigated by including a strain containing a plasmid with the promoter 
region, but not the heterologous protein itself. In order to study the effect of secretion, 
a plasmid containing the heterologous protein, but not the leader, should be included 
in the study. However, this would result in intracellular accumulation which perhaps 
would interfere with other cellular activities. 
Two different cultivation methods were in my studies applied to reach a high number 
of generations; sequential shake flask cultivations (batch cultivations) (Paper A & B) 
and chemostat cultivations (Paper C). During the sequential shake flask cultivations, 
the cells were kept in the exponential growth phase by inoculation of a new shake flask 
before limitation occurred. In this way both the batch and chemostat cultivation 
conditions put a “constant” selection pressure on the cells. Both kinds of cultivations 
were found to result in a decrease in the production of aprotinin, although different 
selection pressure was applied. Growing the strains, which was adapted to unlimited 
conditions, in glucose limited continuous cultivations (dilution rate 0.1 h-1), revealed 
that the changes in the phenotype were linked to the growth conditions under which 
the adaptation occurred. An example of the observed difference can be found when 
looking at the cultivations with the laboratory strain. The batch cultivations revealed a 
decline in aprotinin yield during the first round of adaptation and an increase in the 
last part of the adaptation. The yield was determined to 4.5 mg aprotinin/g biomass, 
2.8 mg aprotinin/g biomass and 3.1 mg aprotinin/g biomass in cultivations with the 
unadapted, adapted for 250 generations and a strain adapted for 500 generations, 
respectively (Paper B). Growing the laboratory strain in short continuous cultivations 
resulted in a slightly increased yield of aprotinin as a function of the adaptation time In 
a chemostat cultivation with the unadapted strain the yield of aprotinin on biomass 
was determined to 2.1 mg/g, in a cultivation with a strain adapted for 250 generations 
the yield was determined to 2.3 mg/g and in a cultivation with a strain adapted for 500 
generations the yield was determined to 2.5 mg/g (Paper B). This was believed to be 
due to the mutations responsible for the changes only occurred in the part of the 
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metabolism which was active during the adaptation period whereas other parts of the 
metabolism were less affected by the adaptation period. 
The overall trend of decreasing protein production with cultivation time was found to 
be global, as it was observed in cultivations with both strain backgrounds and duirng 
both unlimited and limited conditions. The cellular response to the burden caused by 
the heterologous protein production lead to a reduction of the productivity. An 
obvious hypothesis was that plasmid loss was responsible for the decrease in protein 
production. However, plasmid loss was not found to be the only factor responsible for 
the decrease in protein productivity. Determinations of the level of protein 
productivity, plasmid copy number and mRNA revealed that the ratio between the 
diverse parts of protein production differed in samples taken at different time points 
during unlimited growth (Paper A & B). Thus, the process was believed to be regulated 
at several levels. The level of mRNA depends on the number of copies of the plasmid, 
the level of transcription and the mRNA stability (as this has an effect of the degree of 
degradation). Protein production depends on the level of mRNA, but also on 
translation, folding and secretion. The relationship between mRNA and protein 
production can be evaluated by using tunable promoters, generating a whole range of 
different mRNA levels. It will provide information on the regulation of the production 
of one heterologous protein in one host, thus giving further insight into the regulation. 
Another approach is to determine if the heterologous protein is found intracellular, 
perhaps as a Misfolded or partly folded protein. 
In repeated prolonged chemostat cultivations, a difference between the two 
investigated strains was observed (Paper C); the time profile of the aprotinin 
concentration in the cultivation broth in cultivations with the industrial strain were 
identical; whereas some of the randomness believed to be connected to the process of 
adaptation was seen in the cultivations with the laboratory strain. It therefore seem 
that the industrial strain only has the same response to the burden caused by the 
heterologous protein and prolonged glucose-limited cultivation, whereas the response 
of the laboratory strain was more random (but always leading to a lower productivity). 
In depth characterization of the changes occurring during prolonged continuous 
cultivations on the genetic level was conducted by transcriptome analysis of the cells. 
Samples for transcriptome analysis were taken following two strategies: i) using 
sampling at different time points after connection of the continuous feed and ii) with 
sampling at the beginning and the end of the cultivation. In depth, data-driven analysis 
of the gene expression data obtained from sampling at different time points was 
performed in order to be able to identify time related changes in the expression profile 
and correlate these changes with the changes in productivity. Clustering of the 
expression data was performed and the profile of each cluster was compared to the 
time profile of the aprotinin concentration in the cultivation broth. The identification of 
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reporter metabolites, gene ontologies and transcription factors was used to identify 
similarities regarding cultivation time and strain. 
The combination of the analysis of the transcriptome data and data on the production 
level led to several hypotheses on the changes occurring during prolonged glucose 
limited chemostats: 
− A general decrease of transcription from glycolytic promoters as a result of 
adaptation to glucose limited conditions has been reported by other groups. 
Aprotinin was placed under the glycolytic triose phosphate isomerase 
promoter and hence lower expression of this promoter may be a consequence of 
the prolonged growth at glucose limited conditions. In support of this 
hypothesis was the amount of aprotinin produced per copy of the gene 
encoding aprotinin found to decrease during the cultivation. On the other hand 
was the triose phosphate isomerase not found to decrease, however, the gene 
encoding the triose phosphate isomerase was placed under a promoter from S. 
pombe, which might not be regulated as a native S. cerevisiae promoter (Paper C). 
− Aprotinin is a well-known serine protease inhibitor and this activity can have 
an effect in different parts of the metabolism. Serine proteases are present in 
several cellular compartments, e.g. nucleus, vacuole and trans-golgi. The 
decline in aprotinin production could thus be a response to inhibition of the 
serine proteases and a way to restore the activity. 
− The transcriptome analysis identified genes related to degradation of amino 
acids which suggest recirculation of amino acids to occur. This is believed to be 
due to insufficient levels of chaperones and foldases resulting in accumulation 
of partly folded protein.  
The three hypotheses mentioned above were not tested further during my study, but a 
combination of the three is believed to cause the changes observed during prolonged 
chemostat cultivations. The first hypothesis can be tested either by measuring the 
activity of glycolytic enzymes or by placing the heterologous gene under another 
promoter. The new promoter could be one from a low affinity glucose transporter, as 
these should not be down regulated during growth in glucose limited conditions or 
originate from a gene identified by using the gene expression data to identify genes 
with increasing expression during prolonged chemostat cultivation. A test of the 
second hypothesis requires investigation of another model protein, preferably one with 
identical properties except the protease inhibitor activity. It would be very interesting 
to analyze the expression of aprotinin in a strain over expressing different chaperones 
and foldases even though over expression of chaperones and foldases earlier has been 
shown to give unclear results on the effect on protein production. This analysis will 
provide evidence for the last hypothesis. 
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In conclusion, the work performed during my Ph.D. study was focused on production 
of a heterologous protein intended for pharmaceutical applications in Saccharomyces 
cerevisiae. Decreasing productivity has earlier been observed during prolonged 
chemostat cultivation, causing a problem during industrial application. Mapping and 
understanding the changes was the goal of my project. Based on the results, I could 
rule out that neither plasmid stability nor changes in expression of a single gene 
individually led to the decline in productivity. My study has highlighted the 
complexity of heterologous protein production; especially the effect of prolonged 
cultivations. A possible way to maintain a high productivity can be to use a “non-
glycolytic” promoter and to engineer a strain producing a higher number of 
chaperones. 
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Appendix A 
Methods for determination of the amount of 
aprotinin 
This appendix contains detailed information on the methods tested for determination 
of aprotinin in cultivation samples. 
A.1 HPLC 
A Waters HPLC equipped with a UV detector and a C18 column was used for the 
aprotinin determination. The flow rate was 1 ml/min. Two buffers, A and B were used; 
the mixture of the two buffers is shown in Table A.1.  
Eluent A: 2.8% Na2SO4 
  0.4% H3PO4 
  4% CH3CN 
  pH 2.3 
Eluent B: 42.8% CH3CN 
 
 
Figure A.1 shows the time profile of buffer A during the HPLC method. 
Table A.1 Mixture of buffer A and B 
Time Percentage buffer A Percentage buffer B 
0 75 25 
20 30 70 
20.1 75 25 
40 75 25 
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A.2 Immunodetection analysis 
Buffers: 
 TBS buffer: 4.84 g TRIS base, 16 g NaCl dissolved in 2 L of water; pH adjusted to 
7.6 with HCl. 
 TBS-T: 1 mL Tween 20 dissolved in 1 L TBS buffer 
 Blocking solution: 10 g milk powder dissolved in 200 mL TBS-T buffer 
 
Procedure: 
 5 µL of each sample is placed on the nitrocellulose membrane, 0.45 µm (Frisenette 
ASP, B27GE) 
 When all samples are dry the membrane is incubated with the blocking solution 
over night. The milk proteins in the blocking solution will block empty space on 
the membrane. 
 The membrane is rinsed twice with TBS-T followed by three washing steps also 
with the TBS-T buffer (one 15 min and two 5 min). 
 The membrane is incubated with the antibody against aprotinin (primary 
antibody) for 1.5 hour (0.2 mL buffer/cm2 with 1 µL antibody/mL TBS buffer) 
 The membrane is rinsed twice with TBS-T followed by three washing steps also 
with the TBS-T buffer (one 15 min and two 5 min). 
 The membrane is incubated with the antibody against the primary antibody 
(secondary antibody) for 1.5 hour (0.2 mL buffer/cm2 with 1 µL antibody/mL TBS 
buffer) 
 The membrane is rinsed twice with TBS-T followed by three washing steps also 
with the TBS-T buffer (one 15 min and two 5 min). 
 Development of the membrane 
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Figure A.1 The percentage of buffer A during the HPLC method 
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1 part Opti-4CN was mixed with 9 parts of water. For every 10 ml 0.2 ml Opti-
4CN substrate was added just prior to use of the solution. The membrane was 
developed for 5-30 min. 
 The membrane was washed in water and dried between two sheets of filter paper. 
The intensities of the dots were determined by using the programme JACS Paint 
ShopPro, in which black has an intensity of 0 and white 255. 
A.3 Capillary electrophoresis 
A P/ACE MDQ (Beckman Coulter) equipped with a photo diode array detector was 
used for the determinations. Capillaries with an internal diameter of 50 µm with a total 
length of 40 cm were used for the separation. The detection window was placed 10 cm 
before the end of the capillary and the detection was performed by measuring the 
absorbance at 200 nm. Milli-Q water was used for the preparation of all solutions and 
for dilution of samples, if necessary. 
The best results were obtained using a 50 mM phosphate buffer with a pH of 2.5 
containing 5 mM 1,3-diaminopropane. The setup of the method is shown in Table A.2. 
 
 
A.4 Trypsin inhibition 
The activity of aprotinin was determined by inhibition of trypsin. The substrate for the 
trypsin determination was N-α-benzoyl-DL-arginin-p-nitroanilide (BAPNA, Sigma no 
B4875), which upon digestion with trypsin result in the formation of p-nitroanilide, 
which can be quantitatively determined at 405 nm. 
Solutions: 
 Trypsin solution: 1 g/L in 20 mM Ca2+ (2,94 g CaCl2,2H2O in 1 L) 
 Tris/HCl: 100 mM Tris pH adjusted to pH 7,60 with HCl (0,6055 g TRIS in 50 mL) 
 Reagent solution (per sample): 0.870 mg BAPNA dissolved in 50 µL DMSO (this 
solutions should be made fresh) and 350 µL Tris/HCl buffer 
Table A.2 Method for aprotinin determination using the capillary electrophoresis 
Event Value Duration Solution 
Rinse 50 psi 3 min Buffer 
Wait - 0 min Water 
Injection, sample 0.5 psi 10 sec Sample 
Wait - 0 min Water 
Injection 0.5 psi 3 sec Buffer 
Separation 15.0 kV 7 min Buffer 
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 Standard aprotinin solution: 1-10 mg/L 
Procedure: 
 250 µL sample is mixed with 250 µL trypsin solution in analysis tubes for the 
Cobas, mixing is important.  
 The analysis tubes are incubated at 30 °C in 30 min.  
 The samples are analysed on the Cobas 
50 µL sample and 400 µL reagent solution 
Absorbance is measured at 24 sec intervals. 
The amount of aprotinin present in the samples was calculated based on the inhibition 
of the standard solution, thus even though the assay was based on activity the result 
was given as a concentration (mg aprotinin/L). 
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Appendix B 
Supplementary data to chapter 8, Paper B 
Unfolded protein response 
BCK1 DCR2 DFM1 EDE1 GCN4 HAC1 IRE1
 OPI1 PTC2 SLT2 TRL1 VPS74 YHI9 
 
Protein secretion 
ACT1 NCE101 NCE102 SCD5 SEC61 SSH1 SSP120
 STT4 UBX2 YSY6 
 
Protein folding 
ABC1 AHA1 ALF1 APJ1 ASF1 ATP12 ATX1
 BTT1 BUD27 CAJ1 CBP3 CCS1 CCT2 CCT3
 CCT4 CCT5 CCT6 CCT7 CCT8 CDC37 CHS7
 CIN2 CNE1 CNS1 COX17 CPR1 CPR2 CPR3
 CPR4 CPR5 CPR6 CPR7 CPR8 CWC23 CWC27
 DJP1 ECM10 EGD1 EGD2 ERJ5 ERO1 ESS1
 EUG1 FLC1 FLC2 FMO1 FPR1 FPR2 FPR3
 FPR4 GIM3 GIM4 GIM5 GSF2 HCH1 HLJ1
 HSC82 HSP10 HSP104 HSP26 HSP31 HSP32 HSP33
 HSP60 HSP78 HSP82 JAC1 JEM1 JID1 JJJ1
 JJJ2 LHS1 MCX1 MDJ1 MDJ2 MDN1 MGE1
 MPD1 MPD2 MRS11 PAC10 PAC2 PAM18 PDI1
 PFD1 PHB1 PHB2 PHO86 PIH1 PLP1 RBL2
 ROT1 SBA1 SCJ1 SCO2 SEC63 SHR3 SIS1
 SNL1 SNO4 SSA1 SSA2 SSA3 SSA4 SSB1
 SSB2 SSC1 SSE1 SSE2 SSQ1 STI1 TAH1
 TCM62 TCP1 TIM13 TIM8 TIM9 UMP1 VTC1
 XDJ1 YDJ1 YKE2 ZIM17 ZUO1  
 
Chaperone 
ABC1 ADY3 AFG3 AHA1 ALB1 ALF1 APJ1
 APL1 APL2 APL3 APL4 APL5 APL6 APM1
 APM2 APM3 APM4 APS1 APS2 APS3 ARB1
 ARX1 ASF1 ATC1 ATP10 ATP11 ATP12 ATP20
 ATP22 ATP23 ATP7 ATX1 BCS1 BRX1 BTT1
 BUD20 BUD22 BUD27 CAJ1 CAM1 CBF5 CBP3
 CCS1 CCT2 CCT3 CCT4 CCT5 CCT6 CCT7
 CCT8 CDC37 CGR1 CHC1 CHS7 CHZ1 CIC1
 CIN2 CLC1 CNE1 CNS1 COP1 COX11 COX15
 COX16 COX17 COX19 COX20 CPR1 CPR2 CPR3
 CPR4 CPR5 CPR6 CPR7 CPR8 CWC23 CWC27
 DBP10 DBP6 DBP7 DBP8 DBP9 DHR2 DIM1
 DIP2 DJP1 DPH2 DRS1 DUS3 EBP2 ECM10
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 ECM16 EGD1 EGD2 EMG1 ENP1 ENP2 EPS1
 ERJ5 ERO1 ESF1 ESF2 ESS1 EUG1 FAF1
 FLC1 FLC2 FMO1 FPR1 FPR2 FPR3 FPR4
 GAR1 GCD10 GCD14 GDT1 GGA1 GGA2 GIM3
 GIM4 GIM5 GRC3 GSF2 HAS1 HAT1 HAT2
 HCA4 HCH1 HGH1 HIF1 HLJ1 HMT1 HSC82
 HSP10 HSP104 HSP26 HSP31 HSP32 HSP33 HSP42
 HSP60 HSP78 HSP82 IMP3 IMP4 IPI3 JAC1
 JEM1 JID1 JJJ1 JJJ2 KAR2 KRE33 KRI1
 KRR1 LCP5 LHS1 LIA1 LSG1 LTV1 MAK11
 MAK16 MAK21 MAK5 MCX1 MDJ1 MDJ2 MDM10
 MDN1 MGE1 MIM1 MIS1 MPD1 MPD2 MPP10
 MRH4 MRS11 MRT4 MTR4 NAN1 NAP1 NCL1
 NCS2 NEW1 NHP2 NIP1 NIP7 NMD3 NOB1
 NOC2 NOC3 NOC4 NOG1 NOG2 NOP1 NOP13
 NOP14 NOP15 NOP2 NOP4 NOP53 NOP58 NOP7
 NOP8 NOP9 NRP1 NSA1 NSA2 NUC1 NUG1
 OST3 OST6 PAC10 PAC2 PAM18 PDI1 PET100
 PFD1 PHB1 PHB2 PHO86 PIH1 PKR1 PLP1
 PNO1 PPT1 PRO1 PRP43 PRS3 PRS4 PUF6
 PUS1 PUS7 PWP2 RAD9 RBG1 RBL2 RCL1
 REI1 RET2 RET3 RFM1 RIX1 RKI1 RLP24
 RLP7 RMT2 RNP1 RNT1 ROT1 RPA12 RPA135
 RPA34 RPA43 RPA49 RPC19 RPC34 RPC40 RPC82
 RPF1 RPF2 RPL20B RPL40A RPL40B RPL8A RPL8B
 RPP0 RPS31 RRB1 RRP1 RRP12 RRP14 RRP15
 RRP17 RRP3 RRP5 RRP6 RRP8 RRS1 RSA4
 RTT106 SAM50 SAS10 SBA1 SCJ1 SCO1 SCO2
 SDA1 SEC21 SEC26 SEC27 SEC28 SEC63 SFP1
 SGT1 SHR3 SHY1 SIK1 SIR3 SIR4 SIS1
 SKI8 SKP1 SNL1 SNO4 SNU13 SPB4 SPT7
 SQT1 SRO9 SRP40 SSA1 SSA2 SSA3 SSA4
 SSB1 SSB2 SSC1 SSE1 SSE2 SSF2 SSP1
 SSQ1 SSZ1 STI1 TAH1 TAZ1 TCM62 TCP1
 TGS1 TIF4631 TIM13 TIM8 TIM9 TMA20 TMA46
 TOR1 TOR2 TPA1 TRM1 TRM11 TRM2 TRM5
 TRM8 TRM82 TSA1 TSR1 TSR2 UMP1 URB2
 URK1 USO1 UTP10 UTP11 UTP14 UTP15 UTP18
 UTP21 UTP23 UTP30 UTP4 UTP5 UTP6 UTP7
 UTP8 UTP9 VMA21 VMA22 VMA9 VPH1 VPH2
 VPS45 VPS72 VPS75 VTC1 VTC2 VTC3 VTC4
 XDJ1 YBL028C YBL054W YBR238C YBR271W YCR016W YDJ1
 YDL063C YDR161W YEF3 YGR283C YHL039W YIL064W YIL096C
 YIL127C YJR003C YKE2 YLR003C YMR310C YNL022C YNL247W
 YOR021C YOR287C YPT1 YTA12 YTM1 YVH1 ZIM17
 ZUO1 AAH1 
 
Stress 
ACT1 AFG1 AFT2 AGP2 AHA1 AHP1 AIP1
 ALD3 ALK1 ALK2 ALO1 AOS1 APN1 APN2
 ARP4 ARP8 ASK10 ATC1 ATH1 ATX1 BCK1
 BDF1 BDF2 BNI1 BNR1 BUD25 BUD6 BUR2
 BZZ1 CCP1 CDC37 CDC9 CHK1 CIN5 CKA1
 CKA2 CKB1 CKB2 CPR7 CRT10 CSM2 CST9
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 CTA1 CTF8 CTT1 DAK1 DAK2 DAN1 DAN2
 DAN3 DAN4 DCC1 DCR2 DDC1 DDR2 DEF1
 DFM1 DIN7 DNL4 DOG2 DOT5 DUN1 EAF1
 EAF3 EAF5 EAF6 EAF7 EDE1 ELM1 ENA1
 EOS1 EPL1 ERV1 EXO1 FAP7 FRT1 FRT2
 GAD1 GCY1 GLR1 GND1 GON7 GPX1 GPX2
 GRE1 GRE2 GRE3 GRR1 GRX1 GRX2 GRX3
 GRX4 GRX5 HAC1 HAL1 HAL9 HAM1 HAT1
 HAT2 HCH1 HED1 HHT1 HHT2 HIM1 HKR1
 HMI1 HNT3 HOF1 HOG1 HOR2 HOR7 HPR1
 HRR25 HSC82 HSF1 HSP104 HSP12 HSP26 HSP30
 HSP42 HSP78 HSP82 HTA1 HTA2 HTL1 HUG1
 HYR1 IES4 INO80 IQG1 IRA2 IRE1 ISC1
 IST2 KEM1 KRE29 LAS17 LCD1 LIF1 LOT6
 LTV1 MAG1 MCK1 MCR1 MEC1 MEC3 MEI5
 MET18 MET22 MGM101 MGT1 MID2 MIG3 MLH1
 MLH2 MLH3 MLP1 MMS1 MMS2 MMS21 MMS22
 MMS4 MNN4 MPR1 MRE11 MRK1 MSB2 MSH1
 MSH2 MSH3 MSH5 MSH6 MSN2 MSN4 MUS81
 MXR1 MYO3 MYO5 NCE103 NEJ1 NHA1 NHP6A
 NHP6B NPL6 NSE1 NSE3 NSE4 NSE5 NST1
 NTG1 NTG2 NTH1 NTH2 NUP84 OCA1 OGG1
 OPI1 OPY2 OSR10 OSR2 OSR3 OSR4 OSR6
 OSR7 OSR8 OSR9 OXR1 PAU1 PAU10 PAU11
 PAU12 PAU13 PAU14 PAU15 PAU16 PAU17 PAU18
 PAU19 PAU2 PAU20 PAU3 PAU4 PAU5 PAU6
 PAU7 PAU8 PAU9 PBS2 PDR8 PFY1 PHR1
 PIF1 PMS1 POB3 POL30 POL4 POS5 PRE1
 PRE3 PRP19 PRX1 PSO2 PSR1 PSR2 PSY2
 PSY3 PTC2 PTP2 PUP2 RAD1 RAD10 RAD14 
RAD16 RAD17 RAD18 RAD2 RAD23 RAD24 RAD26
 RAD27 RAD28 RAD3 RAD30 RAD33 RAD34 RAD4
 RAD5 RAD50 RAD51 RAD52 RAD53 RAD54 RAD55
 RAD57 RAD59 RAD6 RAD7 RAD9 RCK2 RDH54
 REV1 REV3 REV7 RGD1 RHR2 RIM11 RIM15
 RMI1 ROM2 RPB9 RPL40A RPL40B RPS3 RRD1
 RRD2 RSC9 RTT109 RVB1 RVB2 RVS161 RVS167
 SAC6 SAE3 SAN1 SBP1 SCC2 SCH9 SGS1
 SHO1 SIP18 SIR2 SIS2 SIW14 SKN7 SKT5
 SLG1 SLN1 SLT2 SLX1 SLX4 SLX5 SLX8
 SMC5 SMC6 SML1 SMP1 SOD2 SPT16 SRS2
 SRX1 SSA1 SSA2 SSA3 SSA4 SSK1 SSK2
 SSK22 SSL1 SSL2 STB5 STD1 STE11 STE20
 STF2 SVF1 SWC4 TCO89 TDP1 TEL1 TFB1
 TFB2 TFB4 TFB5 TIM18 TIP1 TIR1 TIR2
 TIR3 TIR4 TMA19 TOF1 TOR1 TPP1 TPS1
 TPS2 TPS3 TRF5 TRM9 TRR1 TRR2 TRX1
 TRX2 TRX3 TSA1 TSA2 TSL1 UBA4 UBC4
 UBC5 UBI4 UFD2 UFO1 UGA2 UMP1 UNG1
 URM1 VPS74 WHI2 WSC4 WSS1 XBP1 XRS2
 YAF9 YAP1 YAR1 YBL055C YBP1 YBR016W YCL033C
 YDR433W YGK3 YGP1 YHB1 YHI9 YIM1 YJL144W
 YKL088W YKU70 YKU80 YLR235C YNG2 YNL190W YNL234W
 YPD1 ZEO1 ZTA1
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Appendix C 
Supplementary data to chapter 9, Paper C 
Table C.1 The results from the correlation of the genes expression to the aprotinin concentration 
in the cultivation with the strain with industrial background. The ten genes with lowest and 
highest correlation to the aprotinin concentration, the Pearson correlation, the number of the 
cluster the genes were assigned to and a description of the genes. 
Gene 
Correla-
tion 
Cluster Description 
LSM2 -0.998 N.C. 
Lsm (Like Sm) protein; part of heteroheptameric complexes (Lsm2p-7p 
and either Lsm1p or 8p): cytoplasmic Lsm1p complex involved in mRNA 
decay; nuclear Lsm8p complex part of U6 snRNP and possibly involved in 
processing tRNA, snoRNA, and rRNA 
YDL186W -0.996 6 Putative protein of unknown function; YDL186W is not an essential gene 
NEJ1 -0.987 6 
Protein involved in regulation of nonhomologous end joining; interacts 
with DNA ligase IV components Dnl4p and Lif1p; repressed by MAT 
heterozygosity; regulates cellular distribution of Lif1p 
OCA6 -0.983 N.C. 
Cytoplasmic protein required for replication of Brome mosaic virus in S. 
cerevisiae, which is a model system for studying replication of positive-
strand RNA viruses in their natural hosts 
ERD2 -0.980 N.C. 
HDEL receptor, an integral membrane protein that binds to the HDEL 
motif in proteins destined for retention in the endoplasmic reticulum; has 
a role in maintenance of normal levels of ER-resident proteins 
SRD1 -0.978 6 
Protein involved in the processing of pre-rRNA to mature rRNA; contains 
a C2/C2 zinc finger motif; srd1 mutation suppresses defects caused by the 
rrp1-1 mutation 
AIM20 -0.977 N.C. 
Putative protein of unknown function; green fluorescent protein (GFP)-
fusion protein localizes to the vacuole; null mutant displays increased 
frequency of mitochondrial genome loss (petite formation) 
MMS22 -0.971 N.C. 
Protein that acts with Mms1p in a repair pathway that may be involved in 
resolving replication intermediates or preventing the damage caused by 
blocked replication forks; required for accurate meiotic chromosome 
segregation 
KRE27 -0.971 N.C. Protein of unknown function; null mutant shows K1 killer toxin resistance 
RDH54 -0.968 N.C. 
DNA-dependent ATPase, stimulates strand exchange by modifying the 
topology of double-stranded DNA; involved in recombinational repair of 
DNA double-strand breaks during mitosis and meiosis; proposed to be 
involved in crossover interference 
The table continues on the next page 
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Table C.1 continued from the previous page 
YOL019W 0.968 12 
Protein of unknown function; green fluorescent protein (GFP)-fusion 
protein localizes to the cell periphery and vacuole 
YDR541C 0.969 12 Putative dihydrokaempferol 4-reductase 
SCS3 0.971 12 
Protein required for inositol prototrophy, identified as an ortholog of the 
FIT family of proteins involved in triglyceride droplet biosynthesis; 
disputed role in the synthesis of inositol phospholipids from inositol 
CDC43 0.975 12 
Beta subunit of geranylgeranyltransferase type I, catalyzes 
geranylgeranylation to the cysteine residue in proteins containing a C-
terminal CaaX sequence ending in Leu or Phe; has substrates important 
for morphogenesis 
SWC4 0.975 N.C. 
Component of the Swr1p complex that incorporates Htz1p into chromatin; 
component of the NuA4 histone acetyltransferase complex 
CYT1 0.975 N.C. 
Cytochrome c1, component of the mitochondrial respiratory chain; 
expression is regulated by the heme-activated, glucose-repressed 
Hap2p/3p/4p/5p CCAAT-binding complex 
SKI8 0.976 N.C. 
Protein involved in exosome mediated 3' to 5' mRNA degradation and 
translation inhibition of non-poly(A) mRNAs as well as double-strand 
break formation during meiotic recombination; required for repressing 
propagation of dsRNA viruses 
SCW4 0.977 N.C. 
Cell wall protein with similarity to glucanases; scw4 scw10 double 
mutants exhibit defects in mating 
PCT1 0.991 N.C. 
Cholinephosphate cytidylyltransferase, also known as 
CTP:phosphocholine cytidylyltransferase, rate-determining enzyme of the 
CDP-choline pathway for phosphatidylcholine synthesis, inhibited by 
Sec14p, activated upon lipid-binding 
AGC1 0.992 N.C. 
Mitochondrial amino acid transporter, acts both as a glutamate uniporter 
and as an aspartate-glutamate exchanger; involved in nitrogen metabolism 
and nitrogen compound biosynthesis 
N.C. Not Clustered, the ratio between the maximal and minimal expression was below 
2 and the gene was therefore not included in the clustering. 
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Table C.2 The results from the correlation of the genes expression to the aprotinin concentration 
in the cultivation with the strain with laboratory background. The ten genes with lowest and 
highest correlation to the aprotinin concentration, the pearson correlation, the number of the 
cluster the genes were assigned to and a description of the genes. 
Gene 
Correlat
ion 
Cluster Description 
HTL1 -0.996 14 
Component of the RSC chromatin remodeling complex; RSC functions in 
transcriptional regulation and elongation, chromosome stability, and 
establishing sister chromatid cohesion; involved in telomere maintenance 
YDR186C -0.988 N.C. 
Putative protein of unknown function; may interact with ribosomes, based 
on co-purification experiments; green fluorescent protein (GFP)-fusion 
protein localizes to the cytoplasm 
SOV1 -0.985 14 Mitochondrial protein of unknown function 
RAD3 -0.983 N.C. 
5' to 3' DNA helicase, involved in nucleotide excision repair and 
transcription; subunit of RNA polymerase II transcription initiation factor 
TFIIH; subunit of Nucleotide Excision Repair Factor 3 (NEF3); homolog of 
human XPD protein 
COS2 -0.983 N.C. 
Protein of unknown function, member of the DUP380 subfamily of 
conserved, often subtelomerically-encoded proteins 
YAL063C-A -0.977 N.C. 
Putative protein of unknown function; identified by expression profiling 
and mass spectrometry 
SUE1 -0.975 N.C. 
Mitochondrial protein required for degradation of unstable forms of 
cytochrome c 
SRN2 -0.975 14 
Component of the ESCRT-I complex, which is involved in ubiquitin-
dependent sorting of proteins into the endosome; suppressor of rna1-1 
mutation; may be involved in RNA export from nucleus 
SAP1 -0.974 N.C. 
Putative ATPase of the AAA family, interacts with the Sin1p transcriptional 
repressor in the two-hybrid system 
CLF1 -0.974 N.C. 
Essential splicesome assembly factor; contains multiple tetratricopeptide 
repeat (TPR) protein-binding motifs and interacts specifically with many 
spliceosome components, may serve as a scaffold during splicesome 
assembly 
The table continues on the next page 
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Table C.2 continued from the previous page 
ODC1 0.969 N.C. 
Mitochondrial inner membrane transporter, exports 2-oxoadipate and 2-
oxoglutarate from the mitochondrial matrix to the cytosol for lysine and 
glutamate biosynthesis and lysine catabolism; suppresses, in multicopy, an 
fmc1 null mutation 
PCP1 0.969 N.C. 
Mitochondrial serine protease required for the processing of various 
mitochondrial proteins and maintenance of mitochondrial DNA and 
morphology; belongs to the rhomboid-GlpG superfamily of intramembrane 
peptidases 
YFR032C 0.970 N.C. 
Putative protein of unknown function; transcribed during sporulation; 
YFR032C is not an essential gene 
TSC10 0.972 N.C. 
3-ketosphinganine reductase, catalyzes the second step in phytosphingosine 
synthesis, essential for growth in the absence of exogenous 
dihydrosphingosine or phytosphingosine, member of short chain 
dehydrogenase/reductase protein family 
TUB2 0.973 N.C. 
Beta-tubulin; associates with alpha-tubulin (Tub1p and Tub3p) to form 
tubulin dimer, which polymerizes to form microtubules 
YIR042C 0.979 2 Putative protein of unknown function; YIR042C is a non-essential gene 
CSR1 0.981 N.C. 
Phosphatidylinositol transfer protein with a potential role in regulating 
lipid and fatty acid metabolism under heme-depleted conditions; interacts 
specifically with thioredoxin peroxidase; may have a role in oxidative stress 
resistance 
ROT1 0.991 N.C. 
Molecular chaperone involved in protein folding in the ER; mutation causes 
defects in cell wall synthesis and in lysis of autophagic bodies, suppresses 
tor2 mutations, and is synthetically lethal with kar2-1 and with rot2 
mutations 
ACH1 0.991 N.C. 
Acetyl-coA hydrolase, primarily localized to mitochondria; phosphorylated; 
required for acetate utilization and for diploid pseudohyphal growth 
SCS7 0.999 N.C. 
Sphingolipid alpha-hydroxylase, functions in the alpha-hydroxylation of 
sphingolipid-associated very long chain fatty acids, has both cytochrome 
b5-like and hydroxylase/desaturase domains, not essential for growth 
N.C. Not Clustered, the ratio between the maximal and minimal expression was below 2 
and the gene was therefore not included in the clustering. 
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Table C.3 The top 30 reporter metabolites when the p-values describing time differences are 
used as input to the reporter algorithm 
Metabolite 
Number of 
neighboursa 
Z-scoreb P-valuec 
Urea 4 298.559 0.001 
4,4-Dimethylzymosterol 2 265.467 0.004 
THRxt 4 245.393 0.007 
L-Glutamyl-tRNA(Glu) 1 224.442 0.012 
Zymosterol 3 223.952 0.013 
Glyoxylate 6 215.679 0.016 
Fumarate 5 213.623 0.016 
Deoxyribose 1 212.656 0.017 
2-Deoxy-D-ribose 5-phosphate 1 212.656 0.017 
SERxt 5 211.015 0.017 
ASNxt 4 209.833 0.018 
GLNxt 4 209.833 0.018 
UREAxt 1 204.201 0.021 
(R)-LactateM 2 202.144 0.022 
3-Phospho-D-glyceroyl phosphate 4 201.349 0.022 
4,4-Dimethylcholesta-8,14,24-
trienol 
2 199.015 0.023 
Urea-1-carboxylate 1 197.341 0.024 
ATTxt 1 194.706 0.026 
Ethanolamine 1 19.321 0.027 
Biotin 3 192.236 0.027 
LEUxt 6 191.346 0.028 
4-Methylzymsterol 2 190.797 0.028 
L-Leucine 7 188.118 0.030 
(R)-Pantoate 2 182.186 0.034 
DihydrofolateM 1 175.867 0.039 
NADP+ 44 170.297 0.044 
NADPH 41 168.493 0.046 
2-Phospho-D-glycerate 6 167.117 0.047 
ProtoporphyrinM 2 16.672 0.048 
L-Threonine 7 16.649 0.048 
a The number of genes associated with the feature 
b The Z-score indicates how many standard deviation an observation is above or 
below the average 
c The probability of the observed transcriptional response to be random 
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Table C.4 The top 30 reporter metabolites when the p-values describing strain differences are 
used as input to the reporter algorithm 
Metabolite 
Number of 
neighboursa 
Z-scoreb P-valuec 
P1,P4-Bis(5'-adenosyl) tetraphosphate 2 293.612 0.002 
3-Hydroxyanthranilate 2 272.569 0.003 
2-Amino-3-carboxymuconate 
semialdehyde 
1 248.493 0.006 
L-Kynurenine 2 240.845 0.008 
3-Hydroxykynurenine 2 240.845 0.008 
Deoxyribose 1 234.788 0.009 
2-Deoxy-D-ribose 5-phosphate 1 234.788 0.009 
4,4-Dimethylcholesta-8,14,24-trienol 2 221.092 0.014 
3-Indoleacetonitrile 1 219.506 0.014 
Indoleacetate 1 219.506 0.014 
alpha-Aminopropiononitrile 1 219.506 0.014 
gamma-Amino-gamma-
cyanobutanoate 
1 219.506 0.014 
3-Oxoacyl-CoA 2 215.934 0.015 
L-Alanine 10 213.508 0.016 
(R)-Pantothenate 3 208.207 0.019 
P1,P4-Bis(5'-guanosyl) tetraphosphate 1 205.515 0.020 
Acetoacetyl-CoA 2 205.371 0.020 
sn-Glycerol 3-phosphateM 1 195.555 0.025 
PhosphatidylglycerophosphateM 1 195.555 0.025 
L-Asparaginyl-tRNA(Asn)M 1 19.399 0.026 
Lanosterol 2 192.666 0.027 
Maltose 4 191.555 0.028 
3-(4-Hydroxyphenyl)pyruvate 5 186.728 0.031 
(3S)-3-Hydroxyacyl-CoA 1 183.605 0.033 
3-Dehydroquinate 1 181.164 0.035 
3-Dehydroshikimate 1 181.164 0.035 
Shikimate 1 181.164 0.035 
Shikimate 3-phosphate 1 181.164 0.035 
MIxt 2 180.304 0.036 
Isopentenyl diphosphate 3 17.579 0.039 
a The number of genes associated with the feature 
b The Z-score indicates how many standard deviation an observation is above or 
below the average 
c The probability of the observed transcriptional response to be random 
 
 
